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MOPS 3-[N-Morpholino] propanesulphonic acid 
MTT 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide 
PBA Polyclonal B cell activation 
PBL Peripheral blood lymphocyte 
PBS Phosphate buffered saline 
PC Phosphorylcholine 
PE Phycoerythrin 
PFA Paraformaldheyde 
PHA Phytohaemagglutinin 
PI Propidium iodide 
PMA Phorbol myristate acetate 
PtC Phosphatidyl choline 
RF Rheumatoid factor 
RPMI Roswell Park Medical Institute 
RT Room temperature 
SA Streptavidin 
SA-CyChrome Streptavidin-CyChrome 
s.e.m. Standard error of the mean 
sheath fluid Osmosol 
sIgM Secreted IgM 
SLE Systemic lupus erythematosus 
SPF Specific pathogen free 
SRBC Sheep red blood cell 
SSC Side Scatter 
TCR T cell receptor 
TD T-dependent 
tem Transmission electron microscope 
TH T helper  
TI T-independent 
TLR Toll-like receptor 
 
Note 1: The B-1 and B-2 descriptors were initially intended to be used to 
describe the cells arising from different lineages although they have been used by 
many investigators to describe the phenotype of the cells (Hayakawa et al., 
2000). In this thesis, the terms will be used to describe the phenotypes of the cells 
as either CD5+ B cells (B-1) or CD5-/conventional B cells (B-2). 
 
Note 2: Populations referred to as “control” in this thesis describe non-stimulated 
populations. 
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Abstract 
 
Periodontal disease is one of the most widespread diseases in humans and is 
characterised by chronic gingival inflammation and B cell accumulation and resorption 
of the crest of alveolar bone with subsequent loss of teeth. Porphyromonas gingivalis 
has been identified as a putative aetiological agent for periodontitis. 
 
The aim of the research presented in this thesis was to investigate, using in vitro 
systems, the responses of autoreactive B-1 and B-2 cells to enterobacterial and non-
enterobacterial lipopolysaccharide (LPS) to shed light on the pathogenesis of chronic 
periodontitis and other diseases involving B cell accumulation and autoantibody 
production. 
 
The hypotheses tested were: 
(1) B cells respond differently to enterobacterial and non-enterobacterial LPS. 
(2) B-1 cells are activated by a lower concentration of LPS than B-2 cells. 
(3) LPS stimulation results in preferential accumulation of B-1 cells. 
 
Findings consistent with these hypotheses would provide new evidence for different 
roles for B-1 and B-2 cells in immune responses and that LPS stimulation could lead to 
B-1 cell accumulation in diseases thus characterised. 
 
Initial experiments investigated the responses of representative B-1 (CH12) and B-2 
(WEHI-279) cell lines to preparations of P. gingivalis and Salmonella enteritidis LPS 
utilising flow cytometric and quantitative molecular methods. The cell lines responded 
differently to the two LPS preparations. There were significant but limited effects on 
viability and proliferation in the WEHI-279 cell line, but no significant changes in 
mRNA expression levels for genes including Toll-like receptors (TLR2, TLR4, RP105), 
immunoglobulin (IgM), cytokines (IL-6, IL-10), co-stimulatory molecules (CD80, 
CD86), and regulators of apoptosis (Bcl-2, Bax). In the CH12 cell line however, LPS 
stimulation had greater effect. Addition of S. enteritidis LPS from a threshold level of 
100ng/mL was found to rescue the cells from death, reflected by the percentage viability 
and proliferation. Stimulation of CH12 cells with S. enteritidis LPS also led to a 
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decrease in expression of RP105 mRNA, which may be part of a negative feedback 
loop. 
 
Interestingly, stimulation with low concentrations P. gingivalis LPS appeared to inhibit 
proliferation but high LPS concentrations stimulated proliferation of CH12 cells, 
although no further significant effects were noted in other analyses. 
Evidence was found that CH12 cells have a high basal level of activation. This suggests 
that this line is constitutively activated. Stimulation with P. gingivalis or S. enteritidis 
LPS did not affect the level of CD80 mRNA expression. It is possible that the CH12 
line constitutively expresses a maximal level of CD80 (and possibly CD86) and further 
stimulation will not cause any increase. 
 
Since S. enteritidis LPS appeared to have more pronounced effects on both B cell 
populations, this LPS was used to further investigate B cell subset responses in a mixed 
splenocyte culture system. Experiments examining percentage viability and number of 
viable cells indicated that B-1 and B-2 B cells responded differently to LPS stimulation. 
A threshold level for B-2 cell response (significant increase in cell number) was found 
to be 100ng/mL LPS, in contrast to the B-1 B cell subset which were only significantly 
different to the unstimulated cells when stimulated with 50µg/mL LPS. By examining 
the expression of CD80, the majority of murine splenic B-1 cells were found to 
activated prior to any LPS stimulation in vitro. In contrast, the B-2 subset showed 
significant increase in CD80 expression only at high (≥10µg/mL) LPS concentrations. 
Studies of the division index of B-1 and B-2 cells showed a significant response in both 
subsets following stimulation with 1µg/mL and 10µg/mL LPS. However, overall, the 
results are inconsistent with LPS driving the preferential accumulation of B-1 cells in 
disease states. 
 
These experiments provided useful evidence that supported the idea that B-1 and B-2 
cells respond differently to LPS. However, these studies were unable to directly address 
the role of P. gingivalis LPS in periodontitis. It may be that P. gingivalis LPS could 
have different effects to S. enteritidis LPS on primary B cells. It is still possible that B-1 
cells may be more sensitive to P. gingivalis, as opposed to S. enteritidis LPS.  
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Studies by other groups have suggested that the TH1/TH2 profile is skewed towards TH2 
in chronic periodontitis and that P. gingivalis may drive this shift via its ability to signal 
through TLR2 (and modulate TLR4 signalling). Further, recent studies in our 
laboratories have found that P. gingivalis gingipains are able to polyclonally activate B 
cells and to break down both IFNγ and IL-12. Future studies should further examine the 
effects of B-1 and B-2 interactions in the mixed lymphocyte system together with 
subsequent studies utilising human periodontitis biopsies. 
 
The results presented in this thesis, together with work undertaken by other 
investigators, suggests that LPS could perturb the normal homeostatic mechanisms of 
the B-1 B cell-subset and increase polyclonal activation therefore contributing to the 
genesis of pathologies such as chronic periodontitis. 
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Preface 
Response to Examiners’ Comments 
 
 
This revised thesis has been prepared in response to comments from three examiners. 
The consensus points between the three examiners were the main drivers of revision 
work undertaken. These points were: 
1) A greater alignment of the studies and theory towards chronic periodontitis. 
This included retitling the thesis to better reflect the material covered and the 
use of LPS from Porphyromonas gingivalis, an oral pathogen implicated in 
the pathogenesis of chronic periodontitis (Van Dyke and Serhan, 2003), in the 
cell line studies; 
2) The inclusion of a B-2 (CD5-) B cell line for comparison with the CH12 CD5+ 
B cell line studies; 
3) Reanalysis of previously presented data, where appropriate, to enhance the 
clarity of presentation; and 
4) Further studies utilising purified murine B-1 and B-2 B cells, possibly from 
the spleens of foetal mice. 
 
No issues arose in dealing with the first three points listed above, and these additional 
studies and reanalyses were undertaken as presented in this thesis. However, there were 
a number of problems regarding the animal studies suggested. Preliminary trials into 
isolation of B-1 cells using magnetic beads resulted in very low yields (see Appendix 
2). Therefore a large number of mice would need to be sacrificed to gain sufficient cells 
for study and this could not be justified. Further, increasingly severe responses to mice 
and asthma affecting the candidate precluded further animal work. Additional molecular 
studies examining viability, activation and LPS receptors were undertaken to enhance 
the B-1 and B-2 cell line studies utilising Salmonella enteritidis and Porphyromonas 
gingivalis LPS. 
An extensive reorganisation of the theoretical and experimental studies was also 
undertaken to better deal with the hypotheses in the light of the greater emphasis on 
chronic periodontitis. 
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 Problem Outline 
 
Periodontitis is a disease of the oral cavity occurring in approximately 10% of the 
population in early (Ripamonti, 1988) and modern humans (Clarke, 1990). 
Advanced/chronic human periodontitis is considered to be B lymphocyte and plasma 
cell lesion (Okada et al., 1983; Tew et al., 1989; Gemmell and Seymour, 1991). A large 
proportion of B lymphocytes found in the lesion are CD5+ (Sugawara et al., 1992). 
 
B cells have been divided into two groups; B-1 and B-2 B cells. B-1 cells are CD5+, 
self-renewing in the periphery, producers of IgM polyreactive antibodies and 
concentrated in the peritoneal cavity. By virtue of these characteristics, B-1 cells have 
been postulated to play a major role in the first line of defence against pathogens. 
 
Both B cell subsets produce and secrete antibodies; however the B-1 repertoire is 
restricted when compared with that of the B-2 subset. B-1 cells have been implicated in 
autoimmunity as B-1 cell derived IgM antibody is polyspecific and is able to bind to 
both self and non-self (bacterial) antigens. B-1 cells are generally relatively low in 
number in the peripheral blood, but accumulations of B-1 cells are found in a number of 
autoimmune diseases including Sjögren’s syndrome and rheumatoid arthritis and in 
diseases with postulated and established bacterial aetiology, including chronic 
periodontitis. The mechanisms for this accumulation are unknown at present. 
 
Lipopolysaccharide (LPS) is a stimulus for polyclonal B cell activation, and stimulation 
with enterobacterial and non-enterobacterial LPS has been shown to have different 
effects on a number of different cell types. Porphyromonas gingivalis is a non-
enterobacterial (Bacteroides) species which has been implicated in the pathogenesis of 
chronic periodontitis. Its LPS has been shown to be structurally different to that of 
enterobacterial LPS and to have lower biological activity in the majority of accepted 
functional assays. 
 
The aim of the studies presented in this thesis is elucidation of the response of B-1 and 
B-2 cells to enterobacterial and non-enterobacterial LPS to shed light on the 
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pathogenesis of chronic periodontitis and other diseases involving B cell accumulations 
and autoantibody production. 
To achieve this aim, B-1 and B-2 cell lines, together with purified murine splenic 
lymphocytes were utilised to examine the B cell response to enteric and non-enteric 
bacterial LPS. 
 
The first chapter of the thesis contains a review of the relevant scientific literature and 
provides a background for the experimental work. The immune response to antigen, and 
particularly the roles of B cells and antibodies, is discussed. B cell development and 
activation and the use of cell lines to examine B cell function extend the B cell focus. 
This is followed by a brief discussion of selected diseases characterised by B-1 cell 
accumulation, including periodontitis. The final section of this chapter describes 
systems thinking and the application of the systems perspective to immunological 
studies and those presented herein. This provides an appreciation of the immune 
response as a system which is essential for an understanding of it roles and properties. 
 
The experimental work is divided into four chapters. In the first of these (Chapter 2), the 
response of the CH12 CD5+ B cell line to Salmonella enteritidis and Porphyromonas 
gingivalis LPS is described. In the second experimental chapter (Chapter 3), the 
response of the WEHI-279 conventional B cell line to S. enteritidis and P. gingivalis 
LPS is described. Both of these chapters examine viability, proliferation and activation 
of the cell lines. The third experimental chapter (Chapter 4) utilises a simplified system 
approach and characterises a simple system to examine B cell responses to LPS. The 
final experimental chapter (Chapter 5) extends this work to examine whether the 
simplified system reflects the response patterns observed in the previously presented 
cell line studies. Each of the experimental chapters concludes with a brief discussion 
that draws together the main conclusions from the experiments in that chapter. 
 
The final chapter contains a discussion of results from the experimental chapters and the 
relationship of the findings to the scientific literature. In addition, potential avenues for 
future work are discussed. 
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Specific hypotheses 
A number of specific hypothesis were formulated regarding the response of B cell 
subsets to LPS: 
  
H1:  B cell subsets respond differently to enteric and non-enteric LPS  
H2:  B-1 cells are activated by a lower concentration of LPS than B-2 cells 
H3:  LPS stimulation results in preferential accumulation of B-1 cells  
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Chapter 1 Immunity 
 
1.1 Introduction 
The goal of this chapter is to provide a background on the biology of different B cell 
populations and how they may be involved in disease processes. In particular, the 
literature concerning the response of B cells to the bacterial product lipopolysaccharide 
LPS is reviewed, and evidence is presented that a subpopulation of B cells (B-1 cells) 
may be particularly sensitive to LPS stimulation.  
 
1.2 Overview 
With more than a century of scientific research lying between our vantage point and that 
of the pioneers of immunology, it is curious to contemplate the ‘sharp antagonism’ that 
existed between the disciples of Paul Ehrlich and those of Elie Metchnikoff (Hektoen, 
1909). Ehrlich’s followers proposed that antibodies were the principal mediators of 
immunity, while those who subscribed to Metchnikoff’s views held that phagocytic 
cells were paramount. The answer of course, is that both are important and work 
together as part of a complex, integrated system.  
 
The complexity of the immune system is suitably illustrated by the biology of B cells. 
Since the discovery that a discrete population of cells produces antibodies (these cells 
were termed ‘B’ cells because of their origin in the bursa of Fabricius in birds) this 
population has been broken down into multiple subcategories; each having different 
origins and functions. The primary division of B cells is into B-1 and B-2 cells. 
Conventional (B-2) cells originate in the bone marrow in mammals and respond to 
protein and non-protein antigen after receiving help from T cells. In contrast, B-1 cells 
are self-replenishing and produce antibodies in the absence of help from T cells. Not 
only are the antigens recognised by these different B cell populations distinct, the 
antibodies produced by them may also have very different roles in immune responses.  
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The bacterial product LPS is an important immune activator and B cell antigen. LPS has 
been well described as being a mitogen for B cells. Despite considerable study on the 
mechanism of action of LPS, as well as its effects on diverse immune cells, it is unclear 
if there are differences in the ability of LPS to activate B-1 and B-2 cells. Furthermore, 
the LPS from individual species of bacteria, although sharing many structural 
similarities, may be significantly different in terms of biological activity. Little is known 
on how LPS derived from different species of bacteria affects B cells. 
 
Given the wealth of evidence demonstrating the distinct behaviour and functions of B-1 
and B-2 cells, it seems possible that these two cells types may have different 
sensitivities to LPS. If indeed this is case, differential sensitivity to LPS could have an 
impact on the way in which immune responses develop. Furthermore, inappropriate 
immune responses to LPS could lead to disease states. Periodontitis is potentially one 
such disease.  
 
1.3 B cells and antibody in immune responses 
The production of antibodies by B cells is one process by which the immune system can 
target effector mechanisms to specific antigens. Antigen specificity is provided by the 
V-region of the antibody, which potentially has extraordinary variability between 
molecules. This is then linked, in the same molecule, to an effector region (the Fc 
portion), which is able to direct conserved effector mechanisms to the antigen. 
 
Antibodies do not simply direct effector mechanisms to antigen. The existence of 
different classes of immunoglobulin, with alternate conserved Fc regions, allows the 
antibody response to be directed towards functionally distinct effector mechanisms. 
This occurs when naïve B cells expressing IgM receive appropriate signals and switch 
their Fc region to alternate isotypes.  
 
1.3.1  T-dependent responses 
The antibody response to most proteins comes primarily from conventional (B-2) cells. 
These cells bind antigen via their B cell receptor (BCR) and present it to cognate T cells 
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in lymphoid tissues. The T cell then provides signals that cause the B cell to become 
activated, to proliferate and finally to differentiate into effector cells. 
 
1.3.1.1 Initiation of immune responses 
Presentation of antigen to naïve T cells is a critical step in the induction of a typical 
thymus-dependent antibody response. This is the checkpoint at which the ‘decision’ to 
respond to an antigen, or not, is made. The most important cell in this initial process is 
the dendritic cell (DC). These cells are very powerful initiators of T cell responses 
(McKeever et al., 1992). Upon contact with pathogens (De Smedt et al., 1996; 
Sparwasser et al., 1998) or ‘danger’ signals derived from the tissue (Gallucci et al., 
1999), they become activated. Activation leads to the stable expression of antigen-MHC 
class II complexes on their surfaces (Cella et al., 1997), as well as the induction of 
costimulatory molecules B7-1 (CD80) and B7-2 (CD86) (De Smedt et al., 1996; 
Gallucci et al., 1999). After activation, dendritic cells migrate to the T cell areas of 
lymphoid tissues (De Smedt et al., 1996) where they interact with B cells (Garside et 
al., 1998). 
 
Not only do the initial responses of the immune system to an antigen/pathogen 
determine if an immune response will occur, they also influence the modality of the T 
cell (and therefore the overall) response. It has been recognised for decades that there is 
a division in the effector phases of immunity into cellular and humoral arms (Parish, 
1972). The cellular basis of this dichotomy was explained in the late 1980s, by 
Mosmann et al., who identified two classes of T helper cell based on their secreted 
cytokine profiles (Mosmann et al., 1986). So-called T helper 1 (TH1) cells are primarily 
involved in cell-mediated immune responses and produce IFN-γ, TNF-β and IL-2. In 
contrast, TH2 cells stimulate the production of antibody by secreting IL-4, IL-5, IL-6 
and IL-13. These two populations cross-regulate each other’s activity (Chretien et al., 
1990; Hasbold et al., 1999). TH1 responses occur in response to intracellular pathogens 
(Hsieh et al., 1993) and are characterised by the activation of macrophages (Stout and 
Bottomly, 1989) and the development of delayed-type hypersensitivity (Cher and 
Mosmann, 1987). Infections with extracellular pathogens, however, result primarily in 
TH2 development and production of antibodies with isotypes such as IgG1 and, in 
extreme cases, IgE (reviewed in Sher and Coffman, 1992). This division of T cell 
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function into TH1/ TH2 is now regarded as overly simplistic (Kelso, 1995), however the 
classification is still useful when interpreting the development of many effector 
functions. 
 
The development of TH1 or TH2 responses depends critically on the early immune 
response. During the initial phases of an immune response, antigen-specific T cells 
secrete a mix of TH1 and TH2 cytokines. These uncommitted cells are termed TH0 cells 
(Street et al., 1990). Activation by DC, as well as the influence of early cytokines, in 
particular IL-12 and IL-4, causes differentiation of TH0 cells into TH1 and TH2 cells 
respectively. If TH0 cells are activated and exposed to IL-12, then T cells become 
committed to IFN-γ production (Seder et al., 1993). In contrast, early IL-4 production 
leads to TH2 polarisation (Le Gros et al., 1990).  
 
The ability of B-2 cells to produce antibodies of different isotypes is a crucial feature of 
the B cell response. Isotypes of different classes are able to link antigen to different 
effector mechanisms. For example, the production of IL-4 by TH2 cells causes the 
production of IgE (Hasbold et al., 1998; Snapper & Paul, 1987). IgE binds specifically 
to FcεRI on mast cells and is involved in the response to parasites (Matsuda et al., 
1990). Alternatively, TH1 cell derived IFN-γ, while weakly enhancing B cell 
proliferation, selectively drives IgG2a production (Hasbold et al., 1999; Snapper & 
Paul, 1987).   
 
1.3.1.2 Foci, germinal centres and bone marrow 
The initial interaction between T cells and B cells occurs in the T cell areas of the 
lymphoid tissue. In the spleen this is the periarteriolar lymphoid sheath (PALS) (Jacob 
et al., 1991), while in the lymph node this occurs in the medulla (Garside et al., 1998). 
After presentation of antigen, T cell help causes B cell division and subsequent 
differentiation to antibody production (Jacob et al., 1991; Jacob and Kelsoe, 1992). 
 
Antibody forming foci dominate the early primary response. They are composed of 
oligoclonal aggregates of antibody-forming cells (AFC) in the PALS. The cells in these 
foci have V genes that are in germline configuration (Jacob et al., 1991; Jacob and 
Kelsoe, 1992; Jacob et al., 1993). Their main function is the immediate production of 
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antibody in an infection, and to allow antigen trapping by follicular dendritic cells (Song 
et al., 1998). 
B cell affinity maturation occurs in the germinal centres. Germinal centres reach a peak 
in size around day 10-12 and remain after the foci disappear (Jacob et al., 1991). In the 
GC reaction, B cells undergo hypermutation of their V genes (Berek et al., 1991), and 
Darwinian selection for antigen that is bound to follicular dendritic cells (Berek and 
Ziegner, 1993). B cells that survive the germinal centre reaction leave and either 
become memory cells (Klaus, 1978; Smith et al., 1997) or AFC in the bone marrow 
(Dilosa et al., 1991; Smith et al., 1997). 
 
1.3.2 T-independent responses 
Subsets of B cells can also become activated and can produce antibody in the absence of 
T cell help. The role of this T-independent (TI) antibody is believed to be the provision 
of rapid protection from pathogens. There is more than one form of T-independent B 
cell response, and underlying each kind of response are different cellular pathways. B 
cells may become activated to secrete antibody either by stimulation with polyclonal 
mitogens (TI-1 responses) or by interaction with high molecular weight polymers (TI-
2). Alternatively, ‘natural’ antibody is produced constitutively in vivo, and exists even 
in the absence of exogenous antigen. 
 
1.3.2.1 TI-1 and TI-2 responses 
T independent antigens are subdivided into two categories: T independent-1 (TI-1) and 
T Independent –2 (TI-2). TI-1 antigens are substances that are capable of directly 
causing the activation and proliferation of B cells, regardless of the B cell specificity. 
The best studied of these is LPS. LPS binds to germline-encoded Toll-like receptors on 
B cells and induces activation (see Section 1.5.2.1.3). In contrast, TI-2 antigens 
specifically activate B cells via the BCR, causing them to proliferate in the absence of T 
cell help (reviewed in Mond et al., 1995). TI-2 antigens have characteristic structural 
features; in particular they have repeated identical epitopes. The bulk of TI-2 antigens 
are polysaccharide chains with repeated motifs, and these are believed to activate B 
cells by extensive cross-linking of the BCR, probably with the help of cytokines derived 
from accessory cells ((see Mond et al., 1995), and Section 1.5.2.2).  
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The response to TI-2 antigens shows several noticeable differences when compared to 
the response to thymus-dependent B cell responses (previously discussed in section 
1.3.1). In TI-2 responses in mice, there is minimal germinal centre activity (Weissman 
et al., 1976) and IgM and IgG3 are the primary isotypes produced (Perlmutter et al., 
1978; McLay et al., 2002). The main site of this antibody production is in the 
extrafollicular foci of the spleen (Garcia de Vinuesa et al., 1999). Although in some 
experimental systems the absence of immunological memory was reported (Klaus and 
Humphrey, 1974), in other systems a significant anamnestic response can be 
demonstrated (Kolb et al., 1993).  
 
The antibody produced upon TI-2 activation is important in the early response to 
encapsulated bacteria (McLay et al., 2002), and viruses that have capsids with repeated 
epitopes (Bachmann and Zinkernagel, 1997). In addition, it has recently been argued 
that TI-antibody aids the development of the T-dependent B-2 response (Baumgarth et 
al., 2000). 
 
In contrast to TI-2 antigens, substances that stimulate a TI-1 response have the intrinsic 
ability to cause polyclonal B cell proliferation and antibody production. The best-
characterised TI-1 antigen is LPS (Peavy et al., 1970; Brooks and Vitetta, 1987; Ogata 
et al., 2000). Despite the ability to non-specifically activate B cells, during the in vivo 
response to LPS, increased titres of anti-LPS antibody are produced (Wannemuehler et 
al., 1984). This LPS-specific antibody is important in the clearance of LPS and 
protection from endotoxic shock (Reid et al., 1997). The activation of B cells by LPS is 
further discussed in Section 1.5.2.1. 
 
1.3.2.2 Natural antibodies 
Natural antibodies are present in the serum of animals in the absence of antigenic 
stimulation (Bos et al., 1988; Diaw et al., 1997; Haury et al., 1997). They are produced 
by B cells, yet they are considered to be part of the innate immune system (Fearon and 
Locksley, 1996). They are polyreactive, and most are of the IgM isotype (Diaw et al., 
1997). Despite its typical low affinity, due to its multimeric structure, IgM is able to 
bind with high avidity to polymeric antigens (Brewer et al., 1994). 
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In addition to recognising exogenous antigens, natural antibodies are also reactive with 
intracellular self-antigens (Bouvet and Dighiero, 1998). Natural antibodies found in 
normal human serum have been shown to react specifically with self-proteins including 
tubulin, actin, thyroglobulin, fetuin, albumin, transferrin, cytochrome c and collagen 
(Dighiero et al., 1985). B cells synthesizing polyspecific natural antibodies are present 
in neonatal nude, germ-free, and antigen-free mice (Avrameas, 1991), which suggests 
that the production of these antibodies is constitutive and does not rely on any external 
antigen stimulation for the initiation of production. This ability of natural antibodies to 
bind to intracellular compounds has been argued to fulfil a useful function as 
polyreactive antibodies bind to cellular debris from dying cells, aiding phagocytosis 
(reviewed in Potter and Melchers, 2000). 
 
Natural antibodies which predominate early in life (Diaw et al., 1997; Bouvet and 
Dighiero, 1998), are encoded by immunoglobulin V genes under germinal, or non-
rearranged, configuration (Diaw et al., 1997). An important peculiarity of natural 
antibodies is that they utilise selected VH gene segments, including VHIII, VHIV and 
VHV. These gene segments seem to be most often in unmutated configuration (Casali 
and Notkins, 1989). 
 
Natural antibodies can be considered to be a phylogenetically conserved first line of 
defence against pathogens (Avrameas, 1991; Diaw et al., 1997) and can lead to the 
enhancement of an ongoing specific immune response (Casali and Notkins, 1989). 
Natural antibody has been found to initiate complement activation (Borsos and Rapp, 
1965), and to enhance monocyte phagocytosis (Avrameas, 1991) and neutrophil 
recruitment (Boes et al., 1998) in response to pathogens. As this “primordial antibody” 
system has persisted as a basic mechanism of immunity in higher vertebrates it may 
confer a survival advantage to the animal in the time when more specific defences are 
being initiated and prepared (Dighiero et al., 1985; Bouvet and Dighiero, 1998). In 
essence, it has been believed that natural antibody’s function is to ‘hold the fort’ in the 
stages of the immune response prior to the development of a T dependent immune 
response. Recently however, it has been shown that natural antibodies may play another 
role. In models of virus infection, natural IgM has been shown to be critical for the 
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development of a productive adaptive antibody response (Baumgarth et al., 2000). This 
is also consistent with studies in secretory IgM-/- (sIgM-/-) mice, which showed that 
these mice mount defective T-dependent IgG responses (Boes et al., 1998; Ehrenstein et 
al., 1998), and that this deficit can be repaired by administration of normal serum IgM 
(Ehrenstein et al., 1998). 
 
1.3.2.3 B-1 cells TI-1, TI-2 and natural antibodies 
Discussion of the role of different populations of B cells in the production of T-
independent or natural antibody presents certain difficulties. The definitions of different 
types of antigens are often hazy and many times they overlap. For example, antibodies 
produced to many TI-1 and TI-2 antigens are also included in ‘natural’ antibody. 
Alternatively, LPS, which is a prototypical TI-1 antigen, also has features of TI-2 
antigens such as the presence of a polysaccharide chain with repeated epitopes 
(Paramonov et al., 2001; Parker et al., 2001).  
 
B-1 cells (see Section 1.4.2 for a description of B-1 cells) are argued to be the major cell 
population responsible for the production of TI-1, TI-2 and natural antibodies.  
 
The evidence for B-1 cells being the primary producers of natural antibody is based on 
studies that showed transfer of B-1 cells into irradiated recipients (Kroese et al., 1989) 
or neonatal mice (Forster and Rajewsky, 1987; Lalor et al., 1989) reconstitutes serum 
natural antibody levels. Furthermore, investigation of the B-1 repertoire has shown that 
antibodies produced by these cells recognise a range of natural IgM specificities. These 
include antibodies to phosphorylcholine (PC) (Masmoudi et al., 1990), phosphatidyl 
choline (PtC) (Hayakawa et al., 1984) and influenza virus (Baumgarth et al., 1999). 
Based on depletion experiments (Su et al., 1991), and ELISpot data (Reid et al., 1997), 
B-1 cells appear to be the major source of LPS-specific antibodies. This antibody is 
biologically relevant, as antibody deficient mice have an increased mortality in response 
to LPS when compared to controls (Reid et al., 1997). 
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1.4 B cell development 
Results from many experimental systems have supported the division of B cells into two 
distinct populations. Conventional (B-2) cells predominate in secondary lymphoid 
tissue. They develop late in ontogeny, are derived from the bone marrow and require T 
cell help for antigen-specific proliferation and antibody production. During an immune 
response B-2 cells typically undergo affinity maturation in germinal centres and switch 
isotype. In contrast, B-1 cells are most common in the peritoneal and pleural cavities 
and are self-replenishing. They produce polyreactive IgM (see section 1.4.2), exhibit 
restricted V-gene usage and do not generally undergo somatic mutation (Brezinschek et 
al., 1997). Initially, B-1 cells were defined on their expression of CD5 (Hayakawa et al., 
1983), a cell-surface marker previously associated with T cells. Subsequently it was 
shown that a CD5- population exists, which has many of the characteristics of CD5+ B 
cells. This has led to the further subdivision of B-1 cells into B-1a (CD5+) and B-1b 
(CD5-) populations (Stall et al., 1992). Although uncertain, it seems likely that B-1 and 
B-2 cells represent distinct cell lineages. 
 
1.4.1 Conventional (B-2) cells. 
The development of B-2 cells is well characterised. Committed B cell precursors 
originate from the bone marrow (Li et al., 1996; Allman et al., 1999). There are three 
important phases in early B-2 cell development. Each of these is defined by 
characteristic steps in the development of the BCR. Initially, bone marrow precursor 
cells have germline heavy and light chain genes. These cells are termed pre-pro B cells 
and are identified by their expression of CD45R/B220 (Li et al., 1996; Ogawa et al., 
2000). Using the products of recombination activating gene (RAG)-1 and RAG-2, pre-
pro B cells rearrange their heavy chain genes and express a surface mu chain (Oettinger 
et al., 1990; Mombaerts et al., 1992). Cells at this stage are termed early B cells. B cells 
that fail to make productive rearrangements are deleted. Following heavy chain 
rearrangement, the mu chain is paired with a surrogate light chain (Karasuyama et al., 
1990). It is believed that this is an important checkpoint in the development of the B cell 
and that cells with mu chains that are unable to productively pair with light chains are 
deleted (Gong and Nussenzweig, 1996). Finally, the B cell rearranges its light chain 
genes and pairs them with the heavy chain, thus making a functional BCR. It is at this 
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stage that the B cell is screened for reactivity to self-antigen. Evidence from a number 
of transgenic models suggests that cells that bind to membrane antigen with high 
affinity are deleted, while those cells binding with low affinity to membrane antigens, or 
to soluble antigens, either become anergic or undergo receptor editing (Goodnow et al., 
1988; Nemazee and Burki, 1989; Hartley et al., 1991; Hartley and Goodnow, 1994; 
Lang et al., 1996; Retter and Nemazee, 1998). 
 
1.4.2 B-1 cells 
It is most likely that B-1 cells are derived from a separate lineage to conventional B-2 
cells. The strongest evidence for this comes from studies examining the ability of 
different precursors to repopulate immunodeficient mice. Cells from foetal liver, with 
non-rearranged V-genes, preferentially give rise to B-1 cells, whereas those from adult 
bone marrow produced conventional B cells (Hardy and Hayakawa, 1991; Kantor et al., 
1992). It has also been argued that CD5+ and conventional B cells might represent 
separate cell lineages much like that of αβ (conventional) and γδ T cells (DeFranco, 
1992) in that these subsets show both characteristic repertoires and locations. 
 
The V-gene usage of the different populations also provides evidence for the existence 
of distinct lineages. B-1 and B-2 cells show distinct patterns of V-gene usage, and this, 
in part, may reflect the origins (foetal liver versus bone marrow) of these cells. Human 
IgM+/CD5+ B cells have been found to contain significantly fewer hypermutated VH 
chain genes than IgM+/CD5- B cells (Brezinschek et al., 1997), and most B-1 cells in 
healthy humans carry unmutated V region genes (Fischer et al., 1997). However, CD5+ 
B cells can be somatically mutated (Brezinschek et al., 1997). 
 
The foetal and neonatal B cell repertoire differs qualitatively from that of the adult at 
both the molecular and cellular level (Cuisinier et al., 1989; Schroeder and Wang, 
1990). Human foetal B-lineage cells rearrange a highly restricted set of VH gene 
segments, and there is preferential rearrangement of certain antibody gene segments 
(Schroeder et al., 1987), including VH6 and VH5 (Cuisinier et al., 1989). Typical 
features of the early repertoire are the predominance of B-1 cells, characteristic 
restriction of V gene usage, and limited development of somatic diversity (Kearney et 
al., 1992). This can be seen at the Ig receptor level by the predominant expression of D 
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proximal VH genes in mice (Holmberg, 1987), and similar expression of VHIII family 
members in humans (Kearney et al., 1992).  It has been suggested that this difference in 
repertoire could be due in part to the time constraint placed on the formation of the B-1 
cell repertoire (this appears to be essentially fixed in mice by the onset of sexual 
maturity) (Lalor and Morahan, 1990).  
 
Evidence from mice with altered BCR signalling pathways also supports the existence 
of separate lineages. For example, deletion of positive influences on BCR signalling 
such as CD19 (Rickert et al., 1995; Inaoki et al., 1997), Vav (Tarakhovsky et al., 1995) 
and Btk (Khan et al., 1995) leads to a relative decrease in B-1 cell numbers. In contrast, 
mutation of the negative regulator SHP-1 (Sidman et al., 1986) or overexpression of 
CD19 (Sato et al., 1996), leads to increased B-1 cell numbers in comparison to 
conventional cells. These results imply that BCR signalling has a positive effect on the 
development of B-1 cells, but not B-2 cells. Although it might be assumed that selection 
based on microbial antigens might be important for B-1 development, this appears not 
to be the case.  A highly reactive B-1 cell repertoire develops in germ-free mice, 
demonstrating that the role of bacterial antigens, while possibly influencing the balance 
of the clones, is not the primary selective stimulus mediating formation of the unique, 
multi-reactive repertoire of this lineage (Lalor and Morahan, 1990; Haury et al., 1997). 
It has been argued that this positive signalling event is, in fact, selection for self-antigen 
(Hayakawa et al., 1999; Hayakawa and Hardy, 2000). 
 
In contradiction to the model of B-1 and B-2 early lineage divergence, it has also been 
argued that this divergence occurs late; following V-gene rearrangement. This has been 
termed the ‘induced differentiation hypothesis’ (Clarke and Arnold, 1998). In this 
model, lineage commitment occurs on interaction with antigen, with B-1 cells 
committing to the B-1 lineage when they bind to T-independent antigen in the absence 
of T cell help (Haughton et al., 1993). It has been shown that conventional B cells, 
under certain circumstances, can express CD5 (Weichert and Schwartz, 1997). For 
example, CD5 expression is induced following challenge with TI-2 antigens such as 
anti-Ig (Cong et al., 1991; Wortis et al., 1995). In this model, the ability of the pro-B 
cell to become a B-1 cell is, under normal circumstances, restricted to a defined period 
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in development. Recognition of antigen during this period leads to upregulation of CD5 
and commitment to the B-1a lineage. 
 
1.4.2.1 Splenic and peritoneal B-1 cells 
Studies (Wells et al., 1994; Fischer et al., 2001) have found that murine splenic B-1 
cells, although similar in a number of respects, are different to peritoneal cavity B-1 
cells. Peritoneal B-1 cells express CDllb (Mac-1) (Kantor et al., 1992; Stall et al., 
1992), and some lack CD43, which is expressed on nearly all splenic B-1 cells (Wells et 
al., 1994). Splenic B-1 cells also differ from peritoneal B-1 cells in transcription factor 
(STAT3, CRE-binding activity, PU.1) and gene expression (IL-10) and in signalling for 
cell cycle progression (PMA response) (Fischer et al., 2001). 
 
1.4.2.2 Homeostatic regulation of B-1 cells 
B-1 cells appear to have no self/non-self discrimination. They are a ubiquitous 
population able to bind both self and foreign antigens (Casali et al., 1987; Murakami 
and Honjo, 1995; Diaw et al., 1997) and are self-renewing (Hayakawa and Hardy, 
1988). Self-antigen has been shown to drive B-1 selection, activation, and possibly self-
renewal (Carmack et al., 1990; Lalor and Morahan, 1990; Arnold and Haughton, 1992; 
Hardy, 1992; Chen and Kearney, 1996). This suggests that this subset would be highly 
regulated in vivo to prevent accumulation of these autoreactive cells.  
There are a number of mechanisms by which control of B-1 cells is accomplished, 
although the level of redundancy of these mechanisms, in terms of control is unknown 
at present.  Feedback regulation of B-1 cells has been suggested by Lalor et al. (Lalor et 
al., 1989), and this may be through binding of B-1 cell-derived IgM (O'Garra and 
Howard, 1992; Bandyopadhyay et al., 1995) or CD5/CD72 interaction (Van de Velde et 
al., 1991; Osman et al., 1992; Jamin et al., 1993; Lankester et al., 1994; Bikah et al., 
1996; Jamin et al., 1996; Jamin et al., 1996; Van de Velde and Thielemans, 1996). 
Feedback regulation may be achieved in the same manner as quorum sensing in bacteria 
(reviewed in Withers et al., 2001); once a particular density of B-1 cells has been 
reached, micro-environmental concentrations of IgM or the number of CD5/CD72 
interactions may reach a level which down-regulates self-renewal. Control of B-1 cells 
may also be achieved though cytokine interactions, as B-1 cells have been shown to be 
responsive to regulation by IL-10 (O'Garra et al., 1992; Velupillai et al., 1996) and 
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IFNγ (Chace et al., 1993; Abed et al., 1994). This regulation may have an autocrine 
component, as B-1 cells produce IL-10 (O'Garra et al., 1990; O'Garra et al., 1992). 
However, these control mechanisms can fail, leading to the accumulation of B-1 cells in 
pathologies such as Sjögren’s syndrome (Plater-Zyberk et al., 1989) and chronic 
periodontitis (Sugawara et al., 1992). The role of bacterial mitogens, if any, in this 
breaking of control is not yet fully understood. 
 
1.5 Pathways of B cell activation 
Conventional B cells require T cell help to become activated (see Section 1.3.1). This 
linking of T cell and B cell antigen recognition provides an important checkpoint that 
prevents activation of autoreactive B cells. In contrast to the stereotypical B cell 
response to monomeric protein antigens, some B cells may become activated by cross-
linking of their BCR in a manner that does not require T cell help (TI-2 antigens). This 
typically occurs in response to non-protein antigens, which have repeated epitopes (see 
Section 1.3.2). Further, some antigens such as LPS are capable of activating B cells in a 
non-clonal manner, by binding to germline-encoded receptors (TI-1 antigens, discussed 
below).  
 
While the division of B cell responses into T-dependent, TI-1 and TI-2 is a useful 
categorisation, it must be recognised that it is a simplification. For example, viral capsid 
proteins can form multimeric arrays on the surface of viral particles, and this structure 
can cause T-independent activation of B cells (Bachmann and Zinkernagel, 1997). 
Alternatively, LPS may not only activate B cells via germline-encoded receptors, but by 
virtue of its multimeric structure it also signals via the BCR in specific cells.  
 
1.5.1 CD40 ligation versus BCR cross-linking 
B cells are able to integrate signals from a range of receptors (Wheeler et al., 1993; 
Snapper et al., 1995; Lam et al., 1999). The two best-characterised influences on B cell 
activation are B cell receptor (BCR) cross-linking and co-stimulation from T cells (via 
CD154/CD40L). At one end of the spectrum, in T-dependent responses, stimulation 
leading to activation and proliferation may be provided solely by CD154 on cognate T 
cells (Hasbold et al., 1998; Lam et al., 1999). Between these two extremes lies a 
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spectrum of stimuli that can lead to activation (Bachmann and Zinkernagel, 1997). 
Complex intracellular pathways are capable of integrating the signals resulting from 
various stimuli. This integration ultimately leads to different outcomes such as 
proliferation, rescue from apoptosis, isotype switching or tolerance. 
 
The membrane protein CD154 (CD40L) is capable of causing activation and 
differentiation of B-2 cells. It is expressed on activated T cells and binds to CD40 on B 
cells (Hasbold et al., 1998; Lam et al., 1999). In most T-dependent responses where the 
antigen is not polyvalent, the BCR appears primarily to function as a means of focusing 
antigen into the MHC class II compartment, thus allowing increased presentation to T 
cells (Rock et al., 1984; Song et al., 1995; Cook et al., 1998). Cells that have the 
highest affinity for antigen are able to garner the most T cell help (Batista and 
Neuberger, 1998).  Antigen presentation and co-stimulatory signalling via CD28 causes 
increased activation of the T cell. In turn, expression of CD154 on T cells is upregulated 
(Johnson-Leger et al., 1998; Yin et al., 1999), which further activates the B cell. The 
specificity of the interaction between antigen-presenting cells and T cells is achieved 
due to the polarised nature of the interaction, which has been termed the 
‘immunological synapse’ (Grakoui et al., 1999).  
 
In contrast to the typical T-dependent response, some B-2 cells are capable of being 
activated by BCR cross-linking alone (Monigini et al., 1992; Fehr et al., 1996; Garcia 
de Vinuesa et al., 1999).  
 
The response of B-1 cells to BCR ligation is very different to that which occurs in B-2 
cells. Ligation of the BCR on B-1 does not induce proliferation (Rothstein and Kolber, 
1988; Morris and Rothstein, 1993; Bikah et al., 1996; Wong et al., 2002), and may 
(Murakami et al., 1992) or may not (Morris and Rothstein, 1993) induce these cells to 
apoptose.  
 
1.5.1.1 BCR/CD40 intracellular signalling pathways 
The signalling complexes of BCR and CD40 molecules belong to the family of 
receptors termed the ‘multi-chain immune recognition receptors’ (MIRR). Individual 
members of this family of receptors have multiple chains that associate together on the 
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surface of the cell to signal. The BCR, for example, is composed of an antibody-like 
antigen-binding domain that is complexed to two types of signalling chain, the α and β 
chains. These signalling chains have a characteristic amino acid motif, termed the 
immunoreceptor-tyrosine-based activation motif (ITAM). Receptor aggregation causes 
cytoskeletal interactions (Holowka et al., 2000) and translocation of the MIRR to 
discrete regions of the membrane, termed lipid rafts, which contain signalling kinases 
(Field et al., 1997; Cheng et al., 1999). These kinases phosphorylate tyrosine residues 
within the ITAM, which allows docking of intracellular signalling proteins that contain 
the Src-homology-2 (SH2) domain. Docking of the SH2 domain cause activation of 
multiple signalling pathways (Bevan and Baumgartner, 1996). 
 
B cell receptor signalling may be modulated by co-ligation of different co-receptors. For 
example, co-ligation of the complement receptor 2 complex to the BCR decreases the 
activation threshold of the cell (Carter and Fearon, 1992; Dempsey et al., 1996). 
Alternately, co-ligation of the inhibitory FcγRIIb1 complex to the aggregated BCR 
increases the activation threshold; this is mediated by the recruitment of 
immunoreceptor tyrosine-based inhibitory motifs (ITIMs) to the signalling complex 
(Sinclair, 2000). Phosphorylation of tyrosine residues on ITIMs causes the recruitment 
of inhibitory signalling molecules such as SHP-1 (Plas et al., 1996). 
 
1.5.1.1.1 CD5 signalling in B cells 
It appears likely that the CD5 expressed on B-1 cells is involved in negative regulation 
of B-1 cell activation. Splenic B-2 cells from mice deficient in CD5 proliferated 
normally in response to CD40 ligation, BCR cross-linking (anti-IgM) or LPS (Bikah et 
al., 1996). Peritoneal B-1 cells also proliferated normally in response to CD40 ligation 
or LPS stimulation. However, in response to BCR cross-linking, B-1 cells from CD5-/- 
mice not only failed to apoptose, but also underwent proliferation (Bikah et al., 1996). 
Further evidence for the role of CD5 comes from experiments involving co-ligation of 
CD5 and the BCR. In the presence of CD5, murine peritoneal cavity B cells do not 
proliferate in response to anti-IgM, but proliferate after cross-linking with anti-CD5 
(Jamin et al., 1996).  
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The biological significance of CD5-mediated signalling appears to be the down-
regulation of autoimmune B cell activation.  In a system in which CD5-/- mice were 
crossed with transgenic mice expressing both hen egg lysozyme (HEL) as well as HEL-
specific B cells, CD5+ B cells were found to be anergic (Hippen et al., 2000).  
 
The molecular mechanisms underlying CD5 inhibition of BCR-induced activation are 
not completely understood, and much of the evidence comes indirectly from studies of 
CD5 function in T cell biology. As with B cells (Lankester et al., 1994), CD5 in T cells 
associates with the antigen receptor (Burgess et al., 1992). In the absence of CD5, 
immature T cells are hyperresponsive to TCR stimulation (Tarakhovsky et al., 1995). 
Following TCR ligation, residues in an ITIM-like domain in the CD5 molecule become 
phosphorylated (Burgess et al., 1992), which presumably leads to recruitment of 
inhibitory molecules such as SHP-1. Co-ligation of the BCR and CD5 also leads to 
phosphorylation of the CD5 molecule, however neither SHP-1 nor SHIP becomes 
associated with the phosphorylated CD5 (Gary-Gouy et al., 2000). Whatever the details 
of the intracellular signalling cascade, it appears that CD5 may increase B-1 cell 
survival due to autocrine production of IL-10 (Gary-Gouy et al., 2002). 
 
Jamin et al. postulated that, in association with CD4/CD29, CD5 is involved in 
CD5+B/CD5+ B cell interactions in non-organ-specific autoimmune diseases (Jamin et 
al., 1993). It seems likely that in CD5+ cells, interaction of CD5 with its ligand CD72 
(Van de Velde et al., 1991) modulates signals transmitted through the BCR (Jamin et 
al., 1996). CD72 is a non-redundant regulator of B cell development and is a negative 
regulator of B cell activation. CD72-/- B cells are hyperproliferative in response to 
various stimuli (Pan et al., 1999). 
 
1.5.2 Polyclonal Activation 
Polyclonal B cells activators (PBAs) are able to activate B cells without the requirement 
for T cell help, using non-Ig surface receptors (Clagett and Engel, 1978). These T-
independent (TI) antigens include dextran sulphate, purified protein derivative of 
tubercle bacteria, Nocardia opaca water-soluble mitogen, and bacterial LPS in the 
murine system and Epstein-Barr virus (EBV) in the human system (Kettman and 
Wetzel, 1980; Casali and Notkins, 1989). LPS has also been found to be a polyclonal 
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activator for malignant (Baeker and Rothstein, 1986) and normal human B cells 
(Ringden et al., 1977; Hammarstrom et al., 1980; Matsushima et al., 1985; Gaidano et 
al., 1989; Settmacher et al., 1990). The effects of polyclonal activation include cytokine 
secretion, Ig production and differentiation (reviewed in Clagett and Engel, 1978). 
Polyclonal B cell activation could provide a selective advantage to the host as it 
provides a (non-specific) first line of defence against invading pathogens. In particular, 
the activation of B-1 cells that secrete polyreactive antibodies may be important. 
Polyclonal B cell responses may be protective in that polyvalent IgM may effectively 
bind to polymeric B cell activators of microbial origin and promote the activation of 
complement and the mobilisation of effector cells. 
 
Although the activation of B-1 cells by PBAs may be beneficial in an immune response, 
long-term exposure to PBAs could result in the destruction of host tissues through 
uncontrolled polyclonal B cell responses and autoantibody production (Abed et al., 
1994). For example, infection with Actinomyces viscosus is associated with plasma-cell 
rich inflammatory gingival disease and chronic inflammatory lesions of other soft 
tissues. A. viscosus produces a PBA that induces proliferation, Ig synthesis and 
differentiation of murine B cells into plasma cells (Clagett and Engel, 1978). 
 
1.5.2.1 LPS signalling 
Many of the components of the mammalian innate immune system are conserved across 
classes and even phyla. In Drosophila melanogaster, the protein encoded by the toll 
gene induces the innate anti-fungal immune response (Lemaitre et al., 1996). The plant 
tobacco mosaic virus resistance gene encodes a protein very similar to Toll, and it 
appears that the immune-response system mediated by Toll represents an ancient host 
defence mechanism (Medzhitov et al., 1997). The insect host defence involves synthesis 
of antimicrobial peptides by the fat body and secretion into the haemolymph. 
Drosophila melanogaster produces seven distinct antimicrobial peptides, allowing it to 
discriminate between various groups of microorganisms and to mount a response 
appropriate to the invading microorganism (Tauszig et al., 2000). 
 
A human homologue of dToll (hToll) was cloned, expressed, and characterised by 
Medzhitov et al in 1997. It was shown to have homology with Drosophila Toll (dToll) 
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over the entire length of the protein chains (Medzhitov et al., 1997). The extracellular 
domain of hToll contains 21 tandemly repeated leucine-rich motifs separated by a non-
leucine-rich repeat region (LRR), similar to dToll. At the N-terminal end of the LRR 
domain there is a 31 amino acid long N-flanking region, while the C-terminal end of the 
LRR domain is flanked by a cysteine-rich domain, which is also present in dToll. The 
cytoplasmic domain is homologous to that of the human IL-1 receptor (Medzhitov et 
al., 1997).  
 
Although initially identified in the field of developmental biology for their role in 
Drosophila dorsoventral patterning (Anderson et al., 1985), Toll-like receptors (TLR) 
have subsequently been shown to have a critical role in the immune system. A number 
of individual TLR have been identified, and each has a distinct specificity for pathogen-
derived products. These include flagellin (TLR5) (Hayashi et al., 2001), dsRNA (TLR3) 
(Alexopoulou et al., 2001), lipopeptides (TLR2 homodimers) (Ozinsky et al., 2000), 
peptidoglycan (TLR2/6 heterodimers) (Ozinsky et al., 2000), unmethylated CpG motifs 
(TLR9) (Hemmi et al., 2000) and LPS (TLR4) (Poltorak et al., 1998; Poltorak et al., 
1998). 
(For the purpose of continuity a more detailed discussion of TLRs in appended to this 
document as Appendix 4.) 
 
1.5.2.1.2 TLR4 is the major LPS receptor 
As early as the 1960s, the C3H/Hej mouse strain was identified as being resistant to the 
effects of LPS (Heppner and Weiss, 1965). This deficit was later attributed to a single 
genetic locus, termed Lps (Watson and Riblet, 1974). In 1998, it was demonstrated that 
TLR4 correlated with the Lps gene, and that TLR4 is primarily responsible for immune 
responses to LPS (Poltorak et al., 1998; Poltorak et al., 1998; Hoshino et al., 1999). The 
mammalian Tlr4 gene was identified as a candidate for Lps (Poltorak et al., 1998), and 
it was later confirmed that Lps is identical to Tlr4 (Poltorak et al., 1998) and that TLR4 
is the gene product that regulates LPS responses (Hoshino et al., 1999). Further studies 
determined that TLR4 is the predominant receptor for LPS in human blood (Tapping et 
al., 2000).  
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It is unclear at present whether LPS binds directly to TLR4, or whether it acts in concert 
with CD14. Early binding studies (Kirkland et al., 1990; Wright et al., 1990) and 
evidence from CD14 deficient mice (Haziot et al., 1996), implicated CD14 as the 
principal LPS binding protein. More recently, CD14 has been shown to co-localise with 
TLR4 following LPS binding (Jiang et al., 2000). However, it has also been suggested 
that TLR4 alone is capable of binding LPS (Poltorak et al., 2000). 
 
1.5.2.1.3  TLR2 as an LPS receptor 
The role of TLR2 in LPS signalling is unclear. Early studies using LPS derived from 
enterobacterial species suggested that TLR2 was a receptor for LPS (Kirschning et al., 
1998). However, subsequent reports argued that this result was artifactual, and that 
TLR2-dependent LPS signalling results from “endotoxin protein” contamination in 
some LPS preparations (Hirschfeld et al., 2000). Further, work by Schwandner et al. 
showed that TLR2 is a receptor for soluble peptidoglycan and lipoteichoic acid 
(Schwandner et al., 1999; Yoshimura et al., 1999); both cell wall components of Gram-
positive bacteria. More recently however, it has been found that highly-purified LPS 
from Porphyromonas gingivalis is capable of activating macrophages from C3H/Hej 
mice (Kirikae et al., 1999; Hajishengallis et al., 2002), and that differential signalling 
occurs in response to P. gingivalis, as opposed to TLR4-dependent E. coli LPS 
(Hirschfeld et al., 2001; Hajishengallis et al., 2002). Indeed, not only does P. gingivalis 
LPS appear to signal solely through the TLR2, it is able to antagonize signalling 
through TLR4 (Yoshimura et al., 2002). 
 
1.5.2.1.4  RP105: A B cell-specific LPS receptor? 
In addition to TLR2 and TLR4, it is appears that a third receptor, RP105, is important in 
the activation of B cells in response to LPS. RP105 is a cell surface protein belonging to 
the leucine rich repeat protein family (Miyake et al., 1995); the family to which TLR 
belong. The significance of RP105 in B cell activation/survival was first recognised 
when it was reported that B cells stimulated with anti-RP105 antibodies were resistant 
to irradiation- or dexamethasone-induced apoptosis (Miyake et al., 1994), but sensitised 
to anti-IgM induced apoptosis (Yamashita et al., 1996). Recently it was shown that B 
cells from mice deficient in RP105 respond poorly to E. coli LPS, which demonstrates 
that this RP105 is important in LPS signal transduction in B cells (Ogata et al., 2000). 
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However, it was also found that RP105-dependent signalling also requires the presence 
of TLR4 (Ogata et al., 2000) and the accessory molecule MD-1 (Miura et al., 1998; 
Nagai et al., 2002). This argues that RP105 and TLR4 work in concert in B cells to 
specifically recognise LPS. Interestingly, in contrast to cells of the 
monocyte/macrophage lineage, B cells express very low levels of TLR4 but high levels 
of RP105 (Akashi et al., 2000; Zarember and Godowsdi, 2002). 
 
1.5.2.1.5  Intracellular TLR signalling pathways 
Toll-like receptors have considerable structural and functional similarities to the IL-1 
receptor (O'Neill and Greene, 1998). As with the IL-1 receptor, TLR4 signalling is 
dependent upon association of the leucine-rich repeat domain with MD-2 (Shimazu et 
al., 1999). This interaction initiates recruitment of the adaptor proteins MyD88 and 
IRAK (Wesche et al., 1997; Medzhitov et al., 1998). Following this, a cascade, 
involving TRAF6 and NIK, culminates in NF-κB activation (Cao et al., 1996). The 
critical role of MyD88 in B cell activation in response to LPS has been demonstrated in 
mice deficient in this molecule. In knockout mice B cells both failed either to proliferate 
or to express increased levels of MHC class II in response to LPS (Kawai et al., 1999). 
TLR2 signalling pathways appear to be different to those activated by TLR4, with 
activation of NF-κB occurring via an alternate pathway involving Rac-1 (Arbibe et al., 
2000). 
 
1.5.2.1.6 Enteric and non-enteric LPS  
It has been suggested that enteric and non-enteric LPS have different chemical 
properties (Kirikae et al., 1999) and can elicit different patterns of adaptive immunity 
(Pulendran et al., 2001). A number of groups have found that the LPS of P. gingivalis 
has a far more moderate endotoxic activity than the LPS from enterobacteria (Nair et 
al., 1983; Fujiwara et al., 1990). Tanamoto (1997) postulated that these differences in 
activity were due to differences in the lipid A moieties between P. gingivalis and 
enterobacteria; the lipid A of P. gingivalis was found to consist of unique branched fatty 
acids with longer carbon-atom chains than those of enterobacteria (Tanamoto et al., 
1997) 
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1.5.2.1.7  Differential responsiveness of B-1 and B-2 cells? 
It may also be that B-1 and B-2 cells differ in their responsiveness to PBAs, with B-1 
cells reported to be much more sensitive to low concentrations of LPS (Chace et al., 
1993). Since B-1 cells produce polyreactive antibodies that are involved in the early 
response to pathogens, preferential activation of these cells is likely to be an important 
protective response.  
 
1.5.2.2 Cytokine control of polyclonal B cell activation 
In addition to stimulation via the BCR or Toll-like receptors, B-1 cells are sensitive to 
the effects of numerous cytokines. Foremost among these is interleukin 10. 
Unstimulated peritoneal B-1 cells produce significant amounts of IL-10 (O'Garra et al., 
1992). This possibly results from co-ligation of the BCR and CD5 (Gary-Gouy et al., 
2002). Importantly, blocking of IL-10 by the administration of anti-IL-10 antibodies 
leads to an absence of peritoneal B-1 cells; however, it is not clear whether this is a 
entirely a direct autocrine activation effect of IL-10, as it is at least partly due to the 
removal of IL-10-mediated inhibition of IFN-γ (Ishida et al., 1992), and there are 
normal numbers of B-1 cells in IL-10 deficient mice (Kuhn et al., 1993). Interestingly, 
IL-10 expression has been reported to be higher in B-1 compared to B-2 cells (O'Garra 
et al., 1992; O'Garra and Howard, 1992). It has also been suggested that the IL-10 
stimulating B-1a cells may come from other sources such as T cells or myeloid cells 
(Nisitani et al., 1998). Further, it is uncertain whether IL-10 acts directly on B-1 cells or 
makes them more sensitive to the actions of other cytokines (Rousset et al., 1992; 
Fluckiger et al., 1994; Balabanian et al., 2002). 
 
Despite the uncertainty of its mechanism of action, IL-10 has been clearly implicated in 
B-1 cell activation and autoantibody production in a number of in vivo systems. In a 
transgenic anti-erythrocyte (self) mouse model, administration of exogenous IL-10 
causes both activation of peritoneal B-1 cells and autoantibody production (Nisitani et 
al., 1995), while anti-IL-10 administration in Fas-deficient, anti-erythrocyte transgenic 
mice prevented autoantibody production (Watanabe et al., 2002). Moreover, IL-10 
mediates expansion of the B-1 population in response to polysaccharide antigens 
(Velupillai et al., 1996).  
 
Chapter 1                    26 
 
T cells can influence the response of B cells to polyclonal activators as well as the 
production of TH cytokines – normal T cells can suppress the response to LPS and 
activated TH1 clones also inhibit B cell antibody production. IFNγ is capable of 
modifying the B cell response to LPS and appears to act directly on B cells in regulating 
sensitivity to LPS. The effect of IFNγ on LPS-induced IgM secretion is most 
pronounced at sub-maximal concentrations of LPS and is not matched by an inhibitory 
effect on differentiation. It is therefore possible that IFNγ is important in regulating a 
subset of B cells that is extraordinarily sensitive to polyclonal activators (Cowdery and 
Fleming, 1992).  
 
Several cytokines have actions that oppose that of IL-10 on B-1 cells. In particular, 
IFNγ is well described for its ability to inhibit the expansion of the B-1 subset in vivo.  
Examples include systems using saline-soluble egg antigens from Schistosoma mansoni 
or the polylactosamine sugar lacto-N-fucopentaose III (Velupillai et al., 1996). IFNγ 
may act as part of a negative feedback loop in the control of the B cell response to 
polyclonal activators as LPS upregulates the expression of the IFNγ receptor on LPS-
activated B cells (Abed et al., 1994). Thus, as LPS activates B cells, it also renders them 
susceptible to inhibition by IFNγ. In systems driven by moderate concentrations of 
polyclonal activators, the major effect of IFNγ is to inhibit differentiation (Abed et al., 
1994). IFNγ has been found to inhibit both conventional and CD5+ B cell differentiation 
by decreasing the precursor frequency of IgM secreting cells (Chace et al., 1993). 
Activated peritoneal macrophages produce PGE2, which inhibits in vitro differentiation 
of peritoneal B-1 cells in a concentration-dependent manner (Chace et al., 1995).  
 
1.6 Cell lines as models of B cell function 
1.6.1 CH12 Cells 
Studies of B-1 cells have been aided by the Chapel Hill (CH) series of lymphomas. 
These cell lines have been demonstrated to have many features associated with the B-1 
B cell subset. 
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1.6.1.1 Phenotype 
The CH12 B lymphoma cell line arose as a peritoneal ascites and disseminated 
lymphoma in a 2a4b mouse 310 days after intra-peritoneal inoculation of 2 x 107 
splenocytes and 20µL of serum from a syngeneic donor previously immunised with 
sheep red blood cells (SRBC) at 35, 14, and 7 days before transfer of spleen cells 
(Arnold et al., 1983). 
The phenotype of CH12 cells is that of a relatively mature B cell. CH12 lacks detectable 
Fc receptors, but expresses CD5 (Arnold et al., 1983). The cell line binds both sheep red 
blood cells (RBC) and chicken RBC, but not human, burro, horse, mouse, or rabbit 
RBC to surface Ig (Arnold et al., 1983). 
CH12 is not permanently frozen at one specific step of differentiation. Under the 
influence of changing growth conditions, either in vivo or in vitro, it can be induced to 
differentiate and secrete Ig. CH12 bears surface IgM indicating that secondary, class 
switching, heavy chain gene rearrangement has not occurred. Under normal conditions 
of growth less than 3% of CH12 cells differentiate to Ig secretion (Arnold et al., 1983). 
In humans, B chronic lymphocytic leukaemia (B-CLL) tumours present phenotypic 
characteristics similar to those of the CH series of murine lymphomas. Approximately 
20% of B-CLL patients develop autoimmune haemolytic anaemia, consistent with an 
anti-phospholipid specificity of the monoclonal antibody produced by the tumour 
(Mercolino et al., 1986). The normal CD5+ B cell precursors of B cell chronic 
lymphocytic leukaemia cells may play a role in other autoimmune diseases, eg human 
systemic lupus erythematosus (SLE) (Mercolino et al., 1986). 
 
1.6.1.2 Repertoire 
Lord and Dutton (1975) suggested that the spontaneous plaque-forming cells found in 
normal spleens are representative of an autoimmune response against antigenic 
determinants to which the animal is continually exposed. They suggested that the 
determinant recognised on BrMRBC becomes exposed in vivo on effete erythrocytes, 
providing a means for their recognition and elimination (Lord and Dutton, 1975). 
Many of the CH lymphomas bear cell surface immunoglobulin that binds to SRBC. The 
hapten recognised by SRBC-binding CH lymphomas is phosphatidyl choline (PtC) 
(Mercolino et al., 1986). The reactive hapten can be exposed on various erythrocytes by 
treatment with the proteolytic enzyme, bromelain. Cells that express this specificity can 
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be found in the spleens of many normal mice, but their number is not increased by 
immunising with SRBC (Cunningham, 1976). These normal, spontaneous plaque-
forming cells (PFC) belong to the CD5+ B cell lineage, as do all the CH lymphomas of 
similar specificity. Reactivity toward phosphorylated autoantigens may be characteristic 
of normal and aberrant CD5+ B cells, and it appears that the CH series of B cell 
lymphomas are neoplastic analogues of normal CD5+ B cells (Mercolino et al., 1986).  
The polyspecificity of many antibodies produced by the CD5+ B cell lineage results 
from the similarity in chemical structure of the antigens recognised. For example, 
repeating membrane phospholipids are similar to nucleic acids (Mercolino et al., 1986). 
CD5+ B cells are responsible for the production of several commonly studied IgM 
autoantibodies. A relationship between anti-DNA and spontaneous anti-erythrocyte 
specificities is suggested. Polyspecificity of antibodies produced by CD5+ B cells for 
structurally related antigens is known in other systems as well. Anti-DNA antibodies 
from SLE patients can recognise cardiolipin (Colaco and Elkon, 1985).   
 
1.6.1.3 Response to Stimulation 
As described in Section 1.6.1.1, CH12 is an inducible monoclonal population with 
known antigen specificity for senescent autologous erythrocytes. Studies in vitro have 
shown that during logarithmic growth in culture, at cell concentrations lower than 6 x 
105/mL, the frequency of detectable plaque-forming cells (PFC) remains well below 
1%. As the cell concentration exceeds this level and the growth rate slows, there is a 
concomitant increase in the proportion of PFC, up to about 3%. Culture of CH12 cells 
for 24-48hr in the presence of 50µg/mL LPS causes a modest increase above the 
intrinsic high rate of proliferation and also a 10 to 20-fold increase in the proportion of 
antibody secreting cells (Haughton et al., 1986). After LPS stimulation CH12 cells 
increase in size, and proliferation is increased. A large proportion (at least 50%) of 
CH12 cells differentiate into antibody-secreting cells. The fraction of antibody-secreting 
cells is similar to the proportion of B cells within individual B cell clones that can be 
driven to secrete antibodies. The striking similarities between the responses of CH12 
cells and normal splenic B cells to LPS stimulation have been argued to make this an 
appropriate model system in which to study surface molecule expression during B cell 
differentiation (Ovnic and Corley, 1987). 
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In addition to antibody production, CH12 cells produce a range of cytokines including 
neuroleukin and IL-1 mRNA and high levels of IL-4 mRNA (O'Garra et al., 1989). The 
IL-4 mRNA is functional. CH12 cells also express high affinity receptors for IL-4. 
CH12 cells express IgM (O'Garra et al., 1989). All murine B lymphomas of the CH 
series (to date) are characterised by the expression of the CD5 surface antigen. It is 
believed that B-1 cells represent their normal counterpart. CH12 constitutively express 
RNA encoding TGFβ and IL-10 and produce varying levels of IL-3, IL-4, and GM-
CSF, but not IL-5 and IFNγ  (O'Garra et al., 1990). The data show a similarity in 
cytokine production by the CD5+ lymphomas and LPS-stimulated B-1 and B-2 normal 
cells: both populations express IL-6, TNFα, TNFβ, and IL-10; neither population 
expresses IL-1, IL-2, IL-5, IL-7, or IFNγ (O'Garra et al., 1990). 
 
1.6.2 WEHI-279 
WEHI-279 originated in the NZC inbred mouse strain derived from an (BALB/c x 
NZB) FI mouse (Warner et al., 1975; Sibley et al., 1980). WEHI-279 cells have Fc 
receptors, high levels of mIgM molecules, and secrete negligible amounts of IgM 
molecules (Warner et al., 1975; Paige et al., 1982). WEHI-279 resemble normal resting 
B cells and can be induced to mature to the state of active Ig secretion (Paige et al., 
1982). WEHI-279 expresses Fas and CD40 and CD40 ligation increases Fas sensitivity 
in WEHI-279 (Koizumi et al., 1996). 
This cell line has been used to study in the effects of IFNγ (Wong et al., 1983; Reynolds 
et al., 1987; Ben Jilani et al., 2001; Yoshikawa et al., 2001), B cell maturation factor 
(Sidman et al., 1984), surface presentation of IgM (Haustein and Von der Ahe, 1986), 
FcεR (Waldschmidt et al., 1988), IL-6 production and effects (Hobbs et al., 1991), Fas-
mediated apoptosis (Koizumi et al., 1996; Wang et al., 2000), CD80 and CD86 function 
(Suvas et al., 2002) in B cells. 
 
1.7 B-1 cell involvement in disease 
An increased number of B-1 cells has been shown to be an important characteristic of 
many autoimmune and chronic inflammatory diseases such as rheumatoid arthritis 
(Section 1.7.1), Sjögren's syndrome (Section 1.7.2), and periodontitis (1.7.3) (Hayakawa 
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et al., 1983; Kipps, 1989; Sugawara et al., 1992).  Other autoimmune diseases are also 
associated with increased accumulation of B-1 cells, as are immunodeficiency states 
including AIDS, chronic lymphocytic leukaemia, and patients immuno-suppressed to 
receive bone marrow transplants. Autoimmune and immunodeficient mice also have 
elevated levels of B-1 cells (Talal et al., 1992). The exact role of this subset in 
pathogenesis has yet to be established, but the production of autoantibodies by these 
cells may play a role in the pathogenesis and continuity of such chronic conditions.  
 
1.7.1 Rheumatoid arthritis 
Rheumatoid arthritis is a chronic inflammatory autoimmune disease characterised by an 
accumulation of B cells in the synovial tissue (Berek and Kim, 1997), with large 
numbers of B cells, including B-1 cells, present in these infiltrates (Plater-Zyberk et al., 
1989). Another feature of rheumatoid arthritis is the presence of inflammatory foci 
within synovial tissue, and these foci have been identified as ectopic germinal centre-
like structures (Berek and Kim, 1997). Also characteristic of the disease is the presence 
of autoantibodies. These antibodies are produced by both conventional and CD5+ B 
cells.  
In patients with rheumatoid arthritis, CD5+ B cells are strikingly increased in number 
(Hardy et al., 1987; Dauphinee et al., 1988; Plater-Zyberk et al., 1989), accounting for 
50% or greater of the circulating B cells (Casali and Notkins, 1989). B-1-derived 
antibodies binding to ssDNA and the Fc fragment of IgG are characteristic of 
rheumatoid arthritis (Casali et al., 1987), and this subset appears to be largely 
responsible for rheumatoid factor (RF) secretion (Hardy et al., 1987). Interestingly, B-1 
cell-derived IgM RF autoantibodies have been shown to undergo an antigen-directed 
affinity maturation process (Mantovani et al., 1993). 
 
1.7.2 Sjögren’s syndrome 
Primary Sjögren’s syndrome is an autoimmune disease characterised by dry eyes and 
mouth resulting from lymphocyte infiltration of lacrimal and salivary glands (Celenligil 
et al., 1990; Talal et al., 1992) and the production of typical autoantibodies (Dorner and 
Lipsky, 2002). The major autoantibodies associated with Sjögren’s syndrome are 
rheumatoid factor, anti-Ro (SS-A), and anti-La (SS-B). Autoantibodies against salivary 
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duct antigens are also found in the serum (MacSween et al., 1967) and, recently, 95% of 
primary Sjögren’s syndrome patients were reported to have serum antibodies against α-
fodrin (Stott et al., 1998). 
B-cell clonal expansion is a key feature of Sjögren’s syndrome (De Vita et al., 2001) 
and CD5+B cells are expanded in the peripheral blood of patients with rheumatoid 
arthritis and primary Sjögren’s syndrome (Dauphinee et al., 1988; Plater-Zyberk et al., 
1989).  
 
1.7.3 Periodontitis  
1.7.3.1 Human disease 
Periodontal disease is one of the most widespread diseases in humans. For example, it is 
estimated that at least 35% of the dentate U.S. adults aged 30 to 90 have periodontitis, 
with 21.8% having a mild form and 12.6% having a moderate or severe form (Albandar 
et al., 1999). Periodontitis is characterised by chronic gingival inflammation and 
resorption of the crest of alveolar bone with subsequent loss of teeth (Lally et al., 1980; 
Clarke, 1990; Aramaki et al., 1998). The different forms of the process are characterised 
by deterioration of the connective tissue and alveolar bone with resultant loss of 
support, tooth mobility, gingival pockets, haemorrhage, and local pain (Liebana and 
Castillo, 1994). 
 
Advanced/progressive human periodontitis is considered by many to be a B lymphocyte 
and plasma cell lesion (Okada et al., 1983; Tew et al., 1989; Gemmell and Seymour, 
1991). Gemmell and Seymour examined the phenotype of B-lymphocytes in 
periodontitis and found that a majority of these cells were activated (Gemmell and 
Seymour, 1991); T cells in periodontitis lesions are also active (Yamazaki et al., 1993). 
The periodontitis lesion in the adult periodontitis patients contains a substantial number 
of B cells, of which 30% demonstrated autoreactive features (Berglundh et al., 2002). 
Up to 38% of B cells from inflamed gingival tissues were determined to be CD5+ and 
many of these cells produced anti-collagen (auto-) antibodies (Sugawara et al., 1992). 
B-1 cells are activated in the inflamed gingival tissues of adult periodontitis patients 
(Aramaki et al., 1998). An increase of CD5+ B cells was also found in the peripheral 
blood of periodontitis patients (Afar et al., 1992). B-1 cells in gingival tissue may be 
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regarded as the first line of defence as they produce polyreactive antibodies to 
phosphorylcholine, LPS, and other commensal bacterial antigens (Aramaki et al., 1998). 
 
Active periodontal disease is associated with a shift in bacterial composition to Gram-
negative bacteria dominated in most cases by anaerobic bacteria (Dahlen, 1993), e.g. 
Porphyromonas gingivalis,  Bacteroides forsythus, Actinobacillus 
actinomycetemcomitans, Prevotella intermedia and Fusobacterium nucleatum ss 
vincentii (Bragd et al., 1987; Socransky and Haffajee, 1992; Socransky et al., 1998).  
 
1.7.3.2 Porphyromonas gingivalis 
Porphyromonas  gingivalis can be found in the gingival tissues and can pass through the 
epithelial barrier. In deeper epithelial layers P. gingivalis can actively invade 
endothelial cells and replicate intracellularly (Deshpande et al., 1998).  
 
P. gingivalis is a non-fermentative pigmented Bacteroides species, isolated principally 
from the human gingival sulcus and differs from B. asaccharolyticus by the production 
of phenylacetic acid, haemagglutination of sheep erythrocytes, trypsin-like activities, 
and antigenicity (reviewed in van Winkelhoff et al., 1988). 
P. gingivalis strains degrade almost all proteins in guinea pig serum, including the C3 
protein. Black-pigmented Bacteroides bacteria can produce leukotoxic substances such 
as low molecular weight fatty acids which directly inhibit polymorphonuclear leukocyte 
chemotaxis. Black-pigmented Bacteroides also inhibit the phagocytic killing of 
facultative bacteria in a mixed bacterial population by a mechanism which depends on 
serum. The LPS of black-pigmented Bacteroides species is different from the LPS of 
Gram-negative facultative anaerobic rods (reviewed in van Winkelhoff et al., 1988). P. 
gingivalis LPS has much less potency than does enterobacterial LPS in some endotoxic 
activities, such as pyrogenicity, chicken embryo lethality, and lethal toxicity to mice 
(Mansheim et al., 1978; Isogai et al., 1996). However, P. gingivalis LPS acts as a 
mitogen and polyclonal activator of B cells (Koga et al., 1985; Isogai et al., 1988; 
Fujiwara et al., 1990).  
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1.7.3.3 Porphyromonas gingivalis related effects in host response 
Tew suggested that a suppression of the spontaneous proliferation response in 
lymphocytes from untreated severe periodontitis patients may reflect changes in 
regulatory T cell function induced by a state of active disease (Tew et al., 1983). A shift 
from a T helper 1 to a T helper 2 response has been observed in chronic diseases and is 
implicated in chronic periodontal inflammation (Gemmell and Seymour, 1994; Rook et 
al., 1994; Gemmell et al., 2001). 
Gemmell and Seymour (Gemmell and Seymour, 1998) have shown that P. gingivalis 
induces IL-1 production by B cells rather than monocytes in periodontitis patients. This 
suggests that lymphocytes (B cells) may be a major source of IL-1 in periodontitis. 
Macrophage-derived IL-1 is a necessary co-factor for LPS-induced polyclonal 
activation (Bucala, 1992). P. gingivalis cysteine proteinases (gingipains) have been 
found to cleave IFNγ (Yun et al., 1999), hydrolyse IL-12 and reduce the IL-12-induced 
IFNγ production from CD4+ T cells (Yun et al., 2001). LPS upregulates expression of 
IFNγR on LPS-activated B cells and induces production of IFNγ (Abed et al., 1994). 
IFNγ produced by TH1 and NK cells activates monocytes and macrophages and inhibits 
IgM secretion and B cell activation. IFNγ may therefore be part of a negative feedback 
loop that regulates B cell response to polyclonal activators (Abed et al., 1994). Decrease 
in IFNγ may permit increased sensitivity to B cell PBA (Chace et al., 1995). 
Macrophages produce IFNγ (reviewed in Gessani and Belardelli, 1998), and the paucity 
of macrophages and their lack of activation within the periodontal tissue (Chapple et al., 
1998), coupled with the cleavage of IFNγ by gingipains could result in unregulated B 
cell activation by periodontal pathogens.  
 
Periodontal diseases are infectious diseases. The aetiology is specific Gram negative 
organisms, such as P. gingivalis and Bacteroides forsythus. While the aetiology of 
periodontitis is bacterial, it is becoming clear that the pathogenesis of disease is 
mediated by the host response (Van Dyke and Serhan, 2003). 
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1.8   In vitro models of complex systems 
The reductionist approach to biological problems has resulted in many important 
insights (Pollard, 2000). The challenge now, however, is to understand how cells and 
organisms as a whole survive and reproduce (Hartwell et al., 1999). 
 
1.8.1 Systems thinking 
“Systems thinking is a discipline for seeing wholes” 
(Senge, 1994). 
 
Skyttner defines a system as a “set of interacting units or elements that form an 
integrated whole intended to perform some function” (Skyttner, 1996). To call 
something a “system”, the parts must be connected together to perform a transformation 
process (or processes). There must be a boundary, inputs and outputs. There must be 
emergent properties, i.e. the whole must provide something that is not available from 
the unconnected parts, output that requires interconnection and interrelationships 
(Harrington et al., 1999). Most systems are collections of parts that form “natural 
wholes” - obvious entities that clearly function to produce outputs that cannot be 
produced by the parts until they are “joined together” into an organised system. The 
essential or defining properties of any system are the properties of the whole which 
none of its parts have, because properties of a system derive from the interaction of its 
parts (Skyttner, 1996; Gruska, 2000). The performance of the system therefore depends 
on how the parts interact, not how they act separately. The essential properties of the 
system are lost when it is disassembled into unconnected parts (Gruska, 2000). 
In a systems perspective one should be careful to consider the system in the context of 
the environment and not as an isolated entity. Thus one should include the interactions 
and relationships between the system and the environment (Bar-Yam, 2000). In one 
sense, a system is defined by its inputs and outputs, and how outputs feed back to be 
inputs. These are the system’s relationship with its environment. 
 
Skyttner lists properties which together comprise a general systems theory. A non-
exhaustive list includes: 
− Unrelated and independent elements do not constitute a system.  
Chapter 1                    35 
 
− Holistic properties impossible to detect by analysis should be possible to define 
in the system.  
− Systemic interaction must result in some goal or final state to be reached or 
some equilibrium point being approached.  
− All systems, if they are to attain their goal, must transform inputs into outputs.  
− The interrelated objects constituting the system must be regulated (detection and 
correction of deviations) so that its goals can be realised. Feedback is therefore a 
requisite of effective control.  
− Systems are generally complex wholes made up of smaller subsystems.  
− In complex systems, specialised units perform specialised functions. This is a 
characteristic of all complex systems. 
− Open systems have equally valid alternative ways of attaining the same 
objectives (divergence) or, from a given initial state, obtain different, and 
mutually exclusive, objectives (convergence) (Skyttner, 1996). 
 
1.8.2 Application to current research 
“A system-level understanding requires a shift in our notion of “what to look for” in 
biology. While an understanding of genes and proteins continues to be important, the 
focus is on understanding a system’s structure and dynamics” (Kitano, 2002). 
 
An examination of the dynamic interaction between individual components of a system 
is required to understand how a particular system functions (Kitano, 2002). Complex 
systems are characterised by networks and the immune system is an example of a 
complex system. Through reductionism, much is now known about the components of 
this system and how they interact which each other. However, knowledge of how 
networks are formed within the immune system and how properties emerge from these 
networks at the level of the system as a whole is still in its early stages (Efroni and 
Cohen, 2002). 
 
Diseases can also be examined using the systemic approach. An understanding of the 
contribution of individual cells and molecules has been developed through the 
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reductionist approach, however the full scale of interactions between these components 
is yet to be recognised.  
 
A full understanding of the complex system that is the immune system and its B cell 
component is beyond the scope of this thesis. However, recognition of the benefits of 
the systemic approach and the contribution of knowledge gained through the 
reductionist approach to systemic understanding drives the studies presented here.  The 
reductionist approach is reflected in the parallel cell line studies examining the effects 
of LPS-stimulated on individual cell types whilst the systemic approach is reflected in 
the mixed splenic lymphocyte cultures. The mixed culture studies presented are initial 
characterisations of a simple system which can provide understanding of the 
interactions between the B-1 and B-2 cell subsets and also their interaction with T cells. 
(Note: T cell involvement is not examined as the focus of the studies presented in this 
thesis are B cell subsets.) 
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Chapter 2 Response of a B-1 cell line to 
lipopolysaccharide 
 
2.1 Introduction 
As described in section 1.5.2.1, the response of B-1 cells, as opposed to B cells, to LPS 
is poorly understood. B-1 cells produce antibodies that participate in early protection 
from infection, and/or may influence the development of the B-2 response (see section 
1.3.2.2). In addition, while some studies have investigated the response of non-B cell 
populations to LPS preparations derived from non-enteric bacteria (see section 
1.5.2.1.6), there is a paucity of studies examining how B cell subsets respond to these 
types of LPS. It was postulated that, in comparison with B-2 cells, very low 
concentrations of LPS may activate B-1 cells, thereby leading to B-1 cell accumulation 
in diseases such as periodontitis. It was therefore important to investigate the response 
of CD5+ cells to different concentrations and types of LPS. 
 
In order to investigate the LPS responsiveness of B-1 cells, the murine B-1 derived cell 
line (CH12 see section 1.6.1) was used. Initial studies used CH12 cells cultured in the 
presence of relatively high concentrations of foetal calf serum (FCS), however the 
effects of LPS stimulation were obscured under these conditions. To avoid this problem, 
the response to LPS was examined in cells that were cultured under serum-limiting 
conditions. CH12 cells were cultured with varying concentrations of either Salmonella 
enteritidis or Porphyromonas gingivalis LPS and the viability, proliferation and 
activation were assessed by a variety of techniques. Moderate concentrations of both S. 
enteritidis and P. gingivalis LPS led to increased survival and proliferation of CH12 
cells. The expression patterns of mRNA for Toll-like receptors were examined by 
quantitative PCR (qPCR). In addition, changes in mRNA levels of cytokines known to 
be involved in B-1 cell activation and survival, as well as mRNA for the apoptotic 
regulators Bcl-2 and Bax, were evaluated (Other regulators of cell behaviour such as 
cyclins, kinases, cell cycle inhibitors and other members of the bcl-2 family of pro/anti-
apoptitic molecules were not examined due to time and budgetary constraints). Despite 
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the array of parameters examined, no clear picture of the mechanisms underlying the 
patterns of proliferation and survival was found. 
 
2.2 Materials and Methods 
2.2.1 CH12 cell line 
The IgM-producing CH12 B lymphoma cell line was a gift of Dr Kenneth W. Beagley 
(Discipline of Pathology, Faculty of Medicine and Health Sciences, University of 
Newcastle, Australia). The cells were cultured in RPMI 1640 medium supplemented 
with 10% FCS (JRH Biosciences, Brooklyn, VIC), 5 x 10-5M 2ME (Sigma, St Louis, 
MO, USA), and antibiotic mixture (penicillin 50IU/mL and streptomycin 50µg/mL; 
Trace Biosciences, Castle Hill, NSW). 
 
2.2.2 Thawing of cells 
Vials of cells was removed from liquid nitrogen storage and placed into a covered water 
bath at 37ºC. When the cells were almost thawed they were transferred to a 15mL 
centrifuge tube and 1mL FCS was added drop-wise, followed by 10mL RPMI/20% FCS 
drop-wise, whilst the tube was shaken gently. The cell suspension was centrifuged at 
4ºC for 10 min at 300g, the supernatant was decanted and the cells resuspended in 
residual medium. Five to 10mL RPMI/20% FCS was added and the concentration and 
viability of cells was determined using Trypan Blue exclusion. The cells were placed in 
a 25cm2 flask and incubated at 37°C and 5% CO2. 
 
2.2.3 Freezing of cells 
Cells were passaged 24hr prior to freezing. The cells were harvested from the culture 
flask and centrifuged 10 min, 4°C at 300g, the supernatant was decanted and the cells 
resuspended in the residual medium. The cells were diluted to 4 x 106 cells/mL in 
RPMI/20% FCS and placed into a beaker of ice and water. An equal volume of cold 
freezing medium (RPMI/20% FCS/20% DMSO) was added drop-wise to the cells with 
gentle shaking. The cells were mixed with a pipette and 1mL aliquots were transferred 
to precooled cryovials (Nunc, Roskilde, Denmark). The cells were placed in a –70°C 
freezer for three days and the transferred to liquid nitrogen storage. 
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2.2.4 Passaging of CH12 
The cells were determined to have a doubling time of approximately 12hr, and hence 
were passaged 1:4 for confluence after 24hr of culture, or 1:8 for confluence after 48hr 
of culture. Passaging at lower than 1:10 resulted in very slow growth, and often death of 
cells in the culture (results not shown).  
Initial studies utilised CH12 cells cultured in medium supplemented with 10% FCS and 
further studies used serum-limiting conditions (3% or 2% FCS depending on batch of 
serum) to slow the doubling time of the line (Zetterberg and Larsson, 1985) and induce 
apoptosis (Dean et al., 1986; Howard et al., 1993; Shichiri et al., 1993; Fang et al., 
1995; Jayadev et al., 1995) in order to examine aspects of the response which could not 
be studied satisfactorily in cultures supplemented with 10% FCS. 
 
2.2.5 Seeding of culture vessels 
Cells were treated with mitogens before seeding in complete medium at 1.56x 105 
cells/mL in 96 well flat-bottomed microtitre plates (Sarstedt, Ingle Farm, SA) to a final 
well volume of 100µL. Eight replicate wells were prepared for each time point, and 
control (non-stimulated), and mitogen-stimulated test population were utilised. 
Cells used for flow cytometric analysis were seeded at 1.56x 105 cells/mL in 25cm2 
cell-culture flasks (Sarstedt) to a final volume of 5mL. Control and mitogen-stimulated 
populations for all time points were cultured for this analysis. 
 
2.2.6 Mitogens 
Salmonella enteritidis LPS, prepared by a phenol-water extraction procedure and 
chromatographically purified, was obtained from Sigma. Note: S. enteritidis LPS was 
used as the work presented in this thesis was initially a continuation of that started by Dr 
WLK Massey at the IDR utilising S. enteritidis LPS. 
Porphyromonas gingivalis LPS (protein free) was prepared (see Appendix 1, section 
“LPS extraction for P. gingivalis”) and provided by Ky-Anh Nguyen of the IDR. 
 
2.2.7 MTT colourimetric assay 
Ten microlitres 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT; 
Sigma) 5mg/mL was added to each cell-containing well of a 96-well microtitre plate 
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and incubated for 3hr at 37°C. The plates were centrifuged for 10 min at 300g and 
18°C. The supernatant was decanted from the wells and 100µL absolute ethanol was 
added to each well and mixed with a pipette. Absorbance was read at 690 and 540nm 
using a Titertek Twinreader Plus (Flow Laboratories, McLean, VA, USA) and change 
in absorbance was calculated to determine biomass (Mosmann, 1983; Loveland et al., 
1992). 
 
2.2.8 5-carboxyfluorescein diacetate-succinimidyl ester (CFSE) 
staining of cells 
The method of Lyons and Parish (1994) was used in CFSE staining of cells: 1 x 108 
cells were harvested from culture and washed twice with serum-free RPMI 1640. The 
cells were resuspended at a concentration of 5 x 107/mL in serum-free RPMI 1640 and 
warmed for 5min at 37°C. 1µL of 1mM CFSE (Molecular Probes, Eugene, OR, USA) 
was added for each mL of cell suspension to give a final CFSE concentration of 1µM. 
The cells were incubated for 10min at 37°C and inverted every 3 - 4min. The reaction 
was stopped with several volumes of cold RPMI/FCS and the cells were washed twice 
with RPMI/FCS prior to addition of mitogens and seeding. 
 
2.2.9 Determination of division index in CFSE-stained B cell 
subsets 
The division index gives a measure of the overall mitotic activity and was determined 
using the method of Angulo and Fulcher (Angulo and Fulcher, 1998).  
The division index = (100-Y)/Y 
Where Y(%) = X0 + X1/2  + X2/4  + X3/8  + X4/16  + X5/32  + X6/64  + X7/128 
X0 is the percentage of undivided cells 
X1-7 are those cells in CFSE division gates 
Two cells of given CFSE intensity arose from the single mitosis of a cell possessing 
CFSE intensity immediately greater. A division index of 1 means 1 mitosis for every 
cell added to the culture, an increase in the value means more mitotic activity. Cells 
dying in culture are ignored by this analysis. If these are a significant proportion of 
mitotic cells then an underestimate of the actual extent of cell division will result.   
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2.2.10 Flow cytometric analysis of CFSE stained cells 
Cultured cells were washed twice with PBS/2% FCS/0.1% NaN3 and were resuspended 
to 2 x 106 cells/mL in sheath/PFA prior to flow cytometric analysis on a FACScan 
(Becton Dickinson, San Jose, CA, USA). Thirty thousand (30,000) cells were counted 
for each sample. 
 
2.2.11 Cell cycle analysis 
Cells were harvested from culture and 106 – 107 cells were resuspended in 5mL PBS in 
a centrifuge tube.  Cells were centrifuged for 6 min at 4°C and approximately 200g and 
resuspended in 500µL PBS using a Pasteur pipette. The cell suspension was transferred 
to FACS tubes containing ice cold 4.5mL 70% ethanol and incubated for approximately 
2hr on ice. Ethanol suspended cells were centrifuged for 5 min, 4°C, 200g and then the 
ethanol was thoroughly decanted. The cell pellet was resuspended in 5mL PBS, 
incubated for 1 min and then centrifuged for 5 min, 4°C, 200g. The cell pellet was 
resuspended in 1mL PI/Triton X-100 staining solution with RNase A and analysed 
within 30 min of staining. 
 
2.2.12 Antibodies for flow cytometry 
PE-conjugated anti-murine Bcl-2 (clone 3F11), purified anti-Bax (clone 6A7), and the 
corresponding isotype-matched controls were purchased from Pharmingen (San Diego, 
CA, USA) (Except Mouse IgG1 which was purchased from Sigma). Fc Block (anti-
murine CD16/CD32, clone 2.4G2) (Pharmingen) was used to prevent non-specific 
binding of murine monoclonals to Fcγ receptors on the cell surface. 
 
2.2.13  Staining of CH12 cells for Bcl-2 and Bax by flow 
cytometry 
The cells were harvested and washed twice with PBS/2% FCS/0.1% Azide and 
resuspended to 1 x 106 cells/mL. One million (1 x 106) cells were placed in analysis 
tubes and 875µL cold PBS was added to the cells and mixed gently. One hundred and 
twenty five microlitres of cold fixation solution was added and the cells were mixed 
again. The cells were incubated for 1hr, 4°C and then centrifuged for 5min, 300g, 4°C. 
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The supernatant was removed and 1mL permeabilisation solution was added to the 
resuspended pellet and mixed gently. The cells were then incubated 15min at 37°C, 
1mL PBS was added and then the cells were centrifuged for 5min, 300g, 4°C and the 
supernatant removed. One hundred microlitres 1° antibody (anti-Bcl2-PE and anti-Bax) 
in permeabilising solution was added to the pellet and mixed well. The cells were 
incubated 30min at 4°C, 1mL washing buffer was added and the cells were centrifuged 
5min, 300g, 4°C. The supernatant was removed and the pellet washed again with 1mL 
washing buffer. One hundred microlitres 2° antibody (FITC anti-mouse-IgG F(ab’)2) in 
permeabilising solution was added to the pellet, mixed well, and then incubated for 
30min, 4°C. One millilitre of washing buffer was added and the cells centrifuged for 
5min, 300g, 4°C. The supernatant was removed and the pellet washed again with 1mL 
washing buffer and centrifuged for 5min, 300g, 4°C. The supernatant was removed and 
the cells resuspended to 106 cells/mL in staining buffer and analysed on a FACScan. 
Isotype matched controls, PE-conjugated for the anti-Bcl-2-PE control and 
unconjugated for the anti-Bax control (together with the 2º FITC-antibody) were used in 
all experiments. 
 
2.2.14 Quantitative PCR 
Quantitative PCR protocols were obtained from Dr H Ball (Department of Pathology, 
University of Sydney). 
Cells were harvested from plate wells and spun down in 2mL microfuge tubes. The 
supernatant was discarded and the cells were resuspended in 1mL Tri-reagent (Sigma) 
and then vortexed. Samples were stored at -70°C until required. 
 
2.2.14.1 RNA Isolation 
Samples were thawed and incubated at room temperature for 5 minutes. Chloroform 
(0.2mL per mL of Tri-reagent originally used) was added to each sample. Samples were 
shaken vigorously for 15 seconds and incubated for 2-15 minutes at room temperature. 
The mixture was centrifuged at 12000g for 15 minutes at 4˚C.  The aqueous phase was 
transferred to a fresh tube and 0.5mL isopropanol per mL of Tri-reagent used in sample 
preparation was added to each sample and mixed. The samples were incubated for 5-10 
min at room temperature and then centrifuged at 12000g for 10 minutes at 4˚C. The  
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supernatant  was removed and the RNA pellet washed by adding 1mL (minimum) of 
75% ethanol per 1mL of Tri-reagent used in sample preparation. The samples were 
vortexed and centrifuged at 7500g for 5 min. The supernatant was removed by 
decanting and pipette. The RNA pellet was briefly dried for 5-10 minutes by leaving the 
eppendorf tubes open on the bench at room temp. The pellet was redissolved in 50µL 
water (dH2O: all RNase free). Samples were stored at -70°C until required. 
 
2.2.14.2 DNase treatment 
DNase treatment was undertaken according to instructions included with the Ambion 
(Austin, Texas) DNA-free™ kit. Briefly, a master mix of 0.1 volume DNase I buffer 
and 1µL DNase I per sample was made up and 5.5µL of this mix was added to each 
sample. The samples were mixed and spun down gently and then incubated for 20-
30min at 37°C. DNase inactivation reagent (0.1 volume) was added to each sample 
which was then thoroughly mixed. Samples were incubated for 2min at room 
temperature and spun down at 10,000 rpm for approximately 1 min. Aqueous RNA was 
pipetted into a new tube and stored at -70°C until required. 
 
2.2.14.3 Determination of RNA concentration 
RNA concentration in each sample was determined by optical density measurement at 
260 nm using a BioRad Ultramark Microplate Reader (Hercules, CA) using Microplate 
Manager v5.1 build 75 and comparing with a standard curve.  
 
2.2.14.4 Reverse transcription of RNA 
Individual samples were prepared in eppendorf tubes, each with 2µg RNA and 1µl of 
oligo dT (0.1µg/µl; Geneworks, Rundle Mall, SA) in a total volume of 11µl, in dH2O 
(RNA plus water to 10µl). Samples were heated to 70˚C for 5-10 minutes and then 
placed on ice and spun briefly to collect contents. A mastermix was made up, with a 
total volume of 9µL per sample: 
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Reagent Details µL/reaction 
5 x RT buffer Invitrogen (Carlsbad, CA, USA) 4 
0.1M DTT Invitrogen 2 
dNTP  Stock with 5µg/µl of each nucleotide in dH2O 
Invitrogen 
2 
RNAse inhibitor Invitrogen 0.5 
MMLV-RT Invitrogen 0.5 
 Total 9µl 
 
 
Mastermix, 9µL, was added to each tube containing RNA. The samples were mixed and 
incubated for 1 hour at 37˚C. The samples were then incubated for a further 3-5 minutes 
at 92˚C. RNase-free water (480µL) was added to each sample and cDNA samples were 
stored at -20˚C until required. 
 
2.2.14.5 Primers 
Primers were designed using Primer Express (Applied Biosystems, Foster City, CA). 
Default settings for real time primer design were used. Target sequences used were 
sourced from the Entrez Nucleotides Database (http://www.ncbi.nlm.nih.gov ). Potential 
cross reactivity of primers with other mRNA species was assessed by using the Basic 
Local Alignment Search Tool (BLAST) and the Entrez Nucleotides Database. Primers 
were purchased from Geneworks and were designed as follows: 
Gene Forward (5’Æ3’) Reverse (5’Æ3’) 
HPRT GCTTTCCCTGGTTAAGCAGTACA CAAACTTGTCTGGAATTTCAAATC 
CD80 AATGGCAGCCAAACTTCTCAAC TGGTTCTGAGAGCACCCACATA 
CD86 TATCTGCCGTGCCCATTTACA TGTGCCCAAATAGTGCTCGTAC 
Bcl-2 GGCATCTGCACACCTGGAT AAGCCCAGACTCATTCAACCA 
Bax GGCCTTTTTGCTACAGGGTTT GCTCAGGTGTCTCCCCAGC 
TLR2 AAGATGCGCTTCCTGAATTTG CCAGCGTCTGAGGAATGCA 
TLR4 CATGGAACACATGGCTGC GGTAATTCATACCCCTGGAAAGG 
RP105 CCGATGTGACGCTATCCTGTAGT CAAAATAGCAAACACGAGCAAGAAT 
IgM AGCTCTTACCCCAGGAGAAGTATGT CAGTCAGGATGCTGTGGGTAAA 
IL-6 ACAAGTCCGGAGAGGAGACTTC CGATTTCCCAGAGAACATGTGT 
IL-10 GCCCTTTGCTATGGTGTCCTTT TGAGCTGCTGCAGGAATGATC 
 
The primers were optimised for the PCR conditions described in Section 2.2.14.7. 
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2.2.14.6 Real time PCR set-up using Sybr green 
For each gene tested a master mix of Sybr green mix plus primers was prepared: 
Reagent Reagent details µL/reaction 
SYBR green master mix Invitrogen  10 
Rox dye Invitrogen  1 
Primer mix Forward and Reverse in dH20 each at 2µM 1 
 Total 12µl 
 
The SYBR green/primer master mix was aliquoted into wells of real time PCR plate 
(12µL per well; Applied Biosystems, Foster City, CA, USA). cDNA was added to each 
well (8µL per well) and the plate was heat-sealed. The plate was briefly spun in a 
centrifuge to ensure solutions were at bottom of plate. 
Positive and negative controls were included for each gene on each plate (see Appendix 
3 for a sample plate layout showing samples and controls). 
 
2.2.14.7 Real time PCR run 
PCR was performed in an Applied Biosystems Real Time PCR instrument (AB7700) 
using the following conditions with a combined annealing and extension step: 
− 50°C  for 2min 
− 95°C for 10min 
− 95°C for 15sec and 60°C for 1min (repeated 40 times). 
The data was collected at 60°C. 
 
2.2.14.8 Dissociation curve analysis 
Dissociation analysis was performed for every plate in an Applied Biosystems Real 
Time PCR instrument (AB7700) using the following conditions: 
− Denaturation step at 95ºC for 15 sec  
− Annealing step at 65ºC for 15 sec  
− Ramp from 65ºC (5 minute ramp time) to 95ºC (15 sec) 
Data was collected from the ramp step. 
According to Sambrook and Russell (2001): 
“The shape of the melting curve indicates whether the amplified products are 
homogenous and the Tm (melting temperature) provides reassurance that the 
correct product has been specifically amplified. Primer-dimers…generally 
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denature at much lower temperatures and can easily be distinguished from the 
amplified target DNA” (p8.94-8.95). 
 
2.2.14.9 Determination of relative levels of expression 
mRNA expression of selected genes was determined using real-time PCR normalised to 
hypoxanthine phosphoribosyltransferase (HPRT).  
 
2.2.15 Statistical Analyses 
Control and LPS-stimulated values were compared for all experiments. Two-way 
ANOVA to compare differences at particular time points between unstimulated and 
stimulated populations, with Tukey's multiple comparison post test to compare 
differences between time points in a population, and one-way ANOVA to test 
differences overall between unstimulated and stimulated populations were performed 
using GraphPad Prism version 3.00 for Windows, GraphPad Software, San Diego 
California USA, www.graphpad.com. All data shown are pooled means from a number 
of experiments. All error bars shown are the standard error of the mean. 
 
2.3 Results 
2.3.1 Response of CH12 cells to Salmonella enteritidis LPS 
2.3.1.1 CH12 cells cultured in RPMI/10%FCS do not show any response 
to S. enteritidis LPS stimulation 
In initial experiments, CH12 cells were cultured in medium containing 10% foetal calf 
serum (FCS) and varying concentrations of Salmonella enteritidis LPS. All cultures 
showed an increase in biomass over the culture period (Figure 2.1) and there were no 
significant differences between any of the LPS-stimulated cultures and corresponding 
unstimulated controls at any timepoint.  Analysis of the viability (Figure 2.2A) and cell 
numbers (Figure 2.2B) mirrored this result. None of the LPS-stimulated cultures were 
significantly different to the control at the corresponding timepoint.  
 
To further characterise the response of CH12 cells to LPS in serum rich conditions, 
activation was determined by measuring CD80 expression by flow cytometry. As shown 
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in Figure 2.3, CH12 cells were gated using forward and side scatter to select the major 
population cluster, and then viable cells from this population were selected for further 
analysis by gating on 7AAD fluorescence levels. The M1 (negative) and M2 (positive) 
regions for anti-CD80-FITC staining were determined using an isotype-matched 
control. The percentage of CD80+ cells was then determined for the viable population 
(Figure 2.4). The percentage of CD80+ CH12 cells was very high for all populations, 
including 95.4% (± s.e.m. 2.3%) of cells at 0hr. Further, the percentage of CD80+ cells 
did not change significantly over the culture period. 
 
2.3.1.2 Serum limitation slows doubling time and reduces viability 
In order to slow the doubling time of the cell lines, the concentration of FCS in the 
culture medium was reduced to a level that slowed proliferation and reduced viability 
(Zetterberg and Larsson, 1985). In medium supplemented with 10% FCS, CH12 cells 
double approximately every 12 hours (author’s preliminary studies, data not shown). An 
initial range of concentrations between 1 and 5% was established from a preliminary 
study (Figure 2.5A), and this was further broken down as shown in Figure 2.5B. 
Supplementation with 3% FCS slowed the doubling time of the cells to 24hr, but the 
viability still remained high. All serum limitation studies included a 10% FCS 
unstimulated control. 
Studies undertaken with S. enteritidis LPS in the CH12 cell line utilised 3% FCS for the 
serum limitation studies. However, a new and different batch of serum (from the same 
manufacturer, JRH Biosciences) was utilised for the P. gingivalis studies in CH12 and 
all studies in the WEHI-279 cell line. It was found that the use of 2% FCS resulted in 
similar patterns of proliferation and viability to that of 3% from the alternate serum 
batch. The results of experiments utilising 3% FCS from the new batch were not 
significantly different to those of utilising 10% FCS from this new batch (data not 
shown). 
 
2.3.1.3 S. enteritidis LPS stimulation ‘rescues’ CH12 cells from death in 
serum-limited cultures 
When cultured under serum-limiting conditions, the viability of CH12 cells decreased 
over the course of the experiment. However, addition of moderate concentrations of S. 
enteritidis LPS significantly diminished this loss of viability (Figure 2.6A). The 
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percentage viability in the cultures stimulated with 100ng/mL, 1µg/mL and 10µg/mL 
LPS were significantly different to the non-stimulated culture overall. All of the 3% 
FCS cultures were significantly different to the control 10% FCS culture. The 
concentration of viable cells (Figure 2.6B) remained low but stable in the control 3% 
FCS and 1pg to 1ng/mL LPS-stimulated cultures. An increase in cell concentration in 
the 10ng/mL LPS culture is noted, but this is not significantly different to the control 
culture. The concentration of cells in the cultures stimulated with 100ng/mL, 1µg/mL 
and 10µg/mL LPS were significantly different to the control culture overall. 
 
2.3.1.4 S. enteritidis LPS stimulation affects population dynamics in 
CH12 cells in serum-limited cultures 
It was important to evaluate the ability of different LPS concentrations to induce 
proliferation in CH12 cells. Cell division was measured by two methods: CFSE dye 
dilution (Lyons and Parish, 1994) and cell cycle analysis.  
For CFSE dye dilution experiments, cells were gated by forward and side scatter and 
7AAD fluorescence to select the viable population, and CFSE fluorescence was 
measured over the culture period (Figure 2.7). Figure 2.7A is an overlay of the 24, 48 
and 72hr histograms shown as B, C and D. In all cultures the division index increased 
over the culture period (Figure 2.8). All 3% FCS cultures (except 100ng/mL LPS) are 
significantly different to the 10% FCS control (data not shown). The 10ng/mL, 
100ng/mL, 1µg/mL and 10µg/mL LPS-stimulated cultures are significantly different to 
the 3% FCS control culture. 
For cell cycle analysis, cells were gated on forward and side scatter and Propidium 
iodide (PI)-Area and Width to gate out doublets (Figure 2.9). The restricted range of 
LPS concentration and time points were chosen for this experiment as they were 
deemed to be the concentrations and time points in which any LPS effects were easily 
discernable (given the results of the previous experiments shown in Figure 2.6 and 
Figure 2.8). Ten nanogram/mL and 100ng/mL LPS were threshold concentrations for 
LPS effects on division index and viability in 3% FCS cultures, and stimulation with 
1µg/mL LPS results were significantly different to 3% FCS control results in the 
previous experiments. As shown in Figure 2.10, at both time points, G0/G1 phase 
percentages in the LPS-stimulated and 10% FCS control cultures were significantly 
lower than the non-stimulated control. S phase percentages were different to 3% FCS 
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control in the 100ng/mL and 1µg/mL LPS-stimulated cultures. The 10% FCS 
unstimulated culture was only significantly different to the 1µg/mL culture at the 48hr 
time point. For cells in the G2/M phase, the 10% FCS unstimulated control was different 
to the 3% FCS control at both time points and was also significantly different to the 
24hr 1µg/mL LPS and 48hr 100ng/mL LPS cultures.  
 
2.3.1.5 Effects of S. enteritidis LPS on CH12 activation  
To assess changes in the activation state of CH12 cells in response to S. enteritidis LPS, 
levels of CD80, CD86 and IgM mRNA were determined using qPCR (for an example of 
typical qPCR raw data, see Figure 2.11). The restricted range of LPS concentration and 
time points were chosen for this experiment as they were deemed to be the 
concentrations and time points in which any LPS effects were easily discernable (given 
the results of the previous experiments shown in Figure 2.6 and Figure 2.8). No 
significant differences were found between control and LPS-stimulated cultures for 
either CD80 (Figure 2.12A) or CD86 (Figure 2.12B). When changes in the mRNA 
expression of sIgM were examined, however, significant differences were found. The 
1µg/mL LPS-stimulated culture was significantly different overall to the control culture. 
In the 100ng/mL and 1µg/mL LPS-stimulated cultures the 48hr timepoint was 
significantly different to the 0 and 24hr timepoints (Figure 2.13). 
 
2.3.1.6 Investigation of molecular events associated with S. enteritidis 
LPS stimulation 
Potential molecular mechanisms underlying the effects of S. enteritidis LPS on CH12 
cells were examined. Bcl-2 and Bax protein levels were measured simultaneously in 
CH12 cells stimulated with S. enteritidis LPS using flow cytometry and RT-qPCR, 
while levels of mRNA for relevant Toll-like receptors and cytokines were examined by 
RT-qPCR. The restricted range of LPS concentration and time points were chosen for 
this experiment as they were deemed to be the concentrations and time points in which 
any LPS effects were easily discernable (given the results of the previous experiments 
shown in Figure 2.6 and Figure 2.8). 
 
 
Chapter 2                    50 
 
2.3.1.6.1  Changes in Bcl-2 and Bax expression 
For determination of Bcl-2 and Bax protein expression, cells were stained for 
intracellular Bcl-2 and Bax simultaneously (Figure 2.14). No statistically significant 
differences were found for Bcl-2/Bax ratios between the serum-limited non-stimulated 
culture and the corresponding LPS-stimulated cultures (see Figure 2.15). In the 3% FCS 
control culture the 48hr ratio was significantly higher than the 24hr ratio – none of the 
other cultures showed a significant difference between the 24 and 48hr values. 
However, overall, the 48hr cultures were significantly different to the 24hr cultures. To 
further examine the Bcl-2/Bax ratio, changes in the ratio of Bax and Bcl-2 mRNA was 
determined using RT-qPCR. The ratio of Bax and Bcl-2 expression was calculated 
(Figure 2.16) and no significant differences were found between control and LPS-
stimulated cultures. 
 
2.3.1.6.2  Changes in Toll-like Receptor mRNA expression 
Levels of mRNA expression of TLR2 (Figure 2.17A) and TLR4 (Figure 2.17B) were 
determined using RT-qPCR. No significant differences overall were found between 
control and LPS-stimulated cultures. At the 24hr timepoint, the level of expression of 
TLR2 in the 100ng/mL and 1µg/mL LPS-stimulated cultures was lower than that of the 
control culture. In contrast to the expression of TLR2 and TLR4, mRNA levels of 
RP105 were significantly affected by S. enteritidis LPS. All LPS-stimulated cultures 
were significantly different overall to the control culture (Figure 2.18). In the 10ng/mL 
LPS-stimulated culture, the 48hr timepoint was significantly lower than both the 0 and 
24hr timepoints. In the 100ng/mL LPS-stimulated cultures the 24 and 48hr timepoints 
were lower than the 0hr timepoint, whilst in the 1µg/mL LPS-stimulated culture only 
the 48hr timepoint was significantly different to the 0hr culture. In both the 100ng/mL 
and 1µg/mL LPS-stimulated cultures the 24hr timepoint was different to the control. 
 
2.3.1.6.3  Changes in IL-6 and IL-10 mRNA expression 
As both IL-6 and IL-10 have been shown to affect B-1 cell activation and survival (see 
section 1.5.2.2), changes in the mRNA of these cytokines were investigated using RT-
qPCR. There were no significant differences in IL-6 mRNA expression between control 
and LPS-stimulated cultures (Figure 2.19A). In contrast, CH12 cells showed a 
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significant increase in IL-10 message at both 24 and 48 hours in cells stimulated with 
100ng/ml S. enteritidis LPS (Figure 2.19B). However, the magnitude of this increase 
was small (1.5 fold increase at 24 hours compared with control.) 
 
2.3.2 Response of CH12 cells to Porphyromonas gingivalis LPS 
2.3.2.1 P. gingivalis LPS affects proliferation but not viability in CH12 
cells 
The response of CH12 cells to P. gingivalis LPS was investigated in serum-limited 
cultures. There were some difficulties interpreting the results of these experiments, as it 
was necessary to use a different batch of FCS to that used in the S. enteritidis studies 
(section 2.3.1.2). Although the batch was re-titrated to determine appropriate serum-
limiting conditions (data not shown), there was some proliferation of cells seen in non-
LPS-stimulated cultures (Figure 2.20). Nevertheless, all 2% FCS cultures were 
significantly different to the 10% FCS unstimulated control culture. 
 
In contrast to the pattern of increased survival seen in S. enteritidis LPS-stimulated 
cultures (see section 2.3.1.3), viability in P. gingivalis LPS-stimulated cultures was not 
significantly different to unstimulated control cultures (Figure 2.20A).  
 
While the concentration of cells in all groups increased over the culture period (Figure 
2.20B), P. gingivalis LPS did appear to affect the cell numbers in culture in a complex 
dose-dependent manner. When present at high concentrations (100ng/mL and 
10µg/mL), P. gingivalis LPS caused increased numbers of cells in culture. However, 
low doses (1pg/mL and 10pg/mL) actually resulted in a significantly decreased number 
of cells in culture (Figure 2.20B). This response pattern was supported by CFSE 
proliferation data. By this measure, low concentrations of P. gingivalis LPS led to a 
decreased proliferation, while high concentrations caused increased proliferation at 24 
hours, but a slight decrease at 72 hours of culture (Figure 2.21). 
 
2.3.2.2 Effects of P. gingivalis LPS on activation  
As with the response to S. enteritidis LPS (section 2.3.1.5), the activation of CH12 cells 
was assessed by examining changes in the expression of CD80, CD86 and sIgM. There 
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were no significant changes in the expression of either CD80 (Figure 2.22A), or CD86 
(Figure 2.22B) between control and LPS-stimulated cultures over the culture period. 
However, the levels of sIgM mRNA in the 1µg/mL stimulated cultures were 
significantly lower than the control at 24 and 48hrs (Figure 2.23). 
 
2.3.2.3 Investigation of molecular events associated with P. gingivalis 
LPS stimulation in CH12 cells 
Potential mechanisms underlying the effects of P. gingivalis LPS on the activation and 
differentiation of CH12 were investigated by determining changes in the expression of a 
range of genes that have shown to be important in the regulation of B cell survival and 
growth. Bcl-2 and Bax mRNA levels were measured simultaneously in CH12 cells 
stimulated with P. gingivalis LPS using RT-qPCR, while levels of mRNA for relevant 
TLR and cytokines were also examined. 
 
2.3.2.3.1  Stimulation with P. gingivalis LPS does not affect the Bax/Bcl-
2 ratio 
Levels of mRNA of the apoptosis regulatory genes Bax and Bcl-2 were determined by 
RT-qPCR and the ratio of their expression was calculated (Figure 2.24). No significant 
differences were found between control and LPS-stimulated cultures. 
 
2.3.2.3.2  Stimulation with P. gingivalis LPS does not affect level of 
expression of Toll-like receptors 
The mRNA expression of relevant TLR was determined in culture using RT-qPCR. 
There were no significant changes in the expression of either TLR2 (Figure 2.25A) or 
TLR4 (Figure 2.25B) mRNA. There was a significant increase in Rp105 expression in 
the 1µg/ml culture (Figure 2.26), however the magnitude of the increase was very small 
(1.5 fold). 
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2.3.2.3.3  Stimulation with P. gingivalis LPS does not cause changes in 
cytokine mRNA levels 
Changes in the levels of IL-6 and IL-10 mRNA in response to P. gingivalis LPS were 
investigated by RT-qPCR (Figure 2.27). There were no significant changes over the 
course of the culture period. 
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Figure 2.1 Effect of S. enteritidis LPS on biomass in 10% FCS cultures 
 
CH12 cells were cultured in medium containing 10% FCS and varying concentrations of LPS. 
Biomass was measured using an MTT-formazan assay (see section 2.2.7). There were no 
statistically significant differences (p<0.05) overall, as determined by two-way ANOVA, 
between the control and LPS-stimulated cultures. Data shown are the means and s.e.m. of six 
pooled experiments.  
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Figure 2.2 Cell viability and concentration (cells/mL) of CH12 cells in 10%FCS 
culture 
 
The viability (A) and concentration (B) of CH12 cells for all concentrations of S. enteritidis LPS 
and all time points was determined using Trypan Blue exclusion. There were no statistically 
significant differences, as determined by two-way ANOVA, between the control and LPS-
stimulated cultures at specific timepoints. Overall significant differences (p<0.05), as 
determined by one-way ANOVA, between the non-stimulated control and LPS-stimulated 
cultures are denoted by a † below the culture descriptor on the X axis.  Data shown are the 
means and s.e.m. of three pooled experiments.  
    
A 
B 
† † †
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Figure 2.3 Representative flow cytometric plots for analysis: 7AAD/CD80 
 
CH12 cells were gated using forward and side scatter to select the population and then further 
gated for viable cells in this population using 7AAD/side scatter. Levels of non-specific staining 
were determined using fluorescently-conjugated isotype-matched controls for anti-CD80-FITC 
(M1 is the negative region and M2 is the positive region). Viable cells were examined for CD80 
staining characteristics. Data shown are from a single representative experiment. 
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Figure 2.4 Changes in CD80 expression in response to S. enteritidis LPS 
 
CH12 cells were cultured in medium containing 10% FCS and varying concentrations of S. 
enteritidis LPS. The percentage of viable CH12 positive for CD80 was determined by flow 
cytometry. There were no statistically significant differences as determined by two-way 
ANOVA with Tukey’s multiple comparison post-test and one-way ANOVA. Data shown are 
the means and s.e.m. of three pooled experiments. 
Chapter 2                    58 
 
0
20
40
60
80
100
120
passage 0 24 48 72
Time (hr)
Pe
rc
en
ta
ge
 v
ia
bi
lit
y
0.000E+00
2.000E+06
4.000E+06
6.000E+06
8.000E+06
1.000E+07
1.200E+07
1.400E+07
1.600E+07
C
el
l n
um
be
r (
ce
lls
/m
L)
10%
5%
1%
10%
5%
1%
 
0
10
20
30
40
50
60
70
80
90
100
passage 0 24 48 72
Time (hr)
Pe
rc
en
ta
ge
 v
ia
bi
lit
y
0.00E+00
2.00E+06
4.00E+06
6.00E+06
8.00E+06
1.00E+07
1.20E+07
C
el
l n
um
be
rs
 (c
el
ls
/m
L)
1%
2%
3%
4%
5%
1%
2%
3%
4%
5%
 
Figure 2.5 Effect of serum supplementation on CH12 viability and proliferation 
CH12 cells were cultured in different concentrations of FCS and the cell number and viability determined 
at 24, 48 and 72 hours. The optimal concentration to FCS to slow the doubling time yet retain viability 
was determined in two stages (bars denote percentage viability and lines denote cell numbers). The first 
stage (A) selected the general range of the new lower FCS concentration between 1% and 5% FCS, whilst 
the second stage (B) identified the optimal concentration as 3% FCS. The CH12 cells cultured in medium 
supplemented with 3% FCS showed a concentration profile not significantly different (p=0.1736) to that 
of murine splenic B-1 cells in control cultures. Data shown are from representative experiments.  
Note: 2% FCS was utilised for the P. gingivalis and qPCR studies as the serum was from a different batch 
and was retitrated to ensure comparable viability and doubling times. 
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Figure 2.6 Effect of S. enteritidis LPS on viability and cell number under limited 
serum conditions 
CH12 cells were cultured in 3% FCS in the presence of different concentrations of S. enteritidis 
LPS. The viability (A) and concentration (B) of CH12 cells was determined using by 
haemocytometer count and Trypan Blue exclusion. Statistically significant differences (p<0.05) 
between the non-stimulated control and LPS-stimulated cultures, as determined by two-way 
ANOVA, are denoted by a * above the relevant time point. Statistically significant differences 
(p<0.05) between the 10% FCS and 3% FCS cultures, as determined by two-way ANOVA, are 
denoted by a # above the relevant time point. Overall significant differences (p<0.05), as 
determined by one-way ANOVA, between the non-stimulated control and LPS-stimulated 
cultures are denoted by a † below the culture descriptor on the X axis. Data shown are the 
means and s.e.m. of three pooled experiments.  
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Figure 2.7  Representative FACScan plots for flow cytometric analysis: 
7AAD/CFSE 
 
CH12 cells were gated using forward and side scatter and 7AAD prior to analysis of CFSE 
staining. (A) is an overlay of the CFSE histograms for  (B) 24hr, (C) 48hr, (D) 72hr of culture. 
M1 indicates cells that have divided once, M2 indicates cells that have divided twice, M3 
indicates cells that have divided three times and M4 indicates cells that have divided four or 
more times. Data shown are from a single representative experiment. 
Chapter 2                    61 
 
 
0
1
2
3
4
5
6
D
iv
is
io
n 
In
de
x
Control 1pg 10pg 100pg 1ng 10ng 100ng 1ug 10ug 10%
72hr
48hr
24hr
 
 
 
 
Figure 2.8 Division index of CH12 cells cultured in RPMI/3% FCS and stimulated 
with S. enteritidis LPS 
 
CH12 cells were cultured in the presence of different concentrations of S. enteritidis LPS and 
the division index (see section 2.2.9) was determined at 24, 48 and 72 hours. Statistically 
significant differences (p<0.05) between the control and LPS-stimulated cultures, as determined 
by two-way ANOVA, are denoted by a * above the relevant time point. Statistically significant 
differences (p<0.05) between the 10% FCS and 3% FCS cultures, as determined by two-way 
ANOVA, are denoted by a # above the relevant time point. Overall significant differences 
(p<0.05), determined by one-way ANOVA, between the control and LPS-stimulated cultures 
are denoted by a † below the category name on the X axis. Data shown are the means and s.e.m. 
of three pooled experiments.   
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Figure 2.9 Representative cell-cycle analysis histograms  
 
CH12 cells were gated using forward and side scatter and FL2-W/FL2-A to exclude doublets. 
Propidium iodide was used to stain DNA to determine cell cycle stages (see section 2.2.11). M1 
indicates cells in G0/G1, M2 indicates cells in S and M3 indicates cells in M phase. Data shown 
are from a single representative experiment. 
Chapter 2                    63 
 
 
 
24hr 48hr
0
10
20
30
40
50 # #
* *****
**
Time
Pe
rc
en
ta
ge
 C
el
ls
in
 G
0/
G
1
   
Control 3% FCS
10ng/mL LPS
100ng/mL LPS
1ug/mL LPS
Control 10% FCS  
24hr 48hr
0
10
20
30
40
50
Time
Pe
rc
en
ta
ge
 C
el
ls
in
 S
* *
#
     
24hr 48hr
0
10
20
30
40
50
* *# ###
Time
Pe
rc
en
ta
ge
 C
el
ls
in
 G
2/
M
 
   
 
Figure 2.10 Cell cycle in CH12 cells cultured in RPMI/3% FCS 
 
The percentage of viable cells in each phase of the cell cycle for control and test samples was 
determined at 24 and 48hr by propidium iodide staining and flow cytometric analysis. For this 
set of experiments a two-way ANOVA way used to determine significant differences; Culture 
(control, S. enteritidis LPS-stimulated etc: p<0.0001) and time (p<0.05) were both shown to 
have significant effects overall on the percentage of cells in G0/G1. For cells in S phase, culture 
(p<0.05) and time (p<0.0001) were also shown to have significant effects on the percentage of 
cells in this phase. There were no significant differences due to culture or time in the G2/M-
phase populations. Statistically significant differences (p<0.05) between the control and LPS-
stimulated cultures, as determined by one-way ANOVA and post-hoc Tukey’s multiple 
comparison test, are denoted by a * above the relevant data point. Statistically significant 
differences (p<0.05) between the 10% FCS and 3% FCS cultures, as determined by two-way 
ANOVA, are denoted by a # above the relevant time point. Data shown are the means and s.e.m. 
of three pooled experiments.  
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Figure 2.11 Representative RT-qPCR amplification and melting curves 
Typical amplification curves for each well of a sample set for the housekeeping gene HPRT is 
shown in panel A. Relative quantities of target genes were determined by normalisation to 
HPRT using the delta-delta Ct method (see section 2.2.14.9). Product purity for all PCR runs 
was determined by melting curve analysis (B). Data shown are from a single representative 
experiment. 
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Figure 2.12 Changes in CD80 and CD86 mRNA expression in response to S. 
enteritidis LPS  
The relative level of expression of the CD80 (A) and CD86 (B) genes as compared with HPRT 
was determined using RT-qPCR for control and S. enteritidis LPS-stimulated populations. 
There were no statistically significant differences as determined by two-way ANOVA with 
Tukey’s multiple comparison post-test for any cultures.  
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Figure 2.13 Changes in sIgM mRNA expression in response to S. enteritidis LPS 
The relative level of expression of secretory IgM was determined using RT-qPCR for control 
and S. enteritidis LPS-stimulated populations. Overall significant differences (p<0.05), as 
determined by one-way ANOVA, between the control and LPS-stimulated cultures are denoted 
by a † alongside the culture descriptor on the X axis. Significant differences between timepoints 
within a culture are denoted by lines connecting the columns. Data shown are the means and 
s.e.m. of three pooled experiments. 
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Figure 2.14 Representative FACScan plots for flow cytometric analysis: Bcl-2/Bax 
 
CH12 cells were gated using forward and side scatter and stained with fluorescent dye-
conjugated antibodies to either Bcl-2 or Bax. Isotype controls were used to establish negative 
(M1) and positive (M2) regions. Data shown are from a single representative experiment. 
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Figure 2.15 Changes in Bcl-2 and Bax expression in CH12 cells in response to S. 
enteritidis LPS 
 
CH12 cells were cultured in the presence of varying concentrations of S. enteritidis LPS and 
Bcl-2 and Bax protein expression was determined by flow cytometry. The Bcl-2/Bax expression 
ratio was determined using the percentage of cells positive for each stain at each S. enteritidis 
LPS concentration and time point. There are no statistically significant differences between the 
different cultures at each time point as determined by two-way ANOVA with Tukey’s multiple 
comparison post test. Overall, the Bcl-2/Bax ratios for the 48hr cultures are significantly 
different to those for the 24hr cultures, denoted by the † on the X axis, as determined by one-
way ANOVA. Data shown are the means and s.e.m. of three pooled experiments.  
†
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Figure 2.16 Changes in the ratio of Bax and Bcl-2 mRNA in response to S. 
enteritidis LPS 
CH12 cells were cultured in the presence of varying amounts of S. enteritidis LPS and the ratio 
of mRNA for BAX and Bcl-2 was determined by RT-qPCR. There are no statistically 
significant differences between the different cultures at each time point as determined by two-
way ANOVA with Tukey’s multiple comparison post test. Data shown are the means and s.e.m. 
of three pooled experiments.  
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Figure 2.17 Effect of S. enteritidis LPS on TLR2 and TLR4 mRNA expression  
CH12 cells were cultured with S. enteritidis LPS at varying concentrations and the expression of 
TLR2 (A) and TLR4 (B) mRNA was examined by RT-qPCR. Statistically significant 
differences (p<0.05) between the control and LPS-stimulated cultures, as determined by one-
way ANOVA and post-hoc Tukey’s multiple comparison test, are denoted by a * above the 
relevant data point. Data shown are the means and s.e.m. of three pooled experiments. 
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Figure 2.18 Effect of S. enteritidis LPS on RP105 mRNA expression 
CH12 cells were cultured with S. enteritidis LPS at varying concentrations and the expression of 
RP105 mRNA was examined by RT-qPCR. Statistically significant differences (p<0.05) 
between the control and LPS-stimulated cultures, as determined by two-way ANOVA, are 
denoted by a * above the relevant time point. Overall significant differences (p<0.05), as 
determined by one-way ANOVA, between the control and LPS-stimulated cultures are denoted 
by a † alongside the culture descriptor on the X axis. Significant differences between timepoints 
in a culture are denoted by the lines connecting the columns. Data shown are the means and 
s.e.m. of three pooled experiments. 
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Figure 2.19 Effect of S. enteritidis LPS on IL-6 and IL-10 mRNA expression 
CH12 cells were cultured with S. enteritidis LPS at varying concentrations and the expression of 
IL-6 (A) and IL-10 mRNA were examined by RT-qPCR. Overall significant differences 
(p<0.05), as determined by one-way ANOVA, between the control and LPS-stimulated cultures 
are denoted by a † alongside the culture descriptor on the X axis. Significant differences 
between timepoints in a culture are denoted by the lines connecting the columns. Data shown 
are the means and s.e.m. of three pooled experiments. 
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Figure 2.20 Effect of P. gingivalis LPS on CH12 viability and cell number. 
CH12 cells were cultured, under serum-limited conditions, with P. gingivalis LPS at varying 
concentrations and the viability (A) and concentration (B) of cells was determined using Trypan 
Blue exclusion. Statistically significant differences (p<0.05) between the control and LPS-
stimulated cultures, as determined by two-way ANOVA, are denoted by a * above the relevant 
time point. Overall significant differences (p<0.05), as determined by one-way ANOVA, 
between the control and LPS-stimulated cultures are denoted by a † below the culture descriptor 
on the X axis. Data shown are the means and s.e.m. of three pooled experiments.  
A 
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Figure 2.21 Division index of CH12 cells cultured in RPMI/2% FCS and stimulated 
with P. gingivalis LPS 
CH12 cells were cultured, under serum-limited conditions, with P. gingivalis LPS at varying 
concentrations and the division index of viable CH12 cells was determined using CFSE. 
Statistically significant differences (p<0.05) between the control and test cultures, as determined 
by two-way ANOVA, are denoted by a * above the relevant time point. Overall significant 
differences (p<0.05), determined by one-way ANOVA, between the control and test cultures are 
denoted by a † below the category name on the X axis. Data shown are the means and s.e.m. of 
three pooled experiments.   
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Figure 2.22 Effect of P. gingivalis LPS on CD80 and CD86 mRNA expression 
CH12 cells were cultured with P. gingivalis LPS at varying concentrations and changes in the 
levels of CD80 (A) and CD86 (B) mRNA were determined using RT-qPCR. Statistically 
significant differences (p<0.05) between the control and test cultures at a particular time point, 
as determined by two-way ANOVA, are denoted by a * above the relevant time point.   
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Figure 2.23 Effect of P. gingivalis LPS on sIgM mRNA expression 
CH12 cells were cultured with P. gingivalis LPS at varying concentrations and changes in the 
levels of sIgM mRNA were determined using RT-qPCR. Overall significant differences 
(p<0.05), determined by one-way ANOVA, between the control and test cultures are denoted by 
a † below the category name on the X axis. Data shown are the means and s.e.m. of three pooled 
experiments. 
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Figure 2.24 Effect of P. gingivalis LPS on BAX/Bcl2 mRNA ratio 
CH12 cells were cultured with P. gingivalis LPS at varying concentrations and changes in ratio 
of BAX to Bcl-2 mRNA was determined using RT-qPCR The Bax/Bcl-2 mRNA expression 
ratio was determined using the relative levels of expression of each gene (as compared with 
HPRT) for each P. gingivalis LPS concentration and time point. There are no statistically 
significant differences between the different cultures at each time point as determined by two-
way ANOVA with Tukey’s multiple comparison post test. Data shown are the means and s.e.m. 
of three pooled experiments.  
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Figure 2.25 Effect of P. gingivalis LPS on TLR2 and TLR4 mRNA expression 
CH12 cells were cultured with P. gingivalis LPS at varying concentrations and changes in the 
levels TLR2 (A) and TLR4 (B) mRNA were determined using RT-qPCR. There are no 
statistically significant differences between the control and test cultures, as determined by two-
way ANOVA. Data shown are the means and s.e.m. of three pooled experiments.
A 
B 
Chapter 2                    79 
 
0 100ng 1µg 10µg
0
1
2
3
0hr
24hr
48hr
LPS Concentration (per mL)
R
el
at
iv
e 
Ex
pr
es
si
on
 L
ev
el
 
 
Figure 2.26 Effect of P. gingivalis LPS on RP105 mRNA expression 
CH12 cells were cultured with P. gingivalis LPS at varying concentrations and changes in the 
levels of  CD80 (A) and CD86 (B) mRNA were determined using RT-qPCR There are no 
statistically significant differences between the control and test cultures, as determined by two-
way ANOVA. Significant differences between timepoints in a culture are denoted by the lines 
connecting the columns.  Data shown are the means and s.e.m. of three pooled experiments. 
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Figure 2.27 Effect of P. gingivalis LPS on IL-6 and IL-10 mRNA expression 
The relative level of expression of IL-6 (A) and IL-10 (B) as compared with HPRT was 
determined using quantitative PCR for control and P. gingivalis LPS-stimulated populations. 
There are no statistically significant differences between the different cultures at each time point 
as determined by two-way ANOVA with Tukey’s multiple comparison post test. Data shown 
are the means and s.e.m. of three pooled experiments. 
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2.4 Discussion 
The aim of the studies presented in this chapter was to investigate the response of the B-
1 cells, using the immortalised CH12 cell line, to enteric (S. enteritidis) and non-enteric 
(P. gingivalis) LPS. Initial efforts at developing a culture system foundered when it 
became apparent that changes in proliferation and activation were obscured in cultures 
containing high concentrations of FCS. Subsequently, a serum-limiting culture system 
was developed that enabled the response to LPS to be examined. 
 
Reduction of the percentage of FCS in culture decreased both the viability and the 
division index of CH12 cells. For unstimulated cells in S. enteritidis LPS experiments, 
CH12 viability decreased over the course of the culture period, and at 72hr viability was 
significantly different to the starting viability (Figure 2.6A), while the concentration of 
viable cells remained relatively stable (Figure 2.6B). This balance was presumably 
maintained by the interacting effects of a low level of proliferation (Figure 2.8 and 
Figure 2.10) offset by the well-described pro-apoptotic effects of serum deprivation 
(Grimm et al., 1996; Hasan et al., 1999). A similar pattern was seen in the P. gingivalis 
LPS experiments, although the picture was not as clear-cut as the growth, and viability 
inhibition that occurred with this particular batch of serum was not as marked. 
Nevertheless, serum limitation led to decreased viability (Figure 2.20A) and 
proliferation (Figure 2.20B and Figure 2.21) in comparison to 10% FCS control 
cultures. As uncontrolled proliferation of immune cells, such as B cells, could 
potentially have dire consequences for organisms, it has been argued (Allen et al., 1993; 
Gordon et al., 1993) that the default program for cell survival in most immune cells is, 
in fact, to apoptose. The apoptosis regulatory pathways in CH12 cells are obviously 
compromised, as the cell is immortal. Nevertheless, limitation of serum allowed the pro- 
and anti-apoptotic effects of different LPS preparations to be examined.  
 
Under serum-limiting conditions, the addition of S. enteritidis LPS at 100ng/ml and 
above led to the rescue of CH12 cells from death (Figure 2.6A), stimulated them to 
enter the cell cycle (Figure 2.10) and caused them to proliferate (Figure 2.8). In contrast, 
P. gingivalis LPS at high concentrations appeared to have no effect on viability (Figure 
2.20A), but did lead to proliferation. The threshold dose for this effect on proliferation 
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was unclear as increased cell numbers in culture were seen for doses of LPS from 
100ng/ml and above (Figure 2.20). However, using the division index as a measure, 
several 72-hour timepoints for different LPS concentrations, and also including the 10% 
FCS control, actually showed a slightly decreased proliferation compared with the 
unstimulated timepoint controls. The fact that the division index of the unstimulated 
control was higher than the 10% FCS control suggests that the unstimulated control at 
this timepoint was artifactually high, possibly being obscured by the relatively high 
background level of proliferation in this series of experiments. Nevertheless, at 24 hours 
of culture, P. gingivalis LPS at a concentration of 10µg/ml caused significant 
proliferation of CH12 cells by this measure. 
 
Despite a series of investigations, the cellular mechanisms underlying the anti-
apoptotic/pro-proliferative effects of the different LPS preparation remained unclear. 
The relative levels of Bcl-2 and Bax have been shown to be important in regulating cell 
survival (see section 2.1). The Bcl-2/Bax ratio did not change in the P. gingivalis LPS 
challenged cells (Figure 2.24), which was in keeping with the lack of cell death seen in 
these cultures. However, in response to S. enteritidis LPS, which at high concentrations 
rescued CH12 cells from death, neither the protein (Figure 2.15) nor mRNA (Figure 
2.16) ratios of these mediators correlated with protection. Although Bcl-2 has been 
implicated in the rescue of many cell types from apoptosis initiated by various stimuli, 
including serum-deprivation (Grimm et al., 1996), it may be that Bcl-2 expression is 
already abnormally high in CH12 cells, and that other parallel pathways are responsible 
for the observed protection. Supporting this argument is evidence that high endogenous 
levels of Bcl-2 are seen in a variety of B-1 lymphomas (Gottardi et al., 1996) and in 
CH12 cells in particular (Brown and Phipps, 1996). Regulation of apoptosis is complex 
and incompletely understood. Other apoptosis regulators such as anti-apoptotic Al/Bfl-
1, Bcl-w, Bcl-xL, Boo/Diva/Bcl-B, and Mcl-1 and pro-apoptotic Bak, Bok/Mtd, Bcl-x, 
and Bcl-GL (reviewed in Marsden and Strasser, 2003) may also play a role in B cell 
survival and death; however, it is beyond the scope of this thesis to further discuss these 
alternative regulators. 
 
The autocrine stimulation of B cells by a range of cytokines, in particular IL-10, has 
also been implicated in promoting B cell survival and proliferation (see section 1.5.2.2). 
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CH12 cells have previously been shown to produce both IL-6 and IL-10 (O'Garra et al., 
1990), so it was possible that an increased production of either of these cytokines may 
have been responsible for the enhanced proliferation seen in LPS simulated cultures. 
This, however, did not appear to be the case. No significant changes were seen in the 
mRNA levels of IL-6 in response to either LPS preparation. Although there was a 
significant increase in IL-10 mRNA in CH12 cells cultured with 100ng/ml of S. 
enteritidis LPS, this increase was small in magnitude and not seen in other stimulated 
cultures. In addition, no significant changes were noted in cultures stimulated with P. 
gingivalis LPS. 
 
Increased activation of CH12 cells by the LPS preparations was not seen. The co-
stimulatory molecules CD80 and CD86 are typically upregulated in activated B cells 
(Ding and Shevach, 1996; Kozono et al., 1998; Nagai et al., 2002), however neither 
CD80 nor CD86 mRNA levels were increased following incubation with either LPS 
preparation (Figure 2.12 and Figure 2.22). Although not directly tested in serum-limited 
cultures, under non serum-limiting conditions the majority of non LPS-stimulated CH12 
cells expressed high levels of CD80 (Figure 2.4), which suggests that these cells have a 
high level of basal activation. In contrast to the lack of effect of LPS on co-stimulatory 
molecule expression, high concentrations of S. enteritidis LPS did cause an increase in 
secretory IgM mRNA (Figure 2.13). This is consistent with previously published reports 
that have demonstrated either increased sIgM mRNA or IgM secretion by CH12 cells in 
response to enteric (E. coli) LPS (Stockdale et al., 1987; Arnold et al., 1988; Bost et al., 
1990). Interestingly, P. gingivalis LPS did not affect sIgM mRNA levels (Figure 2.23), 
which suggests that this LPS may act via alternative signalling pathways. 
 
As described in section 1.5.2.1.2, the primary LPS receptor on macrophages is TLR4, 
while in B cells the predominant receptor appears to be RP105. Alternatively, some 
have argued that TLR2 is important in the recognition of LPS derived from non-enteric 
bacteria such as P. gingivalis. Although it was beyond the resources available to this 
project to investigate the Toll-like receptor signalling pathways in detail, it was practical 
to investigate changes in the levels of mRNA for the major TLR that could be involved 
in the response to enteric and non-enteric LPS. In response to P. gingivalis LPS, there 
were no changes in any of the TLRs examined (Figure 2.25 and Figure 2.26). While 
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there were no changes in the expression of either TLR2 or TLR4 (Figure 2.17) in 
response to S. enteritidis LPS, there was a clear decrease in RP105 expression over the 
course of culture (Figure 2.18). Down-regulation of TLR4 mRNA has been reported in 
macrophage lines in response to enterobacterial LPS (Poltorak et al., 1998; Medvedev et 
al., 2000; Nomura et al., 2000), while the level of TLR2 mRNA was decreased in 
response to bacterial lipoprotein challenge (Wang et al., 2002). Such regulation of 
expression has been argued to contribute to the phenomenon of endotoxin tolerance, 
which is believed to be a mechanism to limit the deleterious effects of macrophage-
derived products on the organism (Medvedev et al., 2000; Nomura et al., 2000; Wang et 
al., 2002). The biological significance of the down-regulation of RP105 seen in the 
present experiments is unclear, but may represent an analogous B cell regulatory 
mechanism.  
 
Whatever the overall biological outcome of changes in RP105 expression, it appears 
that S. enteritidis and P. gingivalis LPS have differential effects on RP105 regulation. It 
is possible that this reflects differential use of TLR in responding to the two LPS 
preparations. It has been suggested that P. gingivalis LPS signals through TLR2 (see 
section 1.5.2.1.3). However, the lack of changes in TLR2 expression in response to 
either LPS preparation makes it difficult to assess if P. gingivalis LPS is signalling via 
this pathway or through some other pathway. However, enterobacterial LPS is argued to 
signal via TLR4, which is associated with RP105 in B cells (see section 1.5.2.1.4). It 
seems likely that S. enteritidis, but not P. gingivalis LPS is acting via this pathway, as in 
the present experiments, RP105 expression was down-regulated by S. enteritidis, but 
not P. gingivalis LPS.  
 
Taken together, these results suggest that LPS from the enteric and non-enteric bacteria 
may have different effects on the activation of B-1 cells. While LPS from the enteric 
pathogen S. enteritidis leads to B-1 cell proliferation and production of antibody at 
moderate concentrations, highly purified LPS derived from the periodontal pathogen P. 
gingivalis had less marked effects. Moreover, the results presented here are consistent 
with at least partially independent signalling pathways between the two types of LPS.
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Chapter 3 Response of a B-2 cell line to 
lipopolysaccharide 
 
3.1 Introduction 
The experiments described in the previous chapter found that a B-1 cell line responded 
differently to Salmonella enteritidis and Porphyromonas gingivalis LPS. Both LPS 
preparations caused proliferation at moderate to high concentrations, while S. enteritidis 
LPS also increased viability of cells and enhanced IgM secretion. As it was postulated 
that B-1 cells are more sensitive to the effects of LPS than B-2 cells, it was also 
important to examine the response of B-2 cells to LPS. 
 
In order to achieve this aim, the WEHI-279 cell line was used as a model for studying 
B-2 cells as this line is responsive to LPS stimulation (Kleine et al., 1985; Hobbs et al., 
1991). As described in section 1.6.2, WEHI-279 cells have Fc receptors, high levels of 
mIgM molecules, and secrete negligible amounts of IgM (Warner et al., 1975; Paige et 
al., 1982).WEHI-279 resembles normal resting B cells and can be induced to mature to 
the state of active Ig secretion (Paige et al., 1982).. As with studies in the previous 
chapter, serum-limiting conditions were used in order to slow the doubling time of the 
line and to enable comparisons to be made between aspects of the B-1 and B-2 cell 
responses. These aspects included proliferation in response to LPS (utilising CFSE 
staining), analysis of cell cycle (using PI), analysis of activation (CD80 and CD86 
expression) and the ratio of the levels of the cell-death related proteins Bcl-2 and Bax 
(using flow cytometry and quantitative real-time PCR). 
 
3.2 Methods 
3.2.1 WEHI-279 
The WEHI-279 cell line was purchased from ATCC (catalogue number CRL-1704; 
Manassas, VA, USA). 
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3.2.2 Cell Culture 
WEHI-279 cells were cultured in DMEM supplemented with 4mM glutamine, 1.5g/L 
sodium bicarbonate, 4.5g/L glucose, 1mM sodium pyruvate, 0.05mM 2-
mercaptoethanol, antibiotic mixture (penicillin 50IU/mL and streptomycin 50µg/mL) 
and 10% FCS. 
(See Sections 2.2.2 Thawing of cells, 2.2.3 Freezing of cells, and 2.2.4 Passaging of 
CH12 as the same methods were utilised for WEHI-279.) 
 
3.2.3 Mitogens 
See Section 2.2.6 Mitogens 
 
3.2.4 Flow cytometry 
See Sections 2.2.8 5-carboxyfluorescein diacetate-succinimidyl ester (CFSE) staining of 
cells, 2.2.9 Determination of division index in CFSE-stained B cell subsets, and 2.2.10 
Flow cytometric analysis of CFSE stained cells. 
LPS concentrations for further analysis were chosen on the basis of significant 
differences in the viability and cell number data to that of the control population. 
 
3.2.5 Quantitative PCR 
See Section 2.2.14 Quantitative PCR and sub-sections. 
 
3.2.6 Statistical Analyses 
Control and LPS-stimulated values were compared for all experiments. Two-way 
ANOVA to compare differences at particular time points between unstimulated and 
stimulated populations, with Tukey's multiple comparison post test to compare 
differences between time points in a population, and one-way ANOVA to test 
differences overall between unstimulated and stimulated populations were performed 
using GraphPad Prism version 3.00 for Windows, GraphPad Software, San Diego 
California USA, www.graphpad.com. All data shown are pooled means from a number 
of experiments. All error bars shown are the standard error of the mean. 
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3.3 Results 
3.3.1 Studies utilising S. enteritidis LPS  
3.3.1.1 High concentrations of S. enteritidis LPS enhance viability but 
do not induce proliferation 
The effect of S. enteritidis LPS on the viability and proliferation of WEHI-279 cells was 
examined by culturing the cells under serum-limiting conditions in the presence of 
varying concentrations of LPS. In the absence of S. enteritidis LPS, the viability WEHI-
279 cells decreased over the course of the experiment (Figure 3.1A). While low 
concentrations of LPS did not have any effect on cell viability, some higher 
concentrations did protect the cells from death. Cells cultured in with 10ng/ml LPS 
showed significantly increased viability at 24 hours in comparison to the unstimulated 
control at the same timepoint. However, there was no clear trend, as most of the higher 
doses tested did not appear to protect the cells from death. Nevertheless, the highest 
concentration of LPS used, 10µg/ml, did show significantly increased viability at both 
24 and 48 hours in comparison to non-stimulated controls (Figure 3.1A). 
 
Despite the decrease in viability for the whole cell populations, cells did in fact appear 
to be proliferating within the cultures. There were modest increases in cell 
concentrations in the non-stimulated controls and all of the test cultures, although the 
magnitude of this increase was much less than that seen in the 10%FCS control (Figure 
3.1B). Perhaps surprisingly, S. enteritidis LPS did not appear to induce further 
proliferation of WEHI-279 cells, as none of the LPS-stimulated cultures were 
significantly different to the control 2% FCS unstimulated culture at the same timepoint 
(Figure 3.1B). These findings were confirmed when proliferation was examined using 
CFSE (Figure 3.2). While the division index increased over the culture period in 
individual cultures, suggesting proliferation was occurring, there did not appear to be an 
induced proliferation in the presence of LPS. In fact, at the 72-hour timepoints in 
several of the cultures, a decreased division index was noted (Figure 3.2).  
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3.3.1.2 S. enteritidis LPS does not affect CD80, CD86 or sIgM mRNA 
levels 
In addition to investigating the effects of S. enteritidis LPS on the survival and 
proliferation of WEHI-279 cells, potential activation effects were also gauged by 
examining changes in the expression of molecules associated with B cell activation. 
Changes in mRNA levels of the co-stimulatory molecules CD80 and CD86, as well as 
the expression of the constant chain of secretory IgM, were determined by RT-qPCR in 
high dose LPS cultures. Neither CD80 (Figure 3.3A), nor CD86 (Figure 3.3B) changed 
significantly over the course of the experiment. Also, sIgM mRNA levels did not 
change with LPS stimulation suggesting that S. enteritidis LPS did not induce increased 
antibody production (Figure 3.5). 
 
3.3.1.3 Investigation of molecular events associated with S. enteritidis 
LPS stimulation  
In order to further investigate the molecular basis of S. enteritidis LPS effects on 
WEHI-279 cells, changes in the mRNA levels of different TLRs, as well as those of the 
apoptosis regulators Bax and Bcl-2, were determined by RT-qPCR in cultures 
stimulated with LPS. Neither the Bax/Bcl-2 mRNA ratio (Figure 3.4), nor the 
expression levels of TLR2 (Figure 3.6A), TLR4 (Figure 3.6B), or RP105 (Figure 3.7) in 
LPS-stimulated cultures were significantly different to unstimulated timepoint controls. 
 
3.3.1.4 Stimulation with S. enteritidis LPS affects cytokine mRNA levels 
Changes in the levels of IL-6 and IL-10 mRNA in response to S. enteritidis LPS were 
investigated by RT-qPCR (Figure 3.8). While there were no significant changes over the 
course of the culture period in IL-6 mRNA expression apart from an increase at 8hr in 
the 1µg/mL culture, the level of IL-10 mRNA expression in the 10µg/mL culture 
increased significantly over the culture period (Figure 3.8B). 
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3.3.2 P. gingivalis LPS studies 
3.3.2.1 Low concentrations of P. gingivalis LPS enhance but high 
concentrations inhibit WEHI-279 proliferation  
The effects of P. gingivalis LPS on the viability and proliferation on WEHI-279 cells 
was investigated by culturing cells in serum-limited conditions in the presence of 
varying concentrations of LPS. As with the experiments described in section 3.3.1.1, in 
the absence of LPS WEHI-279 cells in serum-limited cultures decreased in viability 
over the timecourse of the experiment (Figure 3.9A). In contrast to S. enteritidis LPS 
however, none of the doses of P. gingivalis LPS were associated with changes in 
viability compared to non-stimulated controls at the corresponding timepoints (Figure 
3.9A).  
 
The effects of P. gingivalis LPS on the proliferation of WEHI-279 cells were complex. 
There was some proliferation evident in the non-stimulated control group, as well as in 
most of the LPS-stimulated controls, over the course of the experiment. However, when 
changes in cell number were used to assess proliferation, low doses of LPS (10pg/mL 
and 100pg/mL) caused small, but significant, increases in cell number when compared 
to non-stimulated timepoint controls (Figure 3.9B). High doses of LPS (1µg/mL, 
10µg/mL) however, were associated with reduced cell numbers at 48 and/or 72 hours 
(Figure 3.9B). When proliferation was measured by CFSE dye dilution, significantly 
increased proliferation in response to low dose P. gingivalis was not seen, however cells 
cultured with either 10ng/mL and 1µg/mL LPS clearly showed decreased levels of 
proliferation at both 48 and 72 hours when compared to non-stimulated timepoint 
controls (Figure 3.10). 
 
3.3.2.2 P. gingivalis LPS does not affect CD80, CD86 or sIgM mRNA 
levels 
Since there appeared to be differential effects of P. gingivalis LPS on cellular 
proliferation, both low and high doses of LPS were chosen for further study of 
activation markers. As was found with S. enteritidis LPS (section 3.3.1.2), and despite 
the significant differences in proliferation observed in response to P. gingivalis LPS, no 
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changes were found in mRNA levels for CD80 (Figure 3.11A), CD86 (Figure 3.11B) or 
sIgM (Figure 3.13) in response to different LPS concentrations.  
 
3.3.2.3 Investigation of molecular events associated with P. gingivalis 
LPS stimulation 
As with the response of WEHI-279 cells to S. enteritidis LPS, the molecular basis of the 
effects of P. gingivalis LPS on WEHI-279 cells was investigated. Changes in the 
mRNA levels of different TLR, as well as those of the apoptosis regulators Bax and 
Bcl-2, were determined by RT-qPCR in cultures stimulated with either low or high 
concentrations of LPS. Neither the Bax/Bcl-2 ratio (Figure 3.12), nor the expression 
levels of TLR2 (Figure 3.14A), TLR 4 (Figure 3.14B), or Rp105 (Figure 3.15) in LPS-
stimulated cultures were significantly different to unstimulated timepoint controls. 
While there was an apparent decrease in the Bax/Bcl-2 ratio in the LPS-stimulated 
cultures over time, this was not statistically significant (p>0.05 for all timepoints 
compared with t=0). 
 
3.3.2.4 Stimulation with P. gingivalis LPS does not cause changes in 
cytokine mRNA levels 
Changes in the levels of IL-6 and IL-10 mRNA in response to P. gingivalis LPS were 
investigated by RT-qPCR (Figure 3.16). The only significant change in cytokine mRNA 
expression was for IL-6 between the 24 and 48hr time points in the 1µg/mL culture.  
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Figure 3.1 Effect of S. enteritidis LPS on the viability and concentration of WEHI-
279 cells in serum-limited cultures 
WEHI-279 cells were cultured in serum-limited conditions with S. enteritidis LPS at varying 
concentrations and the viability (A) and concentration (B) of cells was determined using Trypan 
Blue exclusion. Statistically significant differences (p<0.05) between the control and LPS-
stimulated cultures, as determined by two-way ANOVA, are denoted by a * above the relevant 
time point. Overall significant differences (p<0.05), as determined by one-way ANOVA, 
between the control and LPS-stimulated cultures are denoted by a † below the culture descriptor 
on the X axis. Data shown are the means and s.e.m. of three pooled experiments. 
A 
B 
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Figure 3.2 Division index of WEHI-279 cells stimulated with S. enteritidis LPS 
WEHI-279 cells were cultured in serum-limited conditions with S. enteritidis LPS at varying 
concentrations and the division index of viable WEHI-279 was determined using CFSE dilution 
and flow cytometry. Statistically significant differences (p<0.05) between the control and test 
cultures, as determined by two-way ANOVA, are denoted by a * above the relevant time point. 
Overall significant differences (p<0.05), determined by one-way ANOVA, between the control 
and test cultures are denoted by a † below the category name on the X axis. Data shown are the 
means and s.e.m. of three pooled experiments.   
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Figure 3.3 Effect of S. enteritidis LPS on expression of CD80 and CD86 mRNA  
WEHI-279 cells were cultured in serum-limited conditions with S. enteritidis LPS at varying 
concentrations and the relative level of expression of the CD80 (A) and CD86 (B) genes as 
compared with HPRT was determined using RT-qPCR. Data shown are the means and s.e.m. of 
three pooled experiments. 
A 
B 
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Figure 3.4 Effect of S. enteritidis LPS on Bax and Bcl-2 relative expression ratio 
WEHI-279 cells were cultured in serum-limited conditions with S. enteritidis LPS at varying 
concentrations and the Bax/Bcl-2 mRNA expression ratio was determined using the relative 
levels of expression of each gene by RT-qPCR. There are no statistically significant differences 
between the different cultures at each time point as determined by two-way ANOVA with 
Tukey’s multiple comparison post test. Data shown are the means and s.e.m. of three pooled 
experiments.  
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Figure 3.5 Effect of S. enteritidis LPS on expression of sIgM mRNA  
WEHI-279 cells were cultured in serum-limited conditions with S. enteritidis LPS at varying 
concentrations and the relative level of expression of mRNA for sIgM was determined using 
RT-qPCR. Data shown are the means and s.e.m. of three pooled experiments. 
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Figure 3.6 Effect of S. enteritidis LPS on expression of TLR2 and TLR4 mRNA  
WEHI-279 cells were cultured in serum-limited conditions with S. enteritidis LPS at varying 
concentrations and the relative level of expression of TLR2 (A) and TLR4 (B) mRNA was 
determined by RT-qPCR. Data shown are the means and s.e.m. of three pooled experiments. 
B 
A 
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Figure 3.7 Effect of S. enteritidis LPS on expression of RP105 mRNA  
WEHI-279 cells were cultured in serum-limited conditions with S. enteritidis LPS at varying 
concentrations and the relative level of expression of RP105 mRNA was determined using RT-
qPCR. Data shown are the means and s.e.m. of three pooled experiments 
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Figure 3.8 Effect of S. enteritidis LPS on expression of IL-6 and IL-10 mRNA 
WEHI-279 cells were cultured in serum-limited conditions with S. enteritidis LPS at varying 
concentrations and the relative level of expression of IL-6 (A) and IL-10 (B) mRNA was 
determined using RT-qPCR. Statistically significant differences (p<0.05) between the control 
and test cultures, as determined by two-way ANOVA, are denoted by a * above the relevant 
time point. Significant differences between time points at a particular LPS concentration are 
denoted by bars joining the relevant columns. Data shown are the means and s.e.m. of three 
pooled experiments. 
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Chapter 3                    99 
 
control 1pg 10pg 100pg 1ng 10ng 100ng 1ug 10ug 10% FCS
0
25
50
75
100 0
24
48
72
 †  †
*
*
Sample
Vi
ab
ili
ty
 (%
)
 
control 1pg 10pg 100pg 1ng 10ng 100ng 1ug 10ug 10% FCS
0.0×10-00
2.5×1005
5.0×1005
7.5×1005
1.0×1006
1.3×1006
1.5×1006
1.8×1006
2.0×1006
Sample
C
on
ce
nt
ra
tio
n 
(c
el
ls
/m
L)
 †  † † †
*
*
*
*
***
*
 
 
Figure 3.9 Effect of P. gingivalis LPS on the viability and concentration of WEHI-
279 cells in serum-limited cultures  
The viability (A) and concentration (B) of WEHI-279 cells for all concentrations of P. 
gingivalis LPS and all time points with 2% FCS was determined using Trypan Blue exclusion. 
Statistically significant differences (p<0.05) between the control and LPS-stimulated cultures, 
as determined by two-way ANOVA, are denoted by a * above the relevant time point. Overall 
significant differences (p<0.05), as determined by one-way ANOVA, between the control and 
LPS-stimulated cultures are denoted by a † below the culture descriptor on the X axis. Data 
shown are the means and s.e.m. of three pooled experiments. 
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Figure 3.10 Division index of WEHI-279 cells cultured in RPMI/2% FCS and 
stimulated with P. gingivalis LPS 
WEHI-279 cells were cultured in serum-limited conditions with P. gingivalis LPS at varying 
concentrations and the relative level of expression of the division index of viable WEHI-279 
cells was determined using CFSE dye dilution and flow cytometry (see section 2.2.9). 
Statistically significant differences (p<0.05) between the control and test cultures, as determined 
by two-way ANOVA, are denoted by a * above the relevant time point. Overall significant 
differences (p<0.05), determined by one-way ANOVA, between the control and test cultures are 
denoted by a † below the category name on the X axis. In some cases differences between 
control and test were not able to be tested and these are denominated by “n.d.” under the 
appropriate column. Data shown are the means and s.e.m. of three pooled experiments.   
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Figure 3.11 Effect of P. gingivalis LPS on expression of CD80 and CD86 mRNA 
WEHI-279 cells were cultured in serum-limited conditions with P. gingivalis LPS at varying 
concentrations and the relative level of expression of CD80 (A) and CD86 (B) mRNA was 
determined RT-qPCR. There are no statistically significant differences between the different 
cultures at each time point as determined by two-way ANOVA with Tukey’s multiple 
comparison post test. Data shown are the means and s.e.m. of three pooled experiments.  
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Figure 3.12 Effect of P. gingivalis LPS on Bax/Bcl2 mRNA ratio 
WEHI-279 cells were cultured in serum-limited conditions with P. gingivalis LPS at varying 
concentrations and the ratio of Bax/Bcl-2 mRNA was determined using RT-qPCR. There are no 
statistically significant differences between the different cultures at each time point as 
determined by two-way ANOVA with Tukey’s multiple comparison post test. Data shown are 
the means and s.e.m. of three pooled experiments.  
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Figure 3.13 Effect of P. gingivalis LPS on expression of sIgM mRNA  
WEHI-279 cells were cultured in serum-limited conditions with P. gingivalis LPS at varying 
concentrations and the relative level of expression of sIgM mRNA was determined using RT-
qPCR. There are no statistically significant differences between the different cultures at each 
time point as determined by two-way ANOVA with Tukey’s multiple comparison post test. 
Data shown are the means and s.e.m. of three pooled experiments. 
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Figure 3.14 Effect of P. gingivalis LPS on expression of TLR2 and TLR4 mRNA 
WEHI-279 cells were cultured in serum-limited conditions with P. gingivalis LPS at varying 
concentrations and the relative level of expression of TLR2 (A) and TLR4 (B) mRNA was 
determined using RT-qPCR. There are no statistically significant differences between the 
different cultures at each time point as determined by two-way ANOVA with Tukey’s multiple 
comparison post test. Data shown are the means and s.e.m. of three pooled experiments.  
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Figure 3.15 Effect of P. gingivalis LPS on expression of RP105 mRNA  
WEHI-279 cells were cultured in serum-limited conditions with P. gingivalis LPS at varying 
concentrations and the relative level of expression of RP105 mRNA was determined using RT-
qPCR. There are no statistically significant differences between the different cultures at each 
time point as determined by two-way ANOVA with Tukey’s multiple comparison post test. 
Data shown are the means and s.e.m. of three pooled experiments. 
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Figure 3.16 Effect of P. gingivalis LPS on expression of IL-6 and IL-10mRNA 
WEHI-279 cells were cultured in serum-limited conditions with P. gingivalis LPS at varying 
concentrations and the relative level of expression of IL-6 (A) and IL-10 (B) was determined 
using RT-qPCR. There are no statistically significant differences between the different cultures 
at each time point as determined by two-way ANOVA with Tukey’s multiple comparison post 
test. Data shown are the means and s.e.m. of three pooled experiments. 
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3.4 Discussion 
In this chapter, the response of a B-2 cell line (WEHI-279) to both enteric (S. 
enteritidis) and non-enteric (P. gingivalis) LPS was examined. As a model for the 
general B-2 response to different forms of LPS, the WEHI-279 line provides initial 
information regarding the response, and allows comparison with a B-1 cell line (Chapter 
2). In addition, as the species of origin of the LPS may be important in determining B 
cell proliferation, differential activation by different LPS preparations was able to be 
assessed.   
 
A serum-limiting culture system was used in order to decrease cellular proliferation and 
survival. This also allowed comparison to the results of investigations using the CH12 
cell line in a similar serum-limiting culture system (Chapter 2). As was seen with CH12 
cells, there appeared to be a balance between cellular proliferation and apoptosis 
induced by serum limitation. Culture of WEHI-279 cells under serum-limited conditions 
resulted in a reduction of viability over the culture period (Figure 3.1 and Figure 3.9). 
However, in contrast to its effects on CH12 cells (Figure 2.6), S. enteritidis LPS only 
increased cell viability at high concentrations (10µg/ml). In addition, and again in 
contrast to its effects on CH12 cells, S. enteritidis LPS appeared to have no positive 
effect on cell proliferation. There were no significant changes in the number of cells in 
culture in response to any LPS concentration (Figure 3.1B), while there actually 
appeared to be a decrease in proliferation at 72 hours in several of the LPS-stimulated 
cultures when this was assessed by CFSE dye dilution (Figure 3.2). The effects of P. 
gingivalis LPS on WEHI-279 viability and proliferation are not simply explained. As 
with S. enteritidis LPS, there was no effect of P. gingivalis LPS on viability (Figure 
3.9). At low concentrations, culture with P. gingivalis LPS led to increased numbers of 
cells in culture, while high concentrations led to decreased numbers (Figure 3.9). The 
high dose inhibitory effect was confirmed using CFSE dye dilution (Figure 3.10). 
However, the low dose enhancement of proliferation was not evident by this measure, 
which questions the biological significance. It therefore appears that the WEHI-279 
cells are less sensitive than CH12 cells to the pro-survival and proliferative effects of 
both enteric and non-enteric LPS. It may also be that, in contrast to S. enteritidis LPS, 
P. gingivalis LPS actively inhibits WEHI-279 proliferation. These observations suggest 
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that B-2 cells may be less sensitive to the anti-apoptotic and pro-proliferative effects of 
LPS than B-1 cells and, further, that B-2 proliferation may be actively inhibited by high 
concentrations of non-enteric LPS.  
 
As there were few changes seen in viability of WEHI-279 cells in response to P 
gingivalis LPS, it was expected that there would be little or no change in the expression 
of apoptosis regulators in these cultures. This was indeed the case. There was no 
difference in the Bax/Bcl-2 ratio of any of the test cultures when compared with 
timepoint controls (Figure 3.12). In contrast to P. gingivalis LPS-stimulated cultures, 
cells stimulated with 10µg/ml S. enteritidis LPS did have slightly enhanced viability 
(Figure 3.1), however there was no difference between the Bax/Bcl-2 mRNA ratio of 
these cultures and those of the controls (Figure 3.4). The reason for this is unclear, but 
since the magnitude of viability change is not large, the lack of change in the Bax/Bcl-2 
ratio could simply reflect but this. However, it could also indicate that these molecules 
are not important in the regulation of viability of the WEHI-279 cell line. 
 
There were effects of P. gingivalis - and possibly S. enteritidis - LPS, on proliferation, 
however these effects did not correlate with changes in mRNA levels of IL-10 or IL-6. 
In response to S. enteritidis LPS stimulation, changes in proliferation were equivocal, as 
described above. However, there were no significant differences in either IL-10 or IL-6 
mRNA levels between S. enteritidis LPS-stimulated and unstimulated cultures. In 
contrast to the proliferative changes seen in response to S. enteritidis LPS, there was 
clear inhibition of the proliferation of WEHI-279 cells by P. gingivalis LPS. This 
response was not accompanied by any changes in the either IL-10 or IL-6 mRNA 
(Figure 3.16). This data supports the argument that removal of autocrine cytokine 
stimulation is not responsible for the inhibition of WEHI-279 proliferation by P. 
gingivalis LPS. The exact mechanism remains unclear. 
 
In contrast to the effect of LPS on TLR mRNA levels in CH12 cells (see section 2.4), 
there were no effects of either S. enteritidis LPS (Figures 3.6 and 3.7), or P. gingivalis 
LPS (Figure 3.14 and Figure 3.15) on TLR mRNA levels. As described in section 
1.5.2.1, changes in TLR mRNA levels may be involved in the down-regulation of 
responsiveness of cells to LPS. The lack of changes in TLR mRNA levels in response to 
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LPS means that regulation of TLR mRNA levels is unlikely to account for the inhibition 
of proliferation seen in cultures.  
 
Although enhancement of survival and proliferation are critical features of the B cell 
response to LPS, it was also important to determine changes in the activation state of 
cells. In response to LPS, there were no differences in the mRNA levels of the co-
stimulatory molecules CD80 and CD86 between LPS-stimulated and control cultures 
(Figure 3.3 and Figure 3.11). This argues that not only does LPS not stimulate these 
cells to divide, but it also does not activate them. The absence of changes in sIgM 
mRNA (Figure 3.5 and Figure 3.13) also supports a lack of activation/differentiation by 
either LPS preparation. 
 
Taken together, these observations argue that the response of WEHI-279 to LPS is not 
dramatic, but what response there is may differ between LPS from enteric and non-
enteric bacteria. S. enteritidis LPS appears to enhance proliferation at very high 
concentrations, while P. gingivalis LPS may, in fact, inhibit proliferation at similar 
concentrations. Further, there was no apparent activation of these cells as measured by 
co-stimulatory molecule or sIgM expression. The relevance of these results to the 
generalised B-2 response to LPS is unclear. Although the WEHI-279 cell line can be 
thought of as an immortalised ‘typical’ B-2 cell line (see section 1.6.2), immortalised 
cell lines may show certain characteristics that do not reflect the population from which 
they are drawn.  
 
The studies presented in this chapter, together with those dealing with B-1 cells in 
Chapter 2, begin to develop a picture of B cell subset responses to enteric and non-
enteric LPS. However, as the studies were carried out separately in unmixed 
populations, cross-subset effects cannot be examined. A mixed system containing both 
subsets in the same culture presents an opportunity for studying B cell subset 
interactions. Work examining such a system is presented in Chapters 4 and 5 of this 
thesis. 
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Chapter 4 Effects of a high concentration 
(50µg/mL) of lipopolysaccharide on CD5+ 
and conventional murine splenic 
lymphocytes 
 
 
4.1  Introduction 
The two main aims of the studies presented in this thesis are firstly to compare the 
responses of B-1 and B-2 cells to LPS, and secondly to compare the B cell responses to 
LPS preparations derived from enteric (S. enteritidis) and non-enteric (P. gingivalis) 
species. The results of the preceding experimental chapters, which used cell lines as 
model systems, suggested that B cells may not only respond differently to LPS from 
different bacteria, but that there may be differences between the responses of B-1 and 
B-2 cells to LPS derived from a single species. Although there were differential effects 
of P. gingivalis LPS on the responses of both cell lines, the effect was most marked in 
response to S. enteritidis LPS. In particular, it appeared that the B-1 cell line (CH12), 
was rescued from cell death, proliferated and differentiated in response to moderate 
concentrations of S. enteritidis LPS, whereas the proliferation of the B-2 cell line 
(WEHI-279) appeared to be actively inhibited by similar LPS concentrations. Although 
examination of the response of individual cell lines is a useful first step for investigating 
B cell responses, the response of a cell line may not necessarily reflect that of the 
original cell population. In addition, interactions between different cell types (including 
the interaction between B-1 and B-2 cells) may be important in regulating the response 
of B cell subpopulations to LPS. Therefore, a simplified mixed splenocyte culture 
system was developed to contemporaneously examine the response of B-1 and B-2 cells 
to LPS.     
 
As S. enteritidis LPS was shown to cause more marked differences in activation of B-1 
and B-2 cell lines (Chapters 2 and 3), this LPS preparation was chosen for use in the 
Chapter 4                    111 
 
development of the splenocyte culture system. A high concentration of 50µg/mL LPS 
was chosen to ensure that the conventional B cell subset would be appropriately 
stimulated, and to enable the comparison of the CD5+ B cell response to a “normal” 
polyclonal B cell response (Melchers et al., 1975). Young mice (4-6 weeks old) were 
used as the source of splenocytes as the percentage of CD5+ B cells in the spleen 
decreases with age. At this age, the spleens were large enough for good yields of cells, 
but the proportion of CD5+ B cells was still high enough for this population to be 
accurately identified in the flow cytometric analyses.  
 
The activation and proliferation of B-1 and B-2 cell subsets, as well as overall apoptosis 
were assessed after culture with LPS. Activation of stimulated and unstimulated cells 
was identified through the combination of morphological and MTT colourimetric assay 
studies. The activation of B cell subsets was determined using a combination of 7AAD, 
PE-anti-CD5 and FITC-anti-CD80. Activated B cells express CD80 (B7-1) (Hathcock 
et al., 1994; Ding and Shevach, 1996), and the selective gating by forward and side 
scatter of lymphocytes together with the staining levels of the anti-CD5 and anti-CD80 
antibodies on viable cells allowed the identification of activated CD5+ and CD5- B cells. 
Viability status – viable, apoptotic, or degenerate – of B cell subsets was determined 
using 7-aminoactinomycin D (7AAD). Since analyses of tissues from patients with 
chronic periodontitis suggested that many of the B cells within gingival tissues were 
activated (Gemmell and Seymour, 1991; Afar et al., 1992) and that many others were 
degenerate (Joachim et al., 1990), morphology and patterns of death of splenic 
lymphocytes were examined using electron microscopy. Unfortunately, resources did 
not allow immunogold labelling to identify B cell subsets harvested from the in vitro 
cultures, although these studies would be useful in supporting the flow cytometric 
analyses of stimulated and unstimulated cells. 
 
4.2 Materials and Methods 
4.2.1 Mice 
Balb/c mice 4-6 weeks of age were obtained from the Blackburn Animal House Facility, 
University of Sydney, and from the Institute of Dental Research, Sydney. All mice were 
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allowed commercial pellets and water ad libitum until sacrifice by inhalation of 
Fluothane (Zeneca, Cheshire, UK). 
 
4.2.2 Mitogens 
Salmonella enteritidis LPS, prepared by a phenol-water extraction procedure and 
chromatographically purified, was obtained from Sigma (St Louis, MO, USA) and 
diluted to 50µg/mL. 
 
4.2.3 Splenocyte preparation 
Murine splenocyte suspensions were prepared in RPMI 1640 medium (ICN, Costa 
Mesa, CA, USA) supplemented with 10% foetal bovine serum (FCS; Trace), 5 x 10-5M 
2-mercaptoethanol (2ME) (Sigma), and antibiotic mixture (penicillin 50IU/mL and 
streptomycin 50µg/mL; Trace) (RPMI/10% FCS). Spleens were removed from the mice 
and placed into RPMI 1640 medium on ice. The spleens were placed into a petri dish in 
the laminar flow cabinet and mashed using the plunger of a 10mL syringe. A 20mL 
syringe and 18-gauge needle were used to create a single cell suspension, and this was 
then passed through nylon mesh of 200µm pore size (Australian Filter Specialists, 
Blacktown, NSW, Australia) into a 50mL centrifuge tube. The cells were then washed 
twice with RPMI/10% FCS (centrifuge 10 min, 4°C, 300g) and the supernatant 
discarded. The pellet was resuspended in ammonium chloride erythrocyte lysing buffer 
(5mL per spleen used, to a total of 45mL) and incubated for 5 min at room temperature, 
with occasional agitation of the tube. RPMI/10% FCS was added to fill the tube and it 
was centrifuged for 10 min, 4°C at 200g, using a TJ-6 refrigerated centrifuge 
(Beckman-Coulter, Palo Alto, California). The pellet was washed again and 
resuspended in RPMI/10% FCS. The cell suspension was poured into a 50mL 
centrifuge tube precoated with FCS and underlaid with an equal volume of Histopaque-
1083 (Sigma). The tubes were centrifuged for 30 min, 18°C at 400g with no brake to 
allow preservation of layers formed after centrifugation. The buffy layer at the interface 
of the Histopaque-1083 and the medium was collected and added to 40mL RPMI/10% 
FCS and centrifuged 10 min, 4°C at 300g. The supernatant was discarded and the pellet 
resuspended in RPMI/10% FCS and the cell concentration and viability determined, 
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using Trypan Blue staining, prior to seeding and addition of LPS (see Appendix A for 
more detail regarding splenocyte preparation protocols). 
 
4.2.4 Seeding of culture vessels 
Cells were treated with mitogens before seeding in complete medium at 2 x 106 
cells/mL in 96 well flat-bottomed microtitre plates (Sarstedt) to a final well volume of 
100µL. Eight replicate wells were prepared for each time point, and control 
(unstimulated), and mitogen-stimulated test population were utilised. 
Cells used for flow cytometric analysis were seeded at 5 x 106 cells/mL in 25cm2 cell-
culture flasks (Sarstedt) to a final volume of 5mL. Control and mitogen-stimulated 
populations for all time points were cultured for this analysis. 
 
4.2.5 Depletion of adherent cells 
Adherent cells were depleted after 24hr of culture at 37°C and 5% CO2 in a humidified 
atmosphere. The supernatant containing the non-adherent cells was removed and placed 
into a fresh flask or well. The efficacy of depletion was confirmed by flow cytometry 
using Phycoerythrin (PE) conjugated anti-mouse CD11b (Pharmingen) to stain the 
adherent cells before and after depletion, and visual analysis of the cultures. 
 
4.2.6 Preparation of cells for microscopy 
Method as follows from the Electron Microscopy Unit, Institute of Clinical Pathology 
and Medical Research (ICPMR), Westmead Hospital, Westmead, NSW, Australia, and 
adapted from Lazzaro (Lazzaro, 1983). 
 
4.2.6.1 Primary fixation 
1 x 107 cells were collected and spun for 5 min, 4ºC at 300g. The supernatant was 
decanted and the pellet resuspended in PBS and placed into an Eppendorf tube. The 
cells were washed twice with PBS, resuspended in 1mL Karnovsky’s fixative (see 
Appendix B for details) and incubated 4 to 24h at 4°C. The cells were centrifuged for 5 
min, resuspended in 1mL PBS and stored at 4ºC for up to 1 week. 
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4.2.6.2 Secondary fixation and staining 
The fixed cells were spun down and resuspended in a buffered solution of osmium 
tetroxide for 3hr at room temperature. The cells were rinsed with distilled water, 2% 
uranyl acetate was added to cover the sample, and this was then incubated 1hr at room 
temperature whilst mixing continuously. 
 
4.2.6.3 Dehydration 
Tubes were one-quarter filled for each step and incubated for 10min at room 
temperature; 
50% EtOH + 0.1% NaCl, followed by 70% EtOH + 0.1% NaCl, then 95% EtOH + 0.1% 
NaCl, and finally two steps of 100% EtOH. 
 
4.2.6.4 Acetone 
Two acetone steps each comprising quarter filling the tubes with 100% Acetone (dry) 
and incubating for 10 min at room temperature. 
 
4.2.6.5 Infiltration with acetone/resin 
Acetone/resin mixture (1:1) was added to the tubes and incubated for 1hr, followed by 
three changes of resin at 70ºC, each incubated for 10 min. 
 
4.2.6.6 Embedding and Polymerisation 
The samples were embedded in gel caps and the resin allowed to polymerise at 70ºC for 
10hr. 
Sections were further processed for light and electron microscopy by staff of the 
Electron Microscopic Unit, ICPMR, Westmead Hospital. 
 
4.2.7 Transmission electron microscopy 
Sections were cut at 70nm on a Reichert Ultracut ultramicrotome and stained with 
alcoholic uranyl acetate (Fluka, Milwaukee, WI, USA) and Reynold's lead citrate. 
Sections were examined at 80kV in a Philips EM400 electron microscope (Philips 
Electron Optics. Eindhoven, Netherlands) and photographed on Kodak EM film. 
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4.2.8 MTT colourimetric assay 
See section 2.2.7 MTT colourimetric assay 
 
4.2.9 Antibodies for flow cytometry 
PE-conjugated anti-murine CD5 (clone 53-7.3; PE-anti-CD5), FITC-conjugated anti-
mouse B220 (RA3-6B-2; FITC-anti-B220), and FITC-conjugated anti-mouse CD80/B7-
1 (16-10A1; FITC-anti-CD80), and the corresponding isotype-matched controls (I/C) 
were purchased from Pharmingen. Fc Block (anti-murine CD16/CD32, clone 2.4G2), 
also from Pharmingen, was used to prevent non-specific binding of murine monoclonals 
to Fcγ receptors on the cell surface. 
 
4.2.10 Flow cytometric analysis 
Cultured cells were washed twice with PBS containing 2% FCS and 0.1% NaN3 
(PBS/FCS/Azide) and incubated with 0.25µg Fc Block/106 cells (5µL of 0.05mg/mL 
working solution)  for 3 min at 4ºC. The cells were then incubated with 0.25µg/106 cells 
of 7-Aminoactinomycin D (7AAD; Sigma) and 1µg/106 cells of PE-anti-CD5 (25µL of 
0.04mg/mL working solution) and FITC-anti-B220 (20µL of 0.05mg/mL working 
solution) and corresponding I/C at the same concentration were added to I/C tubes, or 
PE-anti-CD5 and FITC-anti-CD80 (20µL of 0.05mg/mL working solution) and 
corresponding I/C at the same concentration were added to I/C tubes, for 30 min at 4ºC. 
The cells were then washed twice with PBS/FCS/Azide and then resuspended to 2 x 106 
cells/mL in Osmosol sheath fluid (Lab Aids, Narrabeen, NSW, Australia) with 2% 
paraformaldehyde (sheath/PFA) prior to flow cytometric analysis on a FACScan 
(BDIS). 
 
4.2.11 Statistical analysis 
Control and LPS-stimulated values were compared for all experiments. Two-way 
ANOVA to compare differences at particular time points between unstimulated and 
stimulated populations, with Tukey's multiple comparison post test to compare 
differences between time points in a population, and one-way ANOVA to test 
differences overall between unstimulated and stimulated populations were performed 
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using GraphPad Prism version 3.00 for Windows, GraphPad Software, San Diego 
California USA, www.graphpad.com. Statview v4.5 (Abacus Concepts Inc, Berkeley, 
CA, USA) was used to assess correlations for Figure 4.6. All data shown are pooled 
means from a number of experiments. All error bars shown are the standard error of the 
mean. 
 
4.3  Results 
4.3.1 Derivation of lymphocytes: spleen versus peritoneal cavity 
The aim of experimental work presented in this chapter was to develop a culture system 
that allowed the investigation of both B-1 and B-2 cell responses to LPS within the one 
culture. It was important to develop a method to isolate large numbers of B-1 cells as 
efficiently as possible from mice. Two anatomical locations were identified in the 
mouse as being potentially suitable for the harvesting of B-lymphocytes: the spleen and 
the peritoneal cavity. The peritoneal cavity is a better source for B-1 cells than the 
spleen as 10 – 20% of total cells able to be harvested in the peritoneal cavity are B-1 
(Hayakawa et al., 1983; Hayakawa et al., 1986), compared to approximately 2 - 5% of 
cells in the spleens of adult mice. (Hayakawa et al., 1983; Hayakawa et al., 1986). 
Younger mice have a greater proportion of CD5+ B cells than older mice (Hayakawa et 
al., 1986), therefore 3-5 week old mice were used to maximise total splenocyte yields 
and percentage of CD5+ B cells. However, preliminary experiments showed that total 
cell yields were greater using spleens than peritoneal washes. Peritoneal washes were 
more time consuming and this led to decreased viability of harvested cells prior to 
seeding into flasks for experiments. Given this, it was determined that the spleen was 
the better source of B cells for the purposes of the experimental work to be performed. 
 
4.3.2 Efficacy of adherent cell depletion  
Non-lymphocyte CD11b+ cells were 5.5% of the cells in spleen cultures prior to 
depletion of adherent cells, and 3.7% of cells after the depletion step (data not shown). 
This finding was supported by morphological analysis of cultures both pre- and post-
depletion. Numerous adherent cells and very few degenerate cells were present in the 
culture flasks before depletion, but fewer than ten adherent cells per 25cm2 culture flask 
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and a greater than ten-fold increase in the number of degenerate cells were found after 
depletion. 
 
4.3.3 Overall view of the splenic lymphocyte response to LPS 
An increase in cell number and size can be seen in the LPS-stimulated culture (Figure 
4.1 F-J) compared to the control (Figure 4.1 A-E). This is apparent after 24hr of culture, 
and by 48hr of culture the field of view is almost full of cells, compared to the sparser 
population in the control flask at the same time point. The cells in the LPS-stimulated 
cultures form clumps/islands from about 48hr of culture onwards. 
 
4.3.4 Ultrastructural analysis of splenic lymphocyte cultures 
Representative transmission electron micrographs of control (Figure 4.2) and LPS-
stimulated (Figure 4.3) cultures add more detail to the data presented in Figure 4.1. 
Figure 4.2a shows lymphocytes at the 0hr time point. The lymphocytes are resting as the 
cytoplasm is relatively scanty and the endoplasmic reticulum (ER) is not easily 
discernable. After 24hr of culture, some apoptotic and degenerate cells, as well as some 
viable, resting lymphocytes, are found in the control culture (Figure 4.2b). These non-
viable cells are characterised by the lack of recognisable features found in viable cells, 
and by the appearance of vacuoles within the cell. More apoptotic and degenerate cells 
are found after 48hr of culture (Figure 4.2c), although some viable cells persist. Cellular 
debris is also present in this image. A higher magnification of three of the cells in 
Figure 4.2c is shown in Figure 4.2d. The cell in the lower half of the image is most 
likely undergoing apoptosis; the mitochondria are intact but the ER has become 
distended and chromatin is packing inside the nucleus. By 72hr most of the cells in the 
control culture are no longer viable. A late stage apoptotic cell can be seen at the middle 
right (Figure 4.2e). The cell has lost its structure and has formed apoptotic bodies. 
Cellular debris and other degenerate cells are also present. Figure 4.2f is a magnified 
image of the late stage apoptotic cell described in Figure 4.2e. The apoptotic bodies are 
more clearly seen in this image, and some organellar fragments, particularly 
mitochondria, are found. After 96hr of culture, virtually all the cells in the culture are 
dead. Some longer-lived, and perhaps relatively hardier, cells are still viable, but most 
cells display signs of apoptosis or secondary necrosis (Figures 4.2g and 4.2h). 
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In contrast to the viability of the control cultures, which decreased continuously from 
the initial seeding value, the ultrastructure of LPS-stimulated cultures showed a 
markedly different response. Figure 4.3a shows an activated lymphocyte after 24hr of 
culture with 50µg/mL LPS. The cytoplasm is greatly increased compared with resting 
cell below it, and the ER has become distended, suggesting that protein synthesis has 
been upregulated. At 48hr of culture, more activated cells are found. The cells in Figure 
4.3b and 4.3c are highly activated. They have a high cytoplasm to nucleus ratio and the 
ER and ribosomes are distinct. Vesicles budding from the Golgi apparatus are also 
visible. Many apoptotic and degenerate cells are found by 72hr of culture, as seen in 
Figure 4.3d. Activated and resting cells (lower half 4.3d as well as 4.3e) are still present, 
but the constituents of the culture change, with more apoptotic cells appearing (Figure 
4.3f). At 96hr of culture most of the cells are apoptotic or degenerate (Figure 4.3g). 
Figure 4.3h is a higher magnification of the early apoptotic cell in the centre of Figure 
4.3g. As described above for apoptotic cells in control cultures, the mitochondria are 
still active, but the ER is distended and the chromatin is clumped (mostly) around the 
edges of the nucleus. 
 
4.3.5 MTT assay of cultured splenic lymphocytes 
The MTT assay of cellular biomass (proliferation and increase in size due to activation) 
was utilised to examine the effects of 50µg/mL LPS on murine splenic lymphocytes 
(Figure 4.4). ∆ absorbance, reflecting change in biomass, in the control culture 
decreased until the 48hr time point, and remained stable for the duration of the culture 
period (although these changes were not significant). The biomass of the LPS-
stimulated culture increased significantly until 72hr of culture and then decreased 
significantly by 96hr. 
 
4.3.6 Viable LPS-stimulated cells increase until 48hr and 
then decrease 
The number of viable and non-viable cells in control and LPS-stimulated cultures was 
determined by Trypan Blue exclusion as presented in Figure 4.5. The number of viable 
cells in the control cultures (A) decreased significantly over the culture period, and the 
number of non-viable cells increased significantly. In the LPS-stimulated cultures (B), 
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the number of viable cells did not change significantly until 96hr. Non-viable cell 
numbers did not increase until 72hr of culture. Viable cell numbers in the LPS-
stimulated culture were significantly different to the control culture at the 48 and 72hr 
timepoints. 
 
4.3.7 Correlation between Trypan Blue and 7AAD viability 
data  
In order to reduce the effects of non-specific staining of apoptotic and degenerate cells 
on the results, 7AAD was used to stain the cells prior to flow cytometric analysis. This 
enabled viable, apoptotic and degenerate populations to be identified during the 
acquisition and analysis of the cultured splenic lymphocytes. To obtain absolute counts 
for B-1 and B-2 cells, there had to be a correlation between the Trypan Blue and 7AAD 
percentage viability data. Culture viability as measured by Trypan Blue and 7AAD (in 
the same cultures) is presented in Figure 4.6A. The only significant difference between 
the Trypan Blue and 7AAD values is at 24hr in the control culture. The Trypan Blue 
and 7AAD values were shown to correlate (Figure 3.6B and C), and therefore the 
absolute numbers of B-1 and B-2 cells can be calculated by combining Trypan Blue 
absolute counts and subset data generated by flow cytometry.  
 
4.3.8 Viability of B cell subsets after LPS stimulation   
The viability of B cell subsets was examined using flow cytometry with the 
combination of CD5-PE, B220-FITC and 7AAD to determine cell subsets and viability 
respectively. Representative flow cytometry data is shown in Figure 4.7. Cells were first 
gated by size and internal complexity, using forward and side scatter (A). This gating 
strategy removes most of the debris as well as a proportion of dead cells from further 
analyses, and also serves to discriminate between lymphocytes and other cells that 
remained despite the enrichment procedure (for example, macrophages and 
eosinophils). After gating on forward and side scatter, cells were gated for viability 
using 7AAD versus side scatter (B). Viable cells show low 7AAD fluorescence, 
apoptotic cells intermediate, and degenerate/late stage apoptosis/necrotic showed high 
7AAD fluorescence. Cells are gated according to their level of 7AAD fluorescence and 
further analysed for division into the B-1 and B-2 cell subsets. Quadrants are set for 
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positive staining using fluorescently conjugated isotype controls (C). A representative 
plot for PE-CD5 and FITC-B220 staining after gating for viable lymphocytes is shown 
in (D). T cells (CD5+/B220-) are seen in the upper left quadrant, and the percentage of 
these cells remains relatively stable over the culture period. B-1 cells are CD5lo/B220+ 
and are 5-10% of the viable lymphocyte population at initial seeding. B-2 cells are CD5-
/B220+, and are approximately 28% of the viable lymphocyte population at 0hr. A large 
debris plume appeared over the culture period, and this plume consisted of dead and 
dying cells and cellular debris (data not shown). The plume increased in size, as there 
were virtually no phagocytic cells available in the cultures to remove this debris.  
 
Figure 4.8 shows cell numbers for B-2 (A) and B-1 (B) B cell subsets in control and 
LPS-stimulated cultures. Conventional B cell numbers decreased over the culture period 
in the control cultures, and were significantly lower than the 0hr value at 24, 48, and 
72hr. In the LPS-stimulated culture there was a trend for an increase in conventional B 
cell numbers, with a peak at 48hr followed by a decline at 72 and 96hr, although the 
differences were not significant. A difference in conventional B cell number between 
the control and the LPS-stimulated cultures was found at 24 and 48hr of culture, 
although in the later stages of culture there was no difference between the control and 
the LPS-stimulated cultures. B-1 cells (B) were strongly represented and numbers did 
not change significantly over time in the control cultures. An increase in the number of 
CD5+ B cells up until 72hr of culture when stimulated by LPS culture was noted, 
although this increase is not statistically significant. There were no significant 
differences between the control and LPS-stimulated B-1 cells. 
 
The percentage of viable B cells in control cultures (Figure 4.9A) decreased 
significantly after 24hr of culture compared to the 0hr value over the culture period and 
the percentage of apoptotic cells increased significantly after 24hr compared to the 0hr 
value. In the LPS-stimulated culture (Figure 4.9B) the percentage of viable cells 
remained stable for the first 48hr of culture but then decreased significantly over the 
remaining time. The percentage of apoptotic and degenerate cells increased significantly 
only at 72 and 96hr of culture as compared to the 0hr value. 
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4.3.9 Activation of B cell subsets after LPS stimulation 
Figure 4.10 shows the gating scheme used for the CD80 and I-A expression 
experiments. The data shown is for one representative experiment utilising CD80-FITC 
staining together with CD5-PE and CD19-CyChrome, however, the same protocol was 
used for cells stained with I-A-FITC, CD5-PE and CD19-CyChrome. 
The activation of B-2 (A) and B-1 (B) cells was measured using CD80 (B7-1) as a 
marker of activation (Figure 4.12). When stimulated with LPS a significantly increased 
percentage of B-2 cells became activated at 48, 72 and 96hr of culture when compared 
to the control culture. At the later stages of culture (48 and 72hr), a significantly greater 
percentage of the LPS-stimulated B-1 cells were activated than in the control cultures. 
Overall, the percentage of CD80+ B-1 cells was significantly different to that of B-2 
cells for both control and LPS-stimulated populations.  
Activation was also measured using I-A expression (Figure 4.12). Overall, the 
percentage of B-2 cells expressing I-A was significantly increased in LPS-stimulated 
cells as compared to the control cells. In the control cultures, the percentage of B-2 cells 
expressing I-A was significantly different over the culture period to the initial level after 
harvesting from murine spleens. At 24 and 96hr the percentage of B-1 cells expressing 
I-A was significantly higher in the in LPS-stimulated culture than in the control culture.  
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Figure 4.1 Photographs of cultures cells in vitro 
Control and 50µg/mL S. enteritidis LPS stimulated cells were cultured in 25cm2 tissue culture 
flasks. 
The cultures were photographed before the cells were harvested for staining at each time point 
(0hr was photographed after seeding). (20x magnification) 
(a) Control 0hr 
(b) Control 24hr 
(c) Control 48hr 
(d) Control 72hr 
(e) Control 96hr 
(f) LPS (50µg/mL) 0hr 
(g) LPS 24hr 
(h) LPS 48hr 
(i) LPS 72hr 
(j) LPS 96hr 
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Figure 4.2 TEM images of control splenic lymphocyte cultures 
Cells from control cultures were harvested and processed for transmission electron microscopy. 
Bars are 1µm. 
(a) 0hr 13.2k x magnification 
(b) 24hr 10.4k x magnification 
(c) 48hr 31.0k x magnification 
(d) 48hr 13.2 x magnification 
(e) 72hr 10.4k x magnification 
(f) 72hr 42.0k x magnification 
(g) 96hr 13.2k x magnification 
(h) 96hr 23.0k x magnification 
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Figure 4.3 TEM images of S. enteritidis LPS Stimulated splenic lymphocyte 
cultures 
Cells from 50µg/mL S. enteritidis LPS stimulated cultures were harvested and processed for 
transmission electron microscopy. Bars are 1µm. 
(a) 24hr 17.8k x magnification 
(b) 48hr 23.0k x magnification 
(c) 48hr 10.4k x magnification 
(d) 72hr 10.4k x magnification 
(e) 72hr 17.8k x magnification 
(f) 72hr 17.8k x magnification 
(g) 96hr 13.2k x magnification 
(h) 96hr 31.0k x magnification 
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Figure 4.4 Change in biomass over the culture period in control and S. enteritidis 
LPS-stimulated splenic lymphocyte cultures 
The MTT-formazan assay was used to examine the change in biomass in control and 50µg/mL 
S. enteritidis LPS-stimulated splenic lymphocyte cultures. This was measured by determining 
the difference in absorbance between the yellow soluble substrate (540nm) and the purple 
insoluble product (690nm). Statistically significant differences (p<0.05) between the control and 
LPS stimulated cultures, as determined by two-way ANOVA, are denoted by a * above the 
relevant time point. Overall significant differences (p<0.05), determined by one-way ANOVA, 
between the control and LPS stimulated cultures are denoted by a † next to the culture 
descriptor on the X axis. Data shown are the pooled means and s.e.m. of five experiments. 
*
* 
* 
† † 
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Figure 4.5 Viable and non-viable cells in control and S. enteritidis LPS-stimulated 
cultures 
The numbers of viable and non-viable cells in control (A) and S. enteritidis LPS-stimulated (B) 
cultures were determined using Trypan Blue exclusion. Statistically significant differences 
(p<0.05) between the control and LPS stimulated cultures, as determined by two-way ANOVA, 
are denoted by a * above the relevant time point. Data shown are the means and s.e.m. of five 
pooled experiments.  
A
B *
*
*
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Figure 4.6 Viability of cultures determined by Trypan Blue and 7-
aminoactinomycin D exclusion 
The percentage viability determined using Trypan Blue exclusion and 7AAD was compared to 
ascertain whether the two methods resulted in the same values (A), and hence whether the two 
results could be combined to derive cell numbers of flow cytometrically determined subsets. 
The correlation matrix (B) and p-value (C) for the two methods are also shown. Data shown are 
the means and s.e.m. of five pooled experiments.  
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Figure 4.7 Representative FACScan plots for flow cytometric analysis 
A specific gating strategy was utilised in order to examine only lymphocytes from the 
splenocyte cultures. Cells were first gated by forward (FSC) and side (SSC) scatter to select 
cells of the correct size and internal complexity (A). Cells meeting these criteria were further 
gated by their 7AAD fluorescence and side scatter to determine viable and non-viable cells (B). 
Apoptotic and degenerate cells are also able to be identified using 7AAD. Fluorescently-
labelled isotype controls were used to set the quadrant parameters for positive and negative 
events, using only those cells that were gated as viable lymphocytes (C). Identification of 
subsets of viable lymphocytes was then able to be performed using, for example, anti-CD5-PE 
and anti-B220-FITC (D) to identify B-1 cells (CD5+/B220+, upper right quadrant), B-2 cells 
(CD5-/B220+, lower right quadrant) T cells (CD5+/B220-, upper left quadrant) and non T or B 
cells (CD5-/B220-, lower left quadrant). Data shown is from a single representative experiment. 
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Figure 4.8 Absolute cell counts for B-2 and B-1 cells 
The numbers of viable B-2 (A) and B-1 (B) cells in control and S. enteritidis LPS stimulated cultures 
were determined by multiplying the percentage of cells classed as B-1 cells (CD5+/B220+) or B-2 cells 
(CD5-/B220+) by the number of viable cells counted by haemocytometer. Statistically significant 
differences (p<0.05) between the control and LPS stimulated cultures at particular time points, as 
determined by two-way ANOVA, are denoted by a * above the relevant time point. Overall significant 
differences (p<0.05), determined by one-way ANOVA, between the control and LPS stimulated cultures 
are denoted by a † next to the culture descriptor on the X axis. Data shown are the means and s.e.m. of 
five pooled experiments.   
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Figure 4.9 Viable and non-viable B cells in Control and LPS-stimulated cultures 
The percentage of total B cells (B-1 + B-2) in Control (A) and S. enteritidis LPS-stimulated (B) 
cultures that were viable or non-viable was determined by 7AAD staining levels of CD5+/B220+ 
and CD5-/B220+ cells. Statistically significant differences (p<0.05) between the control and LPS 
stimulated cultures, as determined by two-way ANOVA, are denoted by a * above the relevant 
time point. Data shown are the means and s.e.m. of five pooled experiments. 
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Figure 4.10 Representative FACScan plots for CD80 and I-A flow cytometric 
analysis 
A specific gating strategy was utilised in order to examine only lymphocytes from the 
splenocyte cultures. Cells were first gated by forward (FSC) and side (SSC) scatter to select 
cells of the correct size and internal complexity. Cells meeting these criteria were further gated 
by their CD5 PE and CD18 Cy-Chrome fluorescence and side scatter to determine B-1 and B-2 
cell subsets. Fluorescently-labelled isotype controls were used to set the quadrant parameters for 
positive and negative events, using only those cells that were selected from the FSC/SSC gates. 
The level of expression of CD80 (as shown here) or I-A was determined for each subset using 
the level of CD80-FITC (or I-A-FITC) fluorescence. Data shown is from a single representative 
experiment. 
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Figure 4.11 Activation of B cell subsets: CD80 expression 
Activation of control and S. enteritidis LPS stimulated B-2 (A) and B-1 (B) cells was examined 
using the CD80 activation marker. Data are presented as the percentage of each subset 
expressing CD80+. Statistically significant differences (p<0.05) between the control and LPS 
stimulated cultures, as determined by two-way ANOVA, are denoted by a * above the relevant 
time point. Overall significant differences (p<0.05), determined by one-way ANOVA, between 
the control and LPS stimulated cultures are denoted by a † next to the culture descriptor on the 
X axis. The control and LPS stimulated B-1 populations are significantly different overall to the 
control and LPS stimulated B-2 populations. Data shown are the means and s.e.m. of five 
pooled experiments.   
A 
B 
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Figure 4.12 Activation of B cell subsets: I-A 
Activation of control and S. enteritidis LPS stimulated B-2 (A) and B-1 (B) cells was examined 
using the I-A activation marker. Data are presented as the percentage of each subset expressing 
I-A+. Overall significant differences (p<0.05), determined by one-way ANOVA, between the 
Control and LPS stimulated cultures are denoted by a † next to the culture descriptor on the X 
axis. Statistically significant differences (p<0.05) between the 0hr and other time points, as 
determined by one-way ANOVA, are denoted by a * above the relevant time point.. Data shown 
are the means and s.e.m. of four pooled experiments.   
A 
B 
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4.4  Discussion 
The results presented in this chapter demonstrate that it was possible to use a non-
fractionated splenocyte culture system to simultaneously investigate the responses of B-
1 and B-2 cells to LPS. By using flow cytometry to identify B-1 and B-2 cells, it was 
possible to dissect these subpopulations out of the overall responding cells. A range of 
parameters, such as viability and activation, could then be investigated for each 
population. 
 
The overall activation of cells in culture was examined by phase contrast microscopy 
and electron microscopy. Using these techniques, it was evident that LPS caused 
significant activation and proliferation of cells in cultures (Figures 4.1, 4.2 and 4.3). 
This was confirmed by the more objective MTT assay (Figure 4.4), and by quantitation 
of viable cells by Trypan Blue exclusion (Figure 4.5). Together, these results indicated 
that in unstimulated cultures, biomass decreased as cells apoptosed, while in LPS-
stimulated cultures, cells became activated and proliferated. Interestingly, by both MTT 
assay and viability counts, it appeared that at 96 hours there was a decrease in the 
number of viable cells in stimulated cultures. A decline in 3H-thymidine uptake by 
mitogen-stimulated splenic cultures by 72 hours has been noted previously (Dziarski, 
1982a). The decline has been ascribed to several possible factors, and a number of 
investigations (Dziarski, 1980; Dziarski, 1982a; Dziarski, 1982b) have led to the 
interpretation that the substantial fall in activity is related to the terminal differentiation 
of B lymphocytes. Certainly, published kinetics of the plaque forming cell (PFC) 
response in mitogen-stimulated cultures are consistent with a switch from proliferation 
to differentiation around 48 hours. Further supporting this are functional and 
morphological studies of mitogen-stimulated populations in vivo and in vitro have 
confirmed a switch to immunoglobulin secretion and plasmacytoid-like morphology 
(Dziarski, 1982a). However, a decline in [3H]-thymidine incorporation has also been 
shown by Mamchak and Hodgkin to be caused by LPS-induced B cell proliferation 
depletion of essential nutrients from the growth medium (Mamchak and Hodgkin, 
2000). 
 
 
Chapter 4                    138 
 
In addition to enabling the morphological investigation of the activation of the overall 
cultures, electron microscopy also allowed apoptosis to be assessed. A consistent 
finding was the marked dilation of the Golgi vesicles in activated cells at 72 hours after 
stimulation. There appeared to be a rapid progression of these cells to death as few 
transitional forms were observed. Dilation of the Golgi apparatus and of the 
endoplasmic reticulum has been noted in apoptotic thymocytes but it occurs after the 
characteristic nuclear changes (Wylie, 1988). The relation of the possible accumulation 
of secretory products to the initiation of a programmed death sequence in B cells is 
unknown. In this context, there is evidence that sialyltransferases, located primarily 
within the Golgi membranes, have an important role in the glycosylation of secreted 
protein (Paulson and Colley, 1989) and of B cell differentiation antigens (Keppler et al., 
1992). Disturbance of this function could explain the accumulation of putative secretory 
proteins, particularly immunoglobulin, in the dying cells. There is the additional 
possibility of disruption of the tubulin network in relation to the location of the 
organising centrioles in proximity to the Golgi complex. These changes could either be 
part of the initiation or the later stages of the death process.  
 
As shown in figure 4.5, there was a discrepancy between the dramatically decreasing 
numbers of viable cells in unstimulated cultures and the less-marked increase in non-
viable cells. This difference could possibly be explained by two mechanisms: firstly, 
that the dead cells were removed from the culture by the very small population of 
macrophages remaining after the purification and depletion steps, and secondly, that the 
dead cells fragmented rapidly into sub-cellular sized debris.  
 
Flow cytometric studies of cell death utilising 7AAD as a marker correlated 
significantly with the Trypan Blue staining of the cultures, allowing for more detailed 
analyses. The different gating patterns shown in Figure 4.7 enabled greater 
characterisation of the responses of the different lymphocyte subsets in combination 
with the Trypan Blue studies. 
 
The CD5+ B cell population was protected from death by the addition of 50µg/mL LPS 
to the culture, but did not become increasingly activated until the very late stages of 
culture. Activation was measured by CD80 expression, and detection of IgM produced 
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by this subset would be useful in further examining the function of the CD5+ B cell in 
the disease state. CD5+ B cells respond differently to conventional B cells when 
stimulated with LPS. The response is later in terms of proliferation (as determined by 
absolute counts shown in Figure 4.8) and activation (as determined by the ratio of 
CD80+ cells to the 0hr value shown in Figure 4.11). An examination of the dose 
response to LPS would allow further dissection of the role of the CD5+ B cell in chronic 
periodontitis and other pathologies with low mitogenic load where an accumulation of 
these cells is found.  
 
Results indicate that 50µg/mL LPS has a protective as well as a proliferative effect on 
conventional and possibly CD5+ B cells. CD5+ B cell numbers remain constant despite 
the increase in the percentage of non-viable cells in both the control and the LPS-
stimulated cultures. CD5+ B cells are known to be self-renewing in the periphery (Hardy 
and Hayakawa, 1986) and this self-renewal is clearly shown in the unstimulated cultures 
where viable cell numbers remain constant over the culture period (Figure 4.8). 
Addition of LPS interferes somehow in this balance between self-renewal and death by 
preventing death in cells that would otherwise die in this process. It can be postulated 
that during the self-renewal process only a certain number of these CD5+ B cells 
survive, perhaps only one of the two daughter cells produced after mitosis. The 
perturbation of this state could lead to an increase in the number of these cells. Such an 
imbalance can be argued to result in an accumulation of this subset in pathologies such 
as chronic periodontitis (Sugawara et al., 1992). Stimulation with 50µg/mL of LPS 
resulted in an increase in activation, as measured by CD80 (B7-1) expression, of 
conventional and CD5+ B cells. 
 
The evolutionary advantage of such polyclonal B cell reactivity to ubiquitous bacterial 
products such as LPS and peptidoglycan are recognised, but the subsequent activation 
of a programmed death sequence would protect the host from multiple autoreactive 
antibodies (Freitas et al., 1986).  In this context the nuclei of splenic B cells, but not T 
cells, contain large amounts of endogenous endonuclease (Cohen et al., 1992).  This is 
compatible with populations primed for rapid activation of programmed death.  
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Chapter 5 Effects of an 8-log range of 
lipopolysaccharide on CD5+ and 
conventional murine splenic lymphocytes 
 
5.1 Introduction 
The results of experiments that used B cell lines (Chapters 2 and 3) suggested that LPS 
from different bacterial species might have differing effects on B cell activation. 
Furthermore, it appeared that B-1 and B-2 subsets might respond differentially to the 
one LPS preparation. Such differential sensitivity to the proliferative and activating 
effects of LPS could explain the selective accumulation of B-1 cells in a number of 
disease states (see section 1.7). In the preceding chapter, a culture system was 
developed that allowed the responses of both B-1 and B-2 cells to be studied 
simultaneously. Using S. enteritidis LPS, it was shown that the viability, proliferation 
and activation of the two subsets, in response to S. enteritidis, could be followed. The 
results of these experiments were also consistent with the cell line studies in that B-1 
and B-2 cells appeared to respond differentially to LPS, however the sensitivity of the 
subsets to LPS at different concentrations was not examined. It was therefore important 
to investigate the effect of differing concentrations of LPS on B-1 and B-2 cells. 
 
The culture system developed in Chapter 4 was used to investigate the responses of B-1 
and B-2 cells to LPS. Although understanding the response of B cells to P. gingivalis 
LPS was a major original focus for the project, S. enteritidis LPS had a more marked 
effect on B cell activation and proliferation and was therefore used in this series of 
experiments. Splenic lymphocytes were stimulated with an 8-log range of LPS 
concentrations and compared to non-stimulated control cultures. Changes in biomass 
were determined by MTT colourimetric assay. The viability, activation, IgM 
production, cell cycle and division index of B-1 and B-2 B cell subsets were examined 
by flow cytometry. 
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5.2 Materials and Methods 
5.2.1 Mice 
BALB/c mice 3-5 weeks of age were obtained from Gore Hill Research Laboratories, 
Gore Hill, NSW, Australia. All mice were allowed commercial pellets and water ad 
libitum until sacrifice by inhalation of Fluothane (Zeneca). 
 
5.2.2 Mitogens 
See 4.2.2 Mitogens 
 
5.2.3 Splenocyte preparation 
See 4.2.3 Splenocyte preparation 
 
5.2.4 Depletion of adherent cells 
Adherent cells were depleted after 1hr of culture at 37°C and 5% CO2. The supernatant 
containing the non-adherent cells was removed and placed into a fresh flask or well.  
 
5.2.5 Seeding of culture vessels 
See 4.2.4 Seeding of culture vessels  
 
5.2.6 MTT colourimetric assay 
See 2.2.7 MTT colourimetric assay 
 
5.2.7 Antibodies for flow cytometry 
PE-conjugated anti-murine CD5 (clone 53-7.3), FITC-conjugated anti-mouse CD19 
(1D3), biotin-conjugated anti-mouse CD19 (1D3), unlabelled- and FITC-conjugated 
anti-mouse IgM (II/41), the corresponding isotype-matched controls, and streptavidin-
CyChrome (SA-CyChrome) were purchased from Pharmingen. Fc Block (anti-murine 
CD16/CD32, clone 2.4G2) (Pharmingen) was used to prevent non-specific binding of 
murine monoclonals to Fcγ receptors on the cell surface. 
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5.2.8 Flow cytometric analysis 
Cultured cells were washed twice with PBS containing 2% FCS and 0.1% NaN3 
(PBS/FCS/Azide) and incubated with 0.25µg Fc Block/106 cells for 3 min at 4ºC. The 
cells were then incubated with 0.25µg/106 cells of 7-Aminoactinomycin D (7AAD; 
Sigma)(Schmid et al., 1992) and 1µg/106 cells of PE-anti-CD5 and FITC-anti-CD19 for 
15 min at 4ºC. The cells were then centrifuged for 3min at 4°C and 1500g, and then 
resuspended to 2 x 106 cells/mL in Osmosol sheath fluid (Lab Aids) with 2% 
paraformaldehyde (sheath/PFA) prior to flow cytometric analysis on a FACScan 
(BDIS). 30,000 viable lymphocytes were analysed for each sample. 
 
5.2.9 5-carboxyfluorescein diacetate-succinimidyl ester (CFSE) 
staining of cells 
See 2.2.8 5-carboxyfluorescein diacetate-succinimidyl ester (CFSE) staining of cells 
 
5.2.10 Determination of division index in CFSE-stained B 
cell subsets 
See 2.2.9 Determination of division index in CFSE-stained B cell subsets 
 
5.2.11 Flow cytometric analysis of CFSE stained cells 
Cultured cells were washed twice PBS/FCS/Azide and incubated with 0.25µg Fc 
Block/106 cells for 3 min at 4ºC. The cells were then incubated with 1µg/106 cells of 
PE-anti-CD5 and biotin-anti-CD19 for 15 min at 4ºC. The cells were then centrifuged 
for 3min at 4°C and 1500g, and the supernatant discarded. The cells were incubated 
with 0.15µg/106 cells of SA-CyChrome for 15 min at 4ºC and then centrifuged for 3min 
at 4°C and 1500g, and the supernatant discarded. The cells were resuspended to 2 x 106 
cells/mL in sheath/PFA prior to flow cytometric analysis on a FACScan (BDIS). 30,000 
lymphocytes were counted for each sample. 
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5.2.12 IgM production in B-1 and B-2 cells 
Cells were harvested from murine spleens as per Section 4.2.3 and then cycloheximide 
(Sigma) was added to the cells, to a final concentration of 10µg/mL. The cells were 
incubated for 6hr at 37°C in 5% CO2 in the presence of cycloheximide to inhibit protein 
synthesis (including IgM). The cells were harvested and then washed cells twice with 
RPMI/FCS. Cells were seeded and stimulated with LPS as mentioned previously, with 
the addition of 1µg/mL Brefeldin A (Sigma) to prevent secretion of proteins (cells were 
incubated for 0-3hr for these experiments). 
Blocking of surface IgM was undertaken using an unlabelled anti-IgM antibody. The 
same clone was used in labelled form to detect intracellular Ig. 
 
5.2.13 Flow cytometric analysis of IgM production by 
splenic B lymphocyte subsets 
Cells were harvested, washed twice with PBS/FCS/Azide and resuspended to 1 x 106 
cells/mL. The cells were then incubated with 0.25µg Fc Block/106 cells for 3 min at 
4ºC, 1µg/106 cells of PE-anti-CD5 and biotin-anti-CD19 and 2µg/106 cells unlabelled 
anti-IgM (clone II/41; to block surface IgM) was added and the cells incubated a further 
15 min at 4ºC. The cells were then centrifuged for 3min at 4°C and 1500g, and the 
supernatant discarded. The cells were incubated with SA-CyChrome (0.15µg/106 cells) 
for 15 min at 4ºC and then centrifuged for 3min at 4°C and 1500g, and the supernatant 
discarded. 875µL cold PBS was added to each tube containing a pellet of 106 stained 
cells, and mixed gently, followed by 125µL cold fixation solution. The cells were 
incubated for 1hr at 4°C and then centrifuged for 5 min, at 4°C and 300g. The 
supernatant was removed and 1mL cold PBS was added to each tube. The cells were 
then centrifuged for 5 min, at 4°C and 300g, and the supernatant removed. 1mL 
permeabilisation solution (PBS/0.2% Tween 20) was added and the cells incubated 
15min at 37°C. 1mL PBS was added and the cells centrifuged for 5 min, at 4°C and 
300g. The supernatant was carefully removed and 3µg/106 cells FITC-anti-IgM (clone 
II/41) in permeabilisation solution was added to the pellet and incubated 30min at 4°C. 
1mL washing buffer (PBS/0.1% Tween 20) was added and the cells centrifuged for 5 
min, at 4°C and 300g. The supernatant was removed and the cells washed again with 
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1mL washing buffer. The cells were resuspended to 2 x 106 cells/mL in PBS/FCS/Azide 
and analysed within 2hr using a FACScan (BDIS). Thirty thousand lymphocytes were 
analysed for each sample. 
 
5.2.14 Cell cycle analysis of B cell subsets 
Cells were harvested, washed twice with PBS/FCS/Azide and resuspended to 1 x 
106/mL. Fc Block (0.25µg /106 cells) was added and the cells incubated for 3 min at 
4ºC. PE-anti-CD5 and FITC-anti-CD19 (and appropriate isotype controls; 1µg/106 cells) 
were added to tubes and incubated 15 min at 4ºC. Tubes were centrifuged for 3 min at 
1500g and 4°C. The supernatant was decanted and 1 to 2mL PBS added to each tube. 
Tubes were centrifuged 5 min at 300g and 4°C. The supernatant was removed and 
875µL cold PBS was added to the pellet and mixed gently. Cold 2%PFA/PBS (125µL) 
was added to each tube, mixed, and incubated for 1hr at 4°C. Tubes were centrifuged 5 
min at 300g and 4°C and the supernatant removed. Cells were resuspended in 1mL 
permeabilisation solution and incubated 15 min at 37°C. PBS (1mL) was added to each 
tube and centrifuged 5 min at 300g and 4°C. The supernatant was removed and cells 
resuspended to 2 x 106/mL in 25µg/mL 7AAD solution. Cells were incubated 30 min at 
4°C and analysed within 2hr. 
 
 
5.2.15 Statistical analysis 
Control and LPS-stimulated values were compared for all experiments. Two-way 
ANOVA to compare differences at particular time points between unstimulated and 
stimulated populations, with Tukey's multiple comparison post test to compare 
differences between time points in a population, and one-way ANOVA to test 
differences overall between unstimulated and stimulated populations were performed 
using GraphPad Prism version 3.00 for Windows, GraphPad Software, San Diego 
California USA, www.graphpad.com. All data shown are pooled means from a number 
of experiments. All error bars shown are the standard error of the mean. 
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5.3 Results 
5.3.1 Cell concentration and viability 
The overall response of the cultures to S. enteritidis LPS was examined by determining 
the total numbers and viability of cells in culture using trypan blue exclusion (Figure 
5.1A and B). In unstimulated control cultures, the cell number and, to a lesser extent, 
viability decreased over the initial culture periods. Moderate to high concentrations of 
LPS, however, appeared to cause proliferation and increased viability. There were 
significantly increased cell numbers, in comparison to non-stimulated controls, in 
cultures containing 100ng/ml, 1ug/ml and 10ug/ml LPS. The percentage viability in the 
cultures stimulated with 1pg, 1ng, 10ng, and 100ng/mL LPS were also significantly 
different overall to that of the control culture (Figure 5.1B). The percentage viability 
was more stable in the cultures stimulated with the higher concentrations of LPS 
(100ng/mL, 1µg/mL and 10µg/mL), as there were no significant differences in viability 
over time. 
 
5.3.2 Biomass increases in LPS-stimulated cultures 
A further measure of the overall response to LPS stimulation was the change in 
biomass. Figure 5.2 shows the relative changes in biomass of control and LPS 
stimulated splenic lymphocyte cultures. There were no significant differences in 
biomass in the control culture over the course of the experiment. In the cultures 
stimulated with 1µg/mL and 10µg/mL LPS the biomass increased significantly up to 
72hr and then decreased at 96hr, although the 96hr values were still highly significantly 
different to the control value for that time point (p<0.0001). This was similar to the 
profile seen for 50µg/mL LPS in Figure 4.4. The biomass in the culture stimulated with 
100ng/mL LPS also increased significantly over the culture period (after 24hr), without 
the decrease seen at 72hr. All the LPS-stimulated cultures were significantly different 
overall to the control culture. 
 
5.3.3 Cell number of B cell subsets 
The number and concentration of B cell subsets was determined using a combination of 
flow cytometric analysis and cell counts using Trypan Blue exclusion staining (Figure 
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5.4). As shown in Figure 5.3, cells were gated first by size (forward scatter) and internal 
complexity (side scatter) (A) to select lymphocytes. The 7AAD fluorescence of these 
gated cells was then examined to select only viable cells (B), that is, those with low 
7AAD fluorescence. Phycoerythrin and FITC-conjugated isotype matched controls were 
used to set the positive and negative levels (C) prior to analysis of anti-CD5-PE and 
anti-CD19-FITC staining levels (D). CD19 was used rather than B220 as the objective 
was to more clearly discriminate between the subsets in order to enhance the results 
obtained with the 3rd colour rather than to use these markers to discriminate between the 
subsets AND assess activation. 
 
While the number of viable B-2 cells decreased over time in the non-stimulated 
cultures, the inclusion of LPS caused a dose-dependent accumulation of these cells. As 
shown in Figure 5.4A, there was a sharp drop in the number of B-2 cells present in 
control cultures from the 0 to 24 hour timepoints. This decrease continued to 48 hours 
and then stabilised. Addition of low concentrations of LPS (<10ng/ml) appeared to have 
no affect on the number of B-2 cells in culture. However, high concentrations of LPS 
(>10ng/ml) led to significantly increased B-2 cell numbers in the cultures.  
 
In contrast to the response of B-2 cells, the number of B-1 cells in culture did not appear 
to be affected by LPS at the concentrations that were tested. For B-1 cells there was also 
an initial drop in cell numbers in non-stimulated control cultures at 24 hours post 
seeding, and there was little further change to 96 hours (Figure 5.4B). A similar pattern 
to the control was seen in LPS-stimulated cultures. Although an overall statistical 
difference was observed between the control cultures and those stimulated with 1pg/ml 
and 100pg/ml, if anything, the numbers of B-1 cells in these cultures was decreased in 
comparison to the control. 
 
5.3.4 CD80 expression increased with LPS stimulation 
The activation of B-1 and B-2 cells in response to S. enteritidis LPS was investigated by 
determining changes in CD80 and MHC expression. This was done was using the 
gating protocol outlined in Figure 5.5. At the start of the experimental period 9.40% (± 
s.e.m. 1.77%) of B-2 cells expressed CD80 compared to 63.23% (± s.e.m. 2.68%) of B-
1 cells (Figure 5.6). CD80 expression was significantly different between the B-1 and 
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B-2 subsets in the control and LPS-stimulated cultures. There was no increase in the 
percentage of B-2 or B-1 cells expressing CD80 in the control and 100ng/mL LPS-
stimulated cultures. B-2 cells in the 1µg/mL and 10µg/mL LPS-stimulated cultures 
express significantly more CD80 overall than cells in the control culture. There was a 
significant difference overall in the percentage of B-1 cells that were CD80+ in the 
cultures stimulated with 1µg/mL and 10µg/mL LPS compared with the unstimulated 
populations.  
 
5.3.5 LPS stimulation increases division index in B-1 and B-2 
cells 
As shown in Figure 5.7, cells were gated to select B-1 and B-2 subsets for further 
analysis of CFSE staining. No CFSE analysis was performed at the 0hr time point as 
fluorescence was too bright immediately after staining the cells (A. Smith, Centenary 
Institute, personal communication). The staining profile of all B cells and the B-1 and 
B-2 subsets at 24hr (A) and 96hr (B) for the control and 10µg/mL LPS-stimulated 
cultures is shown in Figure 5.7. At 24hr no difference (apart from count) can be 
discerned between any of the staining profiles shown. However, at 96hr a tail of cells 
with lower fluorescence than the undivided peak is evidence that division has taken 
place in all subsets in both the control and LPS-stimulated cultures. B-2 cells in cultures 
stimulated with 1µg/mL and 10µg/mL LPS were significantly different to the control 
population (Figure 5.8A). This increase in division index mirrors the increases in viable 
cell concentration and percentage of B-2 cells expressing CD80 shown in Figure 5.4A 
and Figure 5.6A respectively. B-1 cells in cultures stimulated with 1µg/mL and 
10µg/mL LPS were significantly different to the control culture. This is consistent with 
the data shown in Figure 5.4B and Figure 5.6B, where respective increases in viable cell 
concentration and percentage of cells CD80+ were found. 
 
5.3.6 B-1 cells produce more IgM than B-2 cells 
Intracytoplasmic IgM expression was determined for the B-1 and B-2 subsets 0 – 3hr 
after LPS stimulation. Cells were gated to select lymphocytes, isotype-matched controls 
were used to determine the level of non-specific staining for the monoclonal antibodies 
used in the experiment (Figure 5.9), and unlabelled anti-IgM was used to block surface 
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IgM. IgM production (as measured by internal IgM) was not significantly higher in the 
LPS-stimulated cultures compared to the control culture (Figure 5.10). The B-1 subset 
profile of IgM expression (examining control and LPS-stimulated cultures at all time 
points) was significantly different overall (p=0.0047) to that of the B-2 subset, and the 
B-1 subset was also significantly different to the B-2 subset at the 0hr time point – B-1 
cells produced more IgM than B-2 cells – B-1 peak channel is 49.33 (± s.e.m. 16.292) 
and B-2 peak channel is 31.667 (± s.e.m. 13.715). 
 
5.3.7 B-1 cell cycle profiles are different to B-2 profiles  
The cell cycle profiles of B-1 and B-2 cells were examined in order to determine 
whether any differences in the response of these subsets to LPS stimulation was due to 
cell cycle perturbations or changes. Cells were gated using forward and side scatter to 
select the lymphocyte population, quadrants for anti-CD5-PE and anti-CD19-FITC were 
set using isotype matched controls (not shown) and B-1 (CD5+/CD19+) and B-2 (CD5-
/CD19+) subsets were analysed further for 7AAD fluorescence. The percentage of cells 
in each subset at each phase of the cell cycle was then determined using three markers 
on the 7AAD fluorescence histogram (Figure 5.11). Overall, the B-1 subset profiles 
were significantly different to the B-2 subset profiles (Figure 5.12). In particular, at the 
time of culture seeding (0 hours), a higher proportion of B-1, in comparison to B-2 cells 
were in either the S or G2/M phases of the cell cycle. Following culture with LPS, there 
were no statistically significant changes in the percentage of cells in either the S or 
G2/M phases. However, for both B-1 and B-2 populations, there was a significant LPS 
dose-dependent increase in the number of cells in the G0/G1 phase. 
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Figure 5.1 Cell concentration and viability in control and S. enteritidis LPS-
stimulated cultures 
The cell concentration (cells/mL) (A) and viability (B) were determined for control and S. enteritidis 
LPS-stimulated cultures of splenic lymphocytes. Statistically significant differences (p<0.05) between the 
control and LPS-stimulated cultures, as determined by two-way ANOVA, are denoted by a * above the 
relevant time point. Overall significant differences (p<0.05), determined by one-way ANOVA, between 
the control and LPS-stimulated cultures are denoted by a † below the culture descriptor on the X axis. 
Data shown are the means and s.e.m. of five pooled experiments.   
*
*
*
*
*
*
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* * * *
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Figure 5.2 Change in biomass over the culture period in control and S. enteritidis 
LPS-stimulated splenic lymphocyte cultures 
The MTT-formazan assay was used to examine the change in biomass in control and 100ng/mL, 1µg/mL 
and 10µg/mL S. enteritidis LPS-stimulated splenic lymphocyte cultures. This was measured by 
determining the difference in absorbance for the yellow soluble substrate and the purple insoluble 
product. Statistically significant differences (p<0.05) between the control and LPS-stimulated cultures, as 
determined by two-way ANOVA, are denoted by a * above the relevant time point. Overall significant 
differences (p<0.05), determined by one-way ANOVA, between the control and LPS-stimulated cultures 
are denoted by a † below the culture descriptor on the X axis. Data shown are the means and s.e.m. of 
three pooled experiments.   
* *
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Figure 5.3 Representative FACScan plots for flow cytometric analysis 
(7AAD/CD5/CD19) showing gating strategy 
A specific gating strategy was utilised in order to examine only lymphocytes from the splenocyte 
cultures. Cells were first gated by forward (FSC) and side (SSC) scatter to select cells of the correct size 
and internal complexity (A). Cells meeting these criteria were further gated by their 7AAD fluorescence 
and side scatter to determine viable and non-viable cells (B). Apoptotic and degenerate cells are also able 
to be identified using 7AAD. Fluorescently-labelled isotype controls were used to set the quadrant 
parameters for positive and negative events, using only those cells that were gated as viable lymphocytes 
(C). Identification of subsets of viable lymphocytes was then able to be performed using, for example, 
anti-CD5-PE and anti-CD19-FITC (D) to identify B-1 cells (CD5+/CD19+, upper right quadrant), B-2 
cells (CD5-/CD19+, lower right quadrant, T cells (CD5+/CD19-, upper left quadrant) and non T or B cells 
(CD5-/CD19-, lower left quadrant). Data shown are from a single representative experiment. 
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Figure 5.4 Concentration (cells/mL) of viable B-2 and B-1 cells in culture 
The concentration of viable B-2 (A) and B-1 (B) cells for all concentrations of S. enteritidis LPS was 
determined using a combination of 7AAD/CD5/CD19 flow cytometric analysis and Trypan Blue 
exclusion staining. Statistically significant differences (p<0.05) between the control and LPS-stimulated 
cultures, as determined by two-way ANOVA, are denoted by a * above the relevant time point. Overall 
significant differences (p<0.05), determined by one-way ANOVA, between the control and LPS-
stimulated cultures are denoted by a † below the culture descriptor on the X axis. Data shown are the 
means and s.e.m. of ten pooled experiments. 
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Figure 5.5 Representative FACScan plots for flow cytometric analysis: 
CD5/CD19/CD80  
Cells were first gated by forward (FSC) and side (SSC) scatter to select cells of the correct size and 
internal complexity (not shown). Fluorescently-labelled isotype controls were used to set the quadrant 
parameters for positive and negative events, using only those cells that were gated as viable lymphocytes 
(A and B). Identification of subsets of viable lymphocytes was then able to be performed using, for 
example, anti-CD5-PE and anti-CD19-Cy-Chrome (C) to identify B-1 cells (CD5+/CD19+, upper right 
quadrant), B-2 cells (CD5-/CD19+, lower right quadrant, T cells (CD5+/CD19-, upper left quadrant) and 
non T or B cells (CD5-/CD19-, lower left quadrant). The level of CD80 expression, determined using anti-
CD80-FITC, was examined for B-2 (R2 of C) and B-1 (R3 of C) cells. Data shown are from a single 
representative experiment. 
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Figure 5.6 CD80 expression of B-2and B-1 cells 
CD80 expression was examined in viable B-2 (A) and B-1 (B) cells. The percentage of cells CD80+ is 
shown for each time point and concentration of S. enteritidis LPS used in the experiments. Statistically 
significant differences (p<0.05) between the control and LPS-stimulated cultures, as determined by two-
way ANOVA, are denoted by a * above the relevant time point. Overall significant differences (p<0.05), 
determined by one-way ANOVA, between the control and LPS-stimulated cultures are denoted by a † 
below the culture descriptor on the X axis. Data shown are the means and s.e.m. of three pooled 
experiments.  
† 
† † 
A 
B 
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Figure 5.7 Representative FACScan plots for flow cytometric analysis: 
CFSE/CD5/CD19 
As in Figure 5.5, cells were gated using forward and side scatter and the subdivided into B-2 and B-1 
subsets using CD5-PE and CD19-CyChrome staining patterns (positive regions set using isotype matched 
controls). CFSE staining patterns are shown for 24hr (A) and 96hr (B) after seeding for both control and 
10µg/mL LPS-stimulated populations. At each cell division the level of CFSE fluorescence is halved and 
the number of divisions cells have undergone can be determined by examining the level of this 
fluorescence. Data shown are from a single representative experiment. 
A
B 
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Figure 5.8 CFSE division index B-1 and B-2 cells 
CFSE division index at 24, 48 and 72hr is shown for B-2 (A) and B-1 (B) subsets for control and S. 
enteritidis LPS-stimulated cultures. Statistically significant differences (p<0.05) between the control and 
LPS-stimulated cultures, as determined by two-way ANOVA, are denoted by a * above the relevant time 
point. Overall significant differences (p<0.05), determined by one-way ANOVA, between the control and 
LPS-stimulated cultures are denoted by a † below the culture descriptor on the X axis. Data shown are the 
means and s.e.m. of three pooled experiments.   
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Figure 5.9 Representative FACScan plots for flow cytometric analysis: 
CD5/CD19/IgM 
Cells were gated using forward and side scatter to select lymphocytes and positive regions for fluorescent 
staining were determined using fluorescently conjugated isotype matched controls. Lymphocytes were 
divided into B-1 and B-2 B cell subsets using CD5-PE and CD19-Cy-Chrome staining characteristics and 
then analysed for IgM expression using anti-IgM-FITC. Data shown are from a single representative 
experiment. 
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Figure 5.10 IgM production in B cells 
Peak channel (the fluorescence channel with the greatest number of counts) was used to examine the level 
of IgM production in all B lymphocytes (A) and in the B-2 (B) and B-1 (C) subsets for control and S. 
enteritidis LPS-stimulated cells at 0, 1, 2, and 3 hours (n=4 experiments). There were no statistically 
significant differences as determined by two-way ANOVA with Tukey’s multiple comparison post test 
and one-way ANOVA. Data shown are the means and s.e.m. of four pooled experiments. 
A 
B 
C 
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Figure 5.11 Representative FACScan plots for flow cytometric analysis: 
CD5/CD19/7AAD (cell cycle) 
Cells were gated using forward and side scatter to select lymphocytes (and to reduce the number of 
doublets in the analysis) and positive regions for fluorescent staining were determined using fluorescently 
conjugated isotype matched controls. Lymphocytes were divided into B-1 and B-2 B cell subsets using 
CD5-PE and CD19-FITC staining characteristics and then analysed for cell cycle phases using 7AAD. 
M1 shows cells in G0/G1, M2 is cells in S, and M3 is cells in G2/M phase. Data shown are from a single 
representative experiment. 
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Figure 5.12 Cell cycle in B-2 and B-1 cells 
The percentage of B-2 and B-1 cells in each phase of the cell cycle, as measured using 7AAD in 
conjunction with anti-CD5-PE and anti-CD19-FITC, is shown for each concentration of S. enteritidis 
LPS. Statistically significant differences (p<0.05) between the control and LPS-stimulated cultures, as 
determined by two-way ANOVA, are denoted by a * above the relevant time point. Statistically 
significant differences between time points overall and the 0hr values, as determined by one-way 
ANOVA, are denoted by a † below the time category. Data shown are the means and s.e.m. of three 
pooled experiments.  
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5.4  Discussion 
The data presented in this chapter indicate that B-1 and B-2 cells have different basal 
levels of activation and do respond differently to S. enteritidis LPS. However, contrary 
to the original hypothesis, it appears that B-1 cells are less sensitive than B-2 cells to 
the proliferation-enhancing effects of LPS.  
 
As was noted in Chapter 4, B-1 cells appeared to have a higher basal level of activation 
than B-2 cells. In non-stimulated cultures, more B-1 than B-2 cells were in the S and M 
phases of the cell cycle (Figure 5.12), indicating that there was a higher basal level of 
proliferation for these cells. Furthermore, over the course of the culture period, more 
viable B-1 cells remained than B-2 cells (Figure 5.4). In addition to the inherently 
higher proliferative capacity of B-1 cells, a higher percentage of unstimulated B-1, as 
compared to B-2 cells, expressed the activation marker CD80 (Figure 5.6). 
Furthermore, B-1 cells inherently produced more IgM (Figure 5.10). This overall 
picture is consistent with the known biology of B-1 cells. As described in Chapter 1, 
they are self-renewing and may either have a high intrinsic level of activation, or might 
be stimulated by self-antigens within the cultures. 
 
When the response of B-1 and B-2 cells to varying concentrations of S. enteritidis LPS 
was examined, it was found that although moderate to high levels of LPS stimulated 
the proliferation of both B cell subtypes, only B-2 cells accumulated in culture. The net 
number of cells of each subpopulation, at any given time, should largely be determined 
by the combined effects of proliferation and apoptosis. When challenged with high 
doses of LPS, B-2 cells accumulated in number in comparison to control cultures 
(Figure 5.4A). B-1 cells, in contrast, did not show any accumulation in response to LPS 
(Figure 5.4B). As shown in Figure 5.8, both cell populations had significantly raised 
division indices in response to 1µg/ml or 10µg/ml LPS, in comparison to controls. 
Although the proliferation indices of B-2 cells were slightly higher than those of B-1 
cells, which suggested that B-2 cells might be proliferating more rapidly, the 
magnitude of this difference was not large. This indicated that other factors, such as 
changes in the rate of apoptosis, might be influencing the number of each cell type. 
Attempts were made at assessing apoptosis in the cultures by quantifying the 
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hypodiploid peak for each cell type in cell-cycle analysis histograms (cells below 
region M1 in Figure 5.11), however technical difficulties were encountered (apoptotic 
cells tended to clump and stain with antibody non-specifically - data not shown). 
Nevertheless, it is possible that the increase in B-2 cell number in response to LPS is 
due to decreased apoptosis. The lack of change in B-1 cell numbers could equally be a 
result of increased apoptosis in response to LPS. 
 
The finding that the CD5+ B cell subset was essentially unresponsive at low 
concentrations of LPS is in contrast to earlier reports that this subset is very responsive 
to mitogenic stimuli with respect to enhanced secretion of autoantibodies (Hardy et al., 
1987; Hayakawa et al., 1990; Chace et al., 1993). CD5+ B cells in the thymic 
compartment, however, have been demonstrated to have low responsiveness to LPS 
(Miyama-Inaba et al., 1988; Inaba et al., 1990). 
 
It was considered that the increased B-2 cell number in response to LPS might be a 
result of the action of rheumatoid-like IgM produced by B-1 cells acting on B-2 cells. 
A preferential role for CD5
+
 B cells in the secretion of rheumatoid factor (RF)-like 
"regulatory" autoantibody has been demonstrated (Hardy et al., 1987; Hayakawa and 
Hardy, 1988; Hayakawa et al., 1990). It has been postulated that these cells help in the 
activation and development of conventional CD5
-
 B cells (Andersson et al., 1977; 
Hardy et al., 1987; Hardin et al., 1990; Hayakawa et al., 1990). Also in support of this 
hypothesis are findings that human B-1 cell-derived IgM can bind to membrane-bound 
Ig on murine B-2 cells (Weston and Raison, 1991), and that 60% of murine B cells 
respond to anti-µ by entering S phase (DeFranco et al., 1985). If B-1 cell derived IgM 
was responsible for B-2 cell proliferation in this system, CD5+ B cells would have to 
respond to low levels of LPS by increasing production and secretion of IgM (Chace et 
al., 1993). However, the data shown in Figure 5.10 do not support this hypothesis, as 
there is no increase in IgM staining in cultures challenged with low concentrations of 
LPS.  
 
The studies presented in this chapter did not show a difference between B-1 and B-2 
cell responses to low concentrations of LPS. However, the responses of both subsets 
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were able to be examined and further studies could be undertaken within this system to 
analyse other aspects of the B-1 and B-2 cell response to LPS. 
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Chapter 6 General Discussion 
 
The aim of the research presented in this thesis was to investigate, using in vitro 
systems, the response of B-1 and B-2 cells to enterobacterial and non-enterobacterial 
LPS to shed light on the pathogenesis of chronic periodontitis and other diseases 
involving B cell accumulation and autoantibody production. 
 
The hypotheses tested were: 
 
(1) B cells respond differently to enterobacterial and non-enterobacterial LPS. 
(2) B-1 cells are activated by a lower concentration of LPS than B-2 cells. 
(3) LPS stimulation results in preferential accumulation of B-1 cells. 
 
Findings consistent with these hypotheses would provide new evidence for different 
roles for B-1 and B-2 cells in immune responses and that LPS stimulation could lead to 
B-1 cell accumulation in diseases thus characterised. 
 
Initial experiments investigated the responses of representative B-1 and B-2 cell lines to 
P. gingivalis and S. enteritidis LPS. In both cell lines, there were obvious differences in 
the responses to the different LPS preparations. Since S. enteritidis LPS appeared to 
have more pronounced effects on both B cell populations, this LPS was used to further 
investigate B cell subset responses in a mixed splenocyte culture system. The results of 
the splenocyte culture experiments clearly demonstrated that there are differences in the 
responses of B-1 and B-2 cells to LPS. However, overall, the results are inconsistent 
with LPS driving the accumulation of B-1 cells in disease states. 
 
6.1 B cell responses to enteric and non-enteric LPS 
It has long been clear that the immune system is capable of activating a variety of 
effector mechanisms in response to different pathogens. However, despite the huge 
array of effector cells and pathways, only a subset of the available mechanisms is ever 
used. There has been considerable effort spent over many years to understand the 
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pathways underlying this phenomenon. It has become apparent that the eventual effector 
modality may be ‘decided’ by the innate immune system and this decision may occur 
very early in a developing immune response. The phylogenetically conserved cells and 
receptors of the innate immune system recognise invariant pathogen-derived molecules 
(such as LPS) and are capable of setting very distinct effector pathways in train. Indeed, 
since vertebrate immune systems have co-evolved with pathogens over millions of 
years, it is perhaps not surprising that subtle distinctions in the structures of pathogen-
derived molecules may be sensed, and that this may ultimately lead to differing profiles 
of effector activation. An example of this specificity is the putative ability of immune 
cells to respond differently to LPS of enterobacterial and non-enterobacterial origin (see 
section 1.5.2.1.6). 
 
Given the reported accumulation of B cells in periodontitis (see section 1.7.3), it was 
hypothesised that LPS from this organism might be capable of activating B cells to 
cause proliferation and differentiation into antibody secreting cells. This was initially 
examined using the CH12 and WEHI 279 cell lines. The effects of P. gingivalis LPS 
were compared with those of LPS derived from a typical enteric organism, S. enteritidis. 
Results from both cell lines suggest that B cells can respond differently to LPS of 
different origins, and that P. gingivalis LPS can drive B-1 accumulation. 
 
The effects of either LPS preparation on WEHI-279 cells were not marked, but there 
were indications of diverging responses. S. enteritidis LPS failed to affect growth at any 
concentration (Figure 3.2), although viability was increased at the highest dose tested 
(Figure 3.1). In contrast, at high concentrations, P. gingivalis LPS appeared to actively 
inhibit proliferation (Figure 3.10). Measurement of an array of cellular parameters, 
including investigation of the expression of cytokines, co-stimulatory molecules, TLR 
and Bcl2/Bax messages was used in attempt to dissect the mechanisms involved in the 
response. These were largely uninformative, although results did suggest that IL-6 and 
IL-10 may be slightly increased in response to high concentrations of S. enteritidis LPS 
(Figure 3.8). These cytokines may drive both the proliferation and differentiation of B 
cells (see section 1.5.2.2). No further differences were found in the response of this cell 
line to the two LPS preparations. Taken at face value, this suggests that B-2 cells may 
not be strongly affected by either LPS preparation. Although the WEHI-279 line is a 
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useful tool for studying B-2 biology (see section 1.6.2), the effects of inter-subset 
interactions are unable to be examined. A possible method for examining such 
interactions could include a mixed culture of WEHI-279 and CH12 cells, however as 
these lines were cultured in different media (DMEM and RPMI-1640 respectively), this 
was not feasible in the time available. 
 
The response of the CH12 cell line contrasted with that of the WEHI-279 line. CH12 
cells did respond to high concentrations of P. gingivalis LPS by proliferating (Figure 
2.20B and Figure 2.21). However, low concentrations actually appeared to inhibit 
proliferation. In response to S. enteritidis LPS, there was protection from cell death at 
high concentrations of LPS (Figure 2.6A), and a marked proliferation (Figure 2.6B and 
Figure 2.8).  
 
Investigation of the cellular processes triggered in CH12 cells in response to different 
LPS preparations showed diverging patterns. Although the concentrations of the 
different LPS preparations at which CH12 cells proliferated were approximately the 
same, in a range of assays investigating further parameters of the cellular response, 
CH12 cells did not appear to be affected by P. gingivalis LPS. In contrast, high 
concentrations of S. enteritidis LPS did affect antibody and cytokine production, as well 
as the regulation of Toll-like receptor expression. In response to high concentrations of 
S. enteritidis LPS, there was an increase in the expression of secretory IgM message, 
which indicates that this LPS induced differentiation into plasma cells. This is 
consistent with previous reports that showed increased production of IgM by CH12 cells 
in response to enteric LPS (Stockdale et al., 1987; Arnold et al., 1988; Bost et al., 
1990). There was also a small increase in IL-10 mRNA in response to S. enteritidis, but 
not P. gingivalis, LPS (Figure 2.19B and Figure 2.27B). This increase in cytokine 
message was similar to that seen in the WEHI-279 cells and suggests that there may be 
similar pathways involved in both cell lines in response to S. enteritidis LPS. It is 
possible that autocrine stimulation by either or both of these cytokines may be involved 
in driving the proliferation of both cell lines in response to S. enteritidis, but not P. 
gingivalis, LPS. Unfortunately, sufficient time and resources were not available to 
conduct antibody blocking experiments, which would have answered this question 
conclusively. 
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A distinct change in the expression of RP105 mRNA in CH12 cells in response to S. 
enteritidis LPS may shed some light on the processes involved in LPS-stimulation of 
these cells. While there were no changes in TLR expression in CH12 cells in response 
to P. gingivalis LPS, culture with S. enteritidis LPS led to a clear decrease in the 
message of RP105 (Figure 2.18). Modulation of TLR2 has been observed in response to 
bacterial lipoprotein (Wang et al., 2002), while down-regulation of TLR4 has been 
implicated in the phenomenon of endotoxin tolerance in macrophages (Medvedev et al., 
2000; Nomura et al., 2000; Wang et al., 2002). The present study is the first report of 
regulation of the B cell specific RP105 by non-enteric LPS. Given the apparent 
specificity observed in this regulation process (bacterial lipoprotein binds to TLR2 and 
enteric LPS binds to TLR4 – see section 1.5.2.1 and Appendix 4) it appears that 
decreases in TLR expression may be part of a negative feedback loop. The exact initial 
processes involved in B cell activation of by LPS are unclear. RP105 has been shown to 
be highly expressed on B cells (Akashi et al., 2000; Zarember and Godowsdi, 2002), 
and LPS from the enteric bacterium E. coli has previously been shown to stimulate B 
cells via RP105. However, activation via RP105 also requires the presence of some 
level of TLR4 expression (Ogata et al., 2000). In an alternate murine CD5+ B cell line, 
TH2.52, it was reported that the response to LPS requires the presence of CD14 (Koide 
et al., 2001). The role of CD14 in LPS signalling is controversial (see section 1.5.2.1), 
but it appears that it may co-localise with TLR4 and together they may bind LPS. It is 
possible that CD14 could also act in concert with RP105 to bind LPS, although this has 
not been demonstrated. It does seem likely that S. enteritidis LPS acts via RP105. 
Down-regulation of RP105 following prolonged LPS stimulation may represent a 
mechanism to limit B cell proliferation and antibody production. The receptors involved 
in CH12 activation by P. gingivalis LPS are, however, less clear. Although P. gingivalis 
LPS has been postulated to act via TLR2 (see section 1.5.2.1.3), there was no 
modulation of this receptor. The absence of regulation of TLR2 message, in itself, does 
not mean that TLR2 is not involved in the response to P. gingivalis LPS. It could also 
reflect the absence of a pathway linking TLR2 signalling to regulation of TLR4 
expression. 
 
Taken as a whole, the responses of the two cells lines to P. gingivalis LPS are consistent 
with patterns seen in periodontitis. In both the peripheral blood of periodontitis patients 
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(Afar et al., 1992), and within the lesions (Sugawara et al., 1992), CD5+ cells are over-
represented. It is possible that patients with an underlying disorder that increases the 
responsiveness of CD5+ B cells may be predisposed to periodontitis, however, the data 
presented here suggest that P. gingivalis LPS may directly drive the expansion of B-1 
cells while inhibiting the proliferation of B-2 cells.  
 
6.2 Differences in the response of B-1 and B-2 cells to 
LPS 
Differential responsiveness of B-1 and B-2 cells to LPS, if demonstrated, could 
represent a mechanism that enables an organism to mount a co-ordinated and effective 
immune response to pathogens. In some circumstances, however, it could also 
contribute to the development of immunopathology. As described in sections 1.4.2 and 
1.4.1, B-1 and B-2 cells have very different functions in the immune system. One view 
is that B-1 cells are ‘first-responders’ in an immune response. They produce antibodies 
that are polyreactive, and stimulation of B-1 cells is likely to lead to the production of 
antibodies that may not only bind directly to foreign antigen, leading to its clearance 
(see section 1.3.2.2), but may stimulate the development of specific B-2 responses 
(section 1.4.1). From first principles it seems that it would be advantageous to an 
organism if B-1 cells were more sensitive to LPS than B-2 cells. Rapid production of 
natural antibodies would help protect the organism in the early stages of infection, and 
would also assist the development of a more specific adaptive response. A higher 
activation threshold in B-2 cells would mean that these cells, most of which would be 
unlikely to bind to LPS, would not be activated. As with many aspects of immune 
effector functions, however, production of natural antibodies may be a double-edged 
sword. Natural antibodies, by their nature, are polyreactive and may recognise many 
self-antigens (see section 1.3.2.2). Prolonged, uncontrolled B-1 cell activation could 
lead to tissue damage mediated by autoantibodies.  
 
Data from previous studies has suggested that B-1 cells may indeed be very sensitive to 
LPS (Chace et al., 1993; Koide et al., 2001). The data presented in this thesis 
demonstrates that B-1 and B-2 cells do respond differently to LPS, however these 
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differences were not as marked as the literature has previously suggested. Further, while 
experiments using cell lines suggested that B-1 were indeed more sensitive to LPS, the 
results of more physiological mixed splenocyte cultures suggested that, in fact, B-2 
were more responsive than B-1 cells. It may be that B-1 cells are relatively refractive to 
LPS stimulation in order to prevent “overpopulation” in a subset that, “due to their long 
life span and self-renewal capabilities, capabilities…have an increased ability to 
clonally expand and escape negative selection to become malignant” (Zhang et al., 
2001). Transient increases in number may ensure proportional relativity in comparison 
to increased numbers of B-2 cells in infection, thus retaining proportionate amounts of 
“natural” IgM. 
 
6.2.1 Effects of LPS on viability and proliferation of B cell 
subsets 
6.2.1.1 Cell lines 
Initial experiments used cell lines to investigate the response of B-1 and B-2 cells to 
LPS. Cultures that were stimulated with P. gingivalis LPS did not show a clear-cut 
response, but overall the data was consistent with increased sensitivity of CH12 cells 
when compared with the WEHI-279 line. P. gingivalis LPS did not affect viability in 
CH12 cells, but did cause increased cell numbers in culture when present at 100ng/ml 
and higher concentrations (Figure 2.20). In contrast, when WEHI-279 cells were 
cultured with P. gingivalis LPS, low concentrations appeared to enhance proliferation of 
WEHI-279 cells to a slight degree, but high concentrations (similar to those that caused 
proliferation in CH12 cells) actually caused inhibition of growth (Figure 3.9 and Figure 
3.10). 
 
The CH12 studies presented in Chapter 3, using the CD5+ CH12 cell line, showed that 
LPS did affect the survival of these cells. Addition of 100ng/mL and above of S. 
enteritidis LPS to cultures led to increased viability and cell concentration when 
compared to the unstimulated cells (Figure 2.6). The division index of cells stimulated 
with 10ng/mL and upwards of S. enteritidis LPS was significantly different to that of 
the unstimulated control population (Figure 2.8). Essentially, addition of S. enteritidis 
LPS “rescued” these cells from death due to serum starvation and changed the dynamics 
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of the population to resemble that of the unstimulated population cultured in medium 
supplemented with 10% FCS (Figure 2.6). In contrast to its effects on CH12, S. 
enteritidis LPS caused only minimal changes in WEHI-279 proliferation and viability 
(Figure 3.2 and Figure 3.1). Only the highest dose of LPS tested, 10 µg/ml, led to 
increased viability (Figure 3.1A) and, possibly, to proliferation (Figure 3.2).  
 
When viewed as a whole, the cell line experiments supported the hypothesis that B-1 
cells were more sensitive to the effects of LPS. Although both cell lines have been used 
extensively as models to investigate B cell function (see sections 1.6.1 and 1.6.2), it is 
uncertain if the responses of these isolated populations of immortalised cells accurately 
represent in vivo responses. The individual cells lines could, for example, display 
idiosyncratic responses to LPS. Alternatively, the use of isolated populations ignores 
interactions between cell types. It was therefore decided to examine the response of B-1 
and B-2 cells in primary culture. A mixed splenocyte culture system of was developed 
that allowed interaction between a range of immune cell types, and simultaneously 
enabled the investigation of the responses of both B-1 and B-2 subsets (Chapter 4). This 
culture system was subsequently used to determine the relative sensitivities of the two B 
cell subpopulations to S. enteritidis LPS (Chapter 5). 
 
6.2.1.2 Splenocyte cultures 
Surprisingly, given both the published literature (see section 1.5.2.1.7) and the evidence 
gained using cell lines in Chapters 3 and 4, the results of the mixed culture system 
supported neither the hypothises of increased B-1 cell sensitivity to LPS nor the that of 
LPS driving B-1 accumulation. 
 
When the response of CD5+ cells to S. enteritidis LPS was measured by the number of 
cells in culture (Figure 5.4), there was no effect seen in any of the LPS concentrations 
tested. Interestingly, however, high concentrations of LPS did appear to cause increased 
proliferation of B-1 cells (Figure 5.8). Such a discrepancy may be explained by a 
change in the balance of proliferation and cell death. An increase in proliferation that 
was balanced by a simultaneous increase in cell death would lead to a neutral net 
change in cell numbers in culture. As described in section 5.4, there were technical 
difficulties in assessing apoptosis in the different B cell subpopulations, however, 
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considerable apoptosis was seen in cultures stimulated with high dose LPS (Figure 4.9), 
indicating that it was definitely occurring within these cultures. It is possible that LPS 
not only increases the proliferation of B-1 cells, but also sensitises them to apoptosis. 
Such a mechanism could help to limit the expansion of B-1 cells in response to LPS and 
could conceivably protect the organism from the deleterious effects of excessive 
expansion and activation of this population.  
 
In direct contradiction to the original hypotheses, B-2 cells were responsive to S. 
enteritidis LPS at similar concentrations to B-1 cells (Figures 4.8 and Figure 5.4). 
Furthermore, and in contrast with B-1 cells, it was B-2 cells that accumulated in number 
in LPS-challenged splenocyte cultures (Figure 5.4). As with B-1 cells, these changes 
appeared to result from changes in the balance of proliferation and death. The 
accumulation of B-2 cells probably resulted from increased proliferation (Figure 5.8) 
and, possibly, decreased cell death. These observations, at first, appear difficult to 
reconcile with the cell line studies (Chapters 3 and 4). However, there are a number of 
possible explanations. Although both of these cell lines have been used in a range of 
studies investigating many aspects of B cell biology (see sections 1.6.1 and 1.6.2), it is 
possible that one or both of the cell lines might have non-characteristic responses to 
LPS. Alternatively, it may be that there are as yet undefined interactions occurring 
within the more complex mixed culture system. Purification of primary B cell subsets 
and investigation of their separate responses to LPS per the cell line experiments 
presented in this thesis would allow the determination of characteristic subset responses, 
if indeed this is different to that of the cell lines, but would not elucidate any cross-
subset interactions, as is possible in the mixed culture system. 
 
The central thrust of the studies presented here was to investigate potential pathogenic 
mechanisms underlying periodontitis. Consequently, P gingivalis LPS, as well as S. 
enteritidis LPS, was used in initial studies investigating the effects on cell lines. As the 
response to S. enteritidis LPS was more marked, this was chosen for further studies in 
the mixed splenocyte culture system. These experiments provided useful evidence that 
supported the idea that B-1 and B-2 cells respond differently to LPS. However, these 
studies were unable to directly address the role of P. gingivalis LPS in periodontitis. It 
of may be that P. gingivalis LPS has different effects to S. enteritidis LPS on primary B 
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cells. It is still possible that B-1 cells may be more sensitive to P. gingivalis, as opposed 
to S. enteritidis LPS. Unfortunately, time constraints, and a developing severe reaction 
of the candidate to mice, precluded further experiments in this system. Ultimately, 
however, the evidence provided by the mixed system is not consistent with either of the 
two final hypotheses behind these studies: firstly, that B-1 cells do not respond to lower 
concentrations of LPS than do B-2 cells, and secondly, that B-1 cells do not 
preferentially accumulate in response to LPS stimulation. 
 
6.3 Further observations on B-1 cell biology 
6.3.1 Activation 
In addition to the direct investigation of the hypotheses of differential B cell 
responsiveness to LPS and responsiveness to enteric and non-enteric LPS, a further 
salient observation was made over the course of the studies that contributes to the 
understanding of B cell biology. Evidence was found that B-1 cells have a high basal 
level of activation. 
 
When CH12 cells were grown under standard cell culture conditions, the majority of 
these cells were CD80+. This suggests that this line is constitutively activated. 
Stimulation with P. gingivalis or S. enteritidis LPS did not affect the level of CD80 
mRNA expression. It is possible that the CH12 line constitutively expresses a maximal 
level of CD80 (and possibly CD86) and further stimulation will not cause any increase. 
LPS stimulation did not have any effect on CD80 or CD86 mRNA expression in WEHI-
279 cells. This may be due to either a lack of any effect on CD80 and CD86 expression 
or that this line is also maximally expressing these activation markers.  
 
In the splenic lymphocyte cultures, activation status as measured by CD80 expression, 
was different for B-1 and B-2 cells. A majority (63%) of B-1 cells expressed CD80 at 
the start of the experimental period compared to 9% of B-2 cells (Figure 5.6). The 
percentage of B-2 cells expressing CD80 increased when the cells were stimulated with 
concentrations of LPS of 1µg/mL and above. A similar pattern is seen for B-1 cells, 
although the increase in CD80+ cells is significantly less than that for B-2 cells (Figure 
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4.11). An observed decrease at 72hr in the 1µg/mL and 10µg/mL LPS-stimulated 
cultures was most likely due to overgrowth and acidification of medium, followed by 
cell death. Increased activation in both B cell subsets is reflected in the MTT assay data 
(Figures 4.4 and 5.2) and the morphological data shown in Figures 4.1, 4.2 and 4.3. 
Within these studies it was not possible to determine whether the cells shown were B-1 
or B-2 cells, but it was evident that activation did occur. 
 
It is relevant to note that binding of ligands to CD80 and CD86 may regulate apoptosis 
in B cells. In murine splenic B cells, ligation of CD80 or CD86 may modulate antibody 
production, while in a B cell lymphoma, cross-linking of CD80 enhanced the expression 
of the pro-apoptotic molecules caspase-3, caspase-8, Fas, FasL, Bak, and Bax (Suvas et 
al., 2002). In contrast, signalling through CD86 increased the expression of anti-
apoptotic molecules Bcl-w and Bcl-x(L) (Suvas et al., 2002). Thus, it is possible that 
ligation of CD80 and or CD86, by other cells in mixed splenocyte cultures, may affect 
B cell survival. The ratio of Bcl-2 to Bax, anti-apoptosis and pro-apoptosis proteins 
respectively, in CH12 cells in LPS-stimulated cultures was not significantly different to 
the control culture. The ratio was significantly higher at 48hr than at 24hr and this might 
reflect the survival of the cells in the cultures, rather than any LPS-specific effect as the 
ratio in the unstimulated populations was also increased. A trended increase of the Bcl-
2/Bax ratio across the LPS-stimulated and 10% FCS control populations was noted, but 
the differences were not significant. Stimulation with P. gingivalis LPS did not affect 
the Bax/Bcl-2 ratio. Despite increases in proliferation and viability in WEHI-279 cells 
when stimulated with S. enteritidis and P. gingivalis LPS, no change in the Bax/Bcl-2 
ratio was seen for this cell line. 
 
Taken together, this evidence suggests that B-1 cells may have a high basal level of 
activation. Such basal activation is compatible with involvement of these cells in the 
early response to pathogens. A low but continuous level of activation could be one of 
the mechanisms by which CD5+ B cells are able to maintain antibody production 
without stimulation from the foreign antigens for which the antibody is (poly)specific. It 
is of note that signal transducer and activator of transcription (STAT) protein-3 is 
constitutively phosphorylated in B-1 cells, reflecting or causing the activated state of B-
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1 cells and possibly contributing to the self-renewing characteristics of this B cell subset 
(Karras et al., 1997).  
6.4 Implications for pathogenesis of periodontitis 
Advanced/progressive human periodontitis is considered by many to be a B lymphocyte 
and plasma cell lesion (Okada et al., 1983; Tew et al., 1989; Gemmell and Seymour, 
1991). Gemmell and Seymour examined the phenotype of B lymphocytes in 
periodontitis and found that a majority of these cells were activated (Gemmell and 
Seymour, 1991). Up to 38% of B cells from inflamed gingival tissues were determined 
to be CD5+ and many of these cells produced anti-collagen (auto-) antibodies (Sugawara 
et al., 1992). An increase of CD5+ B cells was also found in the peripheral blood of 
periodontitis patients (Afar et al., 1992).  
 
Chronic periodontitis is believed to be exacerbated by the colonisation of the sub-
gingival region by organisms such as Porphyromonas gingivalis, Prevotella intermedia, 
and Fusobacterium nucleatum (Wilson, 1995). It has been suggested by Tew et al., and 
other investigators, that polyclonal activation of these B cells by bacterial mitogens 
derived from such organisms is important in the pathogenesis of the periodontal lesion 
(Tew et al., 1989; Ranney, 1991). LPS (Ringden et al., 1977; Hammarstrom et al., 
1980; Matsushima et al., 1985; Gaidano et al., 1989; Settmacher et al., 1990), togetherr 
with pertussis toxin (Kolb et al., 1990), the B subunit of cholera toxin (Dugas et al., 
1991), Mycoplasma arthritidis MAM (Cole et al., 1996), synthetic 
oligodeoxynucleotides (Liang et al., 1996), Dermatophagoides farinae antigens (Fujii et 
al., 1996), and Nocardia opaca water soluble mitogen (Brochier et al., 1976) among 
others, have been shown to be polyclonal human B cell activators. The amount of LPS 
associated with the root surface of periodontally diseased teeth was shown to range 
from 19 to 394ng per tooth (Wilson, 1995), and the local concentration available to the 
conventional B cells proximal to a diseased tooth could be high enough to result in 
polyclonal activation. 
 
6.4.1 Polyclonal B cell activation in periodontitis 
Progressive disease could be considered to represent a state of failure to prevent the 
ingress of microbial products into the tissues; accordingly, high levels of components 
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such as LPS would be expected. CD5+ B cells are known to be self-renewing in the 
periphery (Hardy and Hayakawa, 1986). The maintenance of stable B-1 cell numbers in 
control unstimulated cultures is most likely due to this mechanism of self-renewal and 
homeostasis (see Figures 4.8 and 5.4*). It can be postulated that during the self-renewal 
process only a certain number of these CD5+ B cells survive, perhaps only one of the 
two daughter cells produced after mitosis. The perturbation of this state could lead to an 
increase in the number of these cells, as seen in Figure 5.8, resulting in an accumulation 
of this subset in pathologies such as chronic periodontitis, as reported by Sugawara et 
al. (Sugawara et al., 1992).  
 
The data suggest that CD5+ B cells are able to respond to LPS, and that LPS perturbs 
the normal population dynamics of this subset. This suggests an extension of the above 
mechanism for the accumulation of CD5+ B cells in chronic periodontitis and other 
pathologies involving such accumulations; trafficking B-1 cells are perhaps kept at a 
site of pathogen infection by chemotactic means where the high local levels of LPS 
result in a perturbation of the normal steady-state/self-renewal of B-1 cells. Fewer B-1 
cells die resulting in more cells available for proliferation, and B-1 cells accumulate 
through decreased death and increased proliferation. Perhaps more trafficking B-1 cells 
are recruited and this removal of B-1 cells from peripheral blood (PB) results in 
proliferation of remaining PB B-1cells to replenish cell numbers to their usual levels. 
The removal of many of the controls of B-1 cell activation and proliferation in this 
model could lead to the accumulation of this subset. 
 
6.4.2 TH1/TH2 profile 
The underlying drive behind the present study has been that B cell accumulation in 
periodontitis could be explained by direct stimulation of B cells by pathogenic bacteria 
and bacterial products, including P. gingivalis LPS. It is possible, however, that other 
less direct pathways are responsible. The most likely candidate pathway is that a strong 
TH2 response is occurring. It has been postulated by a number of investigators that the 
TH1/TH2 profile is skewed towards TH2 in chronic periodontitis (Seymour et al., 1996; 
Gemmell and Seymour, 1998; Yun et al., 2001; Fokkema et al., 2002).  
                                                 
* NB: There is a discrepancy in the absolute numbers of B-1 cells between these two Figures, however for 
each experimental set preseted, the B-1 data was internally consistent with the B-2 data. 
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P. gingivalis LPS may be capable of skewing immune responses towards a TH2 
phenotype by its ability to signal via TLR2. In mice, P. gingivalis LPS, when injected 
with soluble protein antigen, leads to the expression of TH2-associated cytokines (IL-5, 
IL-10 and IL-13) in a non-TLR4-dependent manner. This is in contrast to E. coli LPS, 
which stimulates IFN-γ production in vivo, and IL-12p70 production from cultured 
dendritic cells (Pulendran et al., 2001). Indeed, not only does P. gingivalis LPS appear 
to signal solely through the TLR2, it is able to antagonize signalling through TLR4 
(Darveau et al., 2002; Hajishengallis et al., 2002; Yoshimura et al., 2002). 
 
Both TLR2 and TLR4 are expressed in human periodontal tissues, and the ratio of 
TLR2-positive cells was highest overall in connective tissue subjacent to pocket 
epithelium of the severe group and that of TLR4-positive cells was higher in the severe 
group than in the other groups. PBMC from 8 out of 31 patients with insulin-dependent 
diabetes mellitus showed a significant increase in IL-10 production following challenge 
with 0.01, 0.1 and 1µg/mL P. gingivalis LPS, and only these patients had elevated 
levels of CD5+ B cells (Stein et al., 1997). Aramaki et al. found that the proportion of 
CD5+ B cells and the amount of IL-6 and IL-10 were significantly higher in inflamed 
gingival tissues from patients with adult periodontitis than in peripheral blood from 
healthy subjects (Aramaki et al., 1998). Stein et al. postulate that in “susceptible” 
IDDM patients, exposure to P. gingivalis LPS could induce a hyperactive IL-10 
response in both monocytes and B cells leading to expansion of CD5+ B cells and 
increased levels of autoantibody directed against gingival tissue components (Stein et 
al., 1997). Mahanonda also found that IL-10 significantly enhanced the B cell 
proliferative response, when it is present together with P. gingivalis (Mahanonda et al., 
2002). Periodontopathic bacterial-activated B cells could therefore serve as possible 
antigen presenting cells in periodontitis lesions (Mahanonda et al., 2002). These results 
suggest that TLR2 and TLR4 participate in the innate immune response to stimulation 
by bacterial products in periodontal tissues (Mori et al., 2003). The dominance of B 
cells/plasma cells in the advanced/progressive lesion would suggest a role for TH2 cells. 
If the innate response is poor, low levels of IL-12 would be produced and a poor TH1 
response may occur which may not then contain the infection. Polyclonal B cell 
activation and the subsequent production of IL-4 would encourage a TH2 response, 
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further B cell activation, and antibody production. If these antibodies are protective and 
clear the infection, the disease will not progress, but if on the other hand they are non-
protective, the lesion will persist and continued B cell activation may result in the 
unregulated production of large amounts of IL-1 and subsequent tissue destruction 
(Seymour and Gemmell, 2001). 
 
In addition to differential LPS signalling via TLR2, a further pathway that could lead to 
TH2 deviation has been recently described. Cysteine proteinases (gingipains) of P. 
gingivalis have been found to cleave IFNγ  (Yun et al., 1999), hydrolyse IL-12 and 
reduce the IL-12-induced IFNγ production from CD4+ T cells (Yun et al., 2001). LPS 
upregulates expression of IFNγR on LPS-activated B cells and induces production of 
IFNγ (Abed et al., 1994). IFNγ produced by TH1 and NK cells activates monocytes and 
macrophages and inhibits IgM secretion and B cell activation. Interferon-gamma may 
therefore be part of a negative feedback loop that regulates B cell response to polyclonal 
activators (Abed et al., 1994). Decrease in IFNγ may permit increased sensitivity to B 
cell PBA (Chace et al., 1995). Macrophages produce IFNγ (reviewed in Gessani and 
Belardelli, 1998), and the unresponsiveness of macrophages within the periodontal 
tissue (Chapple et al., 1998), coupled with the cleavage of IFNγ by gingipains could 
result in unregulated B cell activation by periodontal pathogens. The lack of IFNγ, 
together with B cell-produced IL-10, could contribute to the skewing of the TH profile 
to that of TH2, further promoting polyclonal B cell activation. Interestingly, recent work 
in our laboratory has found that P. gingivalis gingipains are able to polyclonally activate 
human B cells and induce IL-4R expression (Yun et al., 2003), thus contributing further 
B cell accumulation stimuli.  
The periodontitis lesion is characterised by tissue destruction and high levels of auto-
antibodies, suggesting a high availability of self-antigen (see section 1.7.3). B-1 cells 
are known producers of auto-reactive antibodies (section 1.3.2.2), and stimulation by 
self-antigens, in conjunction with foreign mediators of activation may further drive the 
polyclonal response and accumulation of B-1 cells with periodontitis lesions. 
 
It can be postulated that unregulated polyclonal B cell activation of the B-1 cell subset 
contributes to the pathogenesis of chronic periodontitis through skewing of the TH 
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response to the TH2 profile via production of IL-10 and destruction of tissues via 
autoantibodies. Accumulation of B-1 cells, constitutively or inducibly, producing IL-10, 
even if the amount produced per cell is relatively low, could lead to locally high 
concentrations of the cytokine and increased opportunity to skew the TH response. 
 
6.5 Future work 
Further studies to elucidate the roles and mechanisms of B-1 and B-2 cell involvement 
in the pathogenesis of periodontitis should include an extension of the mixed population 
studies using P. gingivalis LPS in order to better understand the interactions of the B 
cell subsets with each other and with other cells (for example, T cells and 
macrophages). Specifically, gene expression studies and proteomics would provide data 
concerning cytokine expression and mechanisms of cell death agonists and antagonists. 
An extension of the model would require the sorting of murine B-1 and B-2 cells and 
pulsing each subset with a different tracking dye using for example, PKH26 and 
PKH67. The sorted and labelled cells would then be placed into the same culture and 
the kinetics of each subset examined, together with gene and protein expression. Similar 
studies could be undertaken with human B cells. 
 
Studies presenting modulation of TLR expression (Wang et al., 2001) and function by 
P. gingivalis LPS (Hajishengallis et al., 2002), together with the differential effects of 
LPS-stimulation on TLR expression presented in this thesis suggest interesting avenues 
of study regarding the differential effects of TLR signalling in the immune response and 
the mechanisms of differential responses from the same TLR.  
 
In order to draw more detailed parallels between the mixed cell culture system and 
human disease, an examination of biopsies from healthy controls and patients with 
periodontitis is suggested. This should include the study of the same mediators and 
markers examined in the cell culture work.  
 
6.6 Conclusions 
The studies presented in this thesis have shown that there are differences between B-1 
and B-2 cell responses to enteric and non-enteric LPS, which are consistent with 
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differential roles of these cells in immune responses. LPS was shown to perturb the 
normal homeostatic mechanisms of B-1 cells, a subset which was found to have high 
basal levels of activation and this, together with the “rescue” of serum-starved CH12 
cells, suggests a mechanism by which B-1 cell accumulation in diseases such as 
periodontitis could occur. This has implications both for the treatment of diseases 
characterised by B-1 cell accumulations and postulated roles for this subset in the 
immune response. 
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Appendix 1 
Formulations 
 
Ammonium chloride erythrocyte lysing solution  
10x 
NH4Cl  (1.5M)  80.2g 
NaHCO3 (100mM)  8.4g 
disodium EDTA (1mM) 3.7g 
H2O    to 900mL 
Adjust pH to 7.4 with 1M HCL or NaOH 
Add H2O to 1000mL 
Store up to 6 months at 4ºC 
 
1x 
Dilute 1:10 with H2O fresh before use 
Store cold and discard unused portion 
 
10% BSA 
BSA (Sigma A4503)  1g 
dH2O    9mL 
Place in 37ºC waterbath and allow to dissolve 
Filter (Sartorius minisart-plus) 
Freeze 
 
CFSE stock 
10mM in DMSO 
Stored desiccated at –70°C as 20µL aliquots 
CFSE from Molecular Probes, Eugene, Oregon, USA. Cat: C-1157 
mw 557.47  
5-(and-6)-carboxyfluorescein diacetate, succinimidyl ester *mixed isomers* 
 
Fixation solution for FACS analysis 
PFA  2g 
PBS  100mL 
Heat to not more than 70°C to dissolve 
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Adjust pH to 7.2 with 0.1M HCl or NaOH 
Store protected from light up to 1 month at 4°C 
 
L-Glutamine (200mM solution) 
L-Glutamine   2.922g 
Medium of choice  100mL 
Store frozen 
 
Karnovksy’s fixative for Electron Microscopy 
4% PFA  29.7mL 
PBS   17.8mL 
Glutaraldehyde (50%) 2.5mL 
Mix 
Store 4ºC up to 1 week 
 
Karnovsky’s fixative (EM Unit) 
(2.5% glutaraldehyde, 2.4% formaldehyde in 0.1M MOPS 
Formaldehyde    30mL 
(Polysciences 16% 10mL phials) 
25% Glutaraldehyde   20mL 
1.0M MOPS    20mL 
dH2O to 150mL 
Adjust pH to 7.4 with 1.0M NaOH 
dH2O to 200mL 
 
LPS extraction for P. gingivalis 
Method modified from Westphal, O. & Jann, K. (1965) Bacterial Lipopolysaccharides. 
Extraction with phenol-water and further applications of the procedure. Methods 
Carbohydrate Chemistry 5:83-91 
 
1. For 20g dry weight of bacteria (or equivalent), resuspend in 350mL of dH2O at 65-
68°C (in a water bath). 
2. Add 350mL of 90% phenol solution, preheated to 65-68°C, with vigorous stirring 
for 10-15mins at 65-68°C. 
3. Cool mixture to 10°C on ice. 
4. Centrifuge to separate phases at 8000rpm for 10min (~10000 x g). Remove and keep 
the water phase (normally the upper phase, unless it contains > 0.5M salt). Do not 
disturb the interface. 
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5. Repeat the extraction procedure with the phenol/interface phase using another 
350mL of water at 65-68°C. Keep the water phase after centrifugation. 
6. Dialyse the water phase with dH2O with frequent changes to remove phenol. 
7. May elect to reduce volume using Aquacide etc. before lyophilisation. 
8. Resuspend the pellet in 30mL of buffer (20mM Tris, 2mM MgCl2, 20mM NaCl, 
0.1mM DTT, pH 8). Add pancreatic DNAase I and pancreatic RNase A at 100 
µg/mL and 25 µg/mL, respectively. 
9. Incubate for 2hr. at 37°C. 
10. Add Proteinase K at 100 µg/mL and CaCl2 to 1mM concentration. Incubate for a 
further 2hr at 37°C. Add another 50 µg/mL Proteinase K and incubate for 1 hour. 
[Alternatively, add 1mg/mL of Protease Type XIV (from Streptomyces griseus) and 
500 µg/mL, respectively.] 
11. Remove proteins by adding 10mL of neutral water-saturated phenol, emulsify and 
separate the phases by centrifugation. Keep the aqueous phase. Repeat. 
12. Dialyse against dH20 to remove the phenol and small molecular weight molecules 
post DNase/RNase/protease treatment. 
13. Lyophilise 
 
MOPS 3 (MOPS) Stock 1.0M 
-(N-morpholino) propane sulfonic acid  209.27g 
dH2O  1L 
(add gradually until dissolved) 
NaN3  0.8g 
 
MTT (5mg/mL) 
(3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetralzolium bromide) 
MTT  25mg 
PBS  5mL 
Vortex 
Stand 30min room temperature 
Filter sterilise 
Store 4ºC in foil wrapped bottle 
Absorbance measured at 570nm, background subtraction at 630nm - 690nm 
 
Osmium tetroxide 5% stock 
2 ampoules Osmium (1g each) into PTFE bottle 
Add 40mL dH2O and mix gently 
Leave in fume cupboard for 1 day to dissolve then refrigerate 
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Osmium tetroxide in 2% 0.1M Cacodylate buffer 
5% Osmium tetroxide   4mL  
Sodium cacodylate 1.0M  1.0mL  
Adjust to pH 7.4 with 0.1N HCl 0.62mL 
Add dH2O  up to    10mL  
4% Paraformaldehyde 
PBS (Sterile)   100mL 
Paraformaldehyde (PFA) 4g 
Heat to 70-80ºC shaking gently 
Allow to cool down 
 
Permeabilisation solution for FACS analysis 
Tween 20 200µL (0.22g) 
PBS   100mL   
Store up to 1 month in amber container at 4°C 
Warm to RT before use 
 
Phosphate Buffered Saline (PBS) 
NaCl   8g/L 
KCl   0.2g/L 
KH2PO4  0.2g/L 
NaH2PO4.2H2O 1.15g/L 
Milli Q Water to required volume 
 
PBS/2% FCS/0.1% NaN3 
 
Foetal Calf Serum 2mL 
PBS/NaN3  100mL 
Store 2 - 8ºC for 1 month 
 
PBS/0.1% NaN3 
NaN3  100mg 
PBS  100mL 
Store 2 - 8 ºC for up to 2 months 
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PBS/2% PFA/0.1% NaN3 
Paraformaldehyde 2g 
PBS   100mL 
Heat to 56ºC in a water bath until the PFA goes into solution  
allow to cool to room temperature and adjust pH to 7.4 (0.1M NaOH, 0.1M HCl) 
Add 100mg NaN3 and dissolve 
Store 2 - 8ºC for 1 month 
 
RPMI 1640 
RPMI       1 pack 
2-Mercaptoethanol     3.43µL 
Sodium Bicarbonate (7.5% solution)   27mL 
Penicillin/Streptomycin (5000IU/mL solution) 10mL 
Milli Q water to 1000mL 
Supplement with 10% FCS and L-Glutamine if required (2mL/100mL 200mM stock) 
 
Sodium cacodylate Stock 1M 
Sodium cacodylate 214.03g 
dH2O   1L 
 
Spurr low-viscosity epoxy resin 
Vinylcyclohexene dioxide ERL 4206 (VCD) 50g 
Diglycidyl ether of polyethylene glycol (DER736) 32.5g 
Nonenyl succinic anhydride (NSA)   130g 
Diethyl amino ethanol (DMAE)   2g 
(cure time 8hr) 
Mix thoroughly using mechanical stirrer in fume cupboard 
Dispense into bottles, store in freezer 
 
Variations of Spurr 
Reagent Std Hard Soft Fast cure Slow cure 
VCD 10 10 10 10 10 
DER736 6 4 7 6 6 
NSA 26 26 26 26 26 
DMAE 0.4 0.4 0.4 1.0 0.2 
Cure at 70ºC 8 hr 8 hr 8hr 3 hr 16 hr 
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Trypan Blue Dye 
Trypan Blue (40% Dye Content) 400mg 
PBS     100mL 
Filter sterilise 
Store 2 - 8ºC protected from light 
 
4% aqueous Uranyl acetate 
Uranyl acetate (Fluka) 2g 
dH2O    50mL 
Cover flask with foil and mix until dissolved 
Store 4ºC 
Washing buffer for FACS analysis 
Tween 20  100µL  (0.11g) 
PBS   100mL   
Store up to 1 month at 4°C  
 
Working solution - 0.1M  MOPS (tissue wash) 
1M MOPS stock 100mL 
dH2O   800mL 
pH to 7.4 with NaOH  
Make up to 1L 
 
Working solution - 0.1M (tissue wash) 
Sodium cacodylate 1M 100mL 
dH2O    800mL 
pH to 7.4 with HCl 
Make up to 1L 
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Appendix 2 
Spleens 
 
The method of cell suspension preparation required some preliminary testing. Initially, 
the protocol was as follows; 
1. Mice sacrificed using Halothane, spleens removed and placed into RPMI 
1640 medium, on ice; 
2. Spleens were cut into smaller pieces using a sterile scissors and then 
squashed through a metal mesh, using the butt of a 20mL syringe, into a 
petri dish; 
3. The cell suspension was then layered over 10mL FCS and left to stand for 
10 min at room temperature; 
4. The red upper layer was then removed and layered over 10mL FCS in a new 
tube; 
5. The layered suspension was then centrifuged for 10 min (300g, 4ºC); 
6. The supernatant was decanted and 4mL RPMI 1640 was added to the 
resuspended pellet; 
7. The suspension was then layered over 4mL Ficoll (Pharmacia) in a 15mL 
centrifuge tube; 
8. The layered suspension was then centrifuged for 30 min (400g, 18ºC); 
9. The lymphocyte layer was removed and added to 40mL RPMI in a 50mL 
centrifuge tube; 
10. The cell suspension was centrifuged was then centrifuged for 10 min (300g, 
4ºC), and; 
11. The supernatant was decanted and 10mL RPMI/10% FCS was added to the 
resuspended pellet. 
However, the lymphocyte yields from harvested spleens prepared in this manner were 
highly variable and generally lower than expected (see Figure B.1A and B). 
 
A new preparation method, suggested by Dr WLK Massey (personal communication), 
and the one subsequently used for the experiments shown, with an addition of an 
erythrocyte lysis step, resulted in significantly higher lymphocyte yields from harvested 
spleens (Figure B.1B, C and D – new method used from 14/7/97).   
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The new method was as follows; 
1. Mice were sacrificed using Halothane, spleens removed and placed into RPMI 1640 
medium, on ice; 
2. Spleens were placed in petri dish and mashed using the butt of a 20mL syringe 
3. The cell suspension was suctioned up with a syringe and 18g needle and jetted over 
the petri dish surface a series of times 
4. An autoclaved piece of nylon mesh (200µm pore size) was “tented” into the top of a 
50mL centrifuge tube. The cell suspension and debris were then poured through the 
mesh. 
5. The suspension was washed twice with RPMI 1640/10% FCS 
6. After the final wash the pellet was resuspended in erythrocyte lysing buffer (approx 
5mL/spleen) 
7. The suspension was incubated 5 minutes at room temperature with occasional 
shaking 
8. RPMI was added to fill the tube and the suspension was centrifuged for 10 minutes 
(200g, 4ºC) 
9. The pellet was washed again and resuspended in RPMI 1640/10% FCS 
10.The cell suspension was transferred into a centrifuge tube precoated with FCS and 
underlaid with an equal volume of Histopaque 1083  
11.The layered suspension was centrifuged for 30 minutes (400g, 18ºC) 
12.The buffy layer containing the lymphocytes was removed and added to 40mL RPMI 
1640/10% FCS 
13.The cell suspension was centrifuged for 10 minutes (300g, 4ºC) and the remaining 
pellet resuspended in RPMI 1640/10% FCS prior to seeding 
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Figure A.1 Average lymphocyte yield/spleen 
The average lymphocyte yield per spleen is shown for experiments conducted in 1996 
(A), 1997 (B), 1998 (C) and 1999 (D). (No error bars are shown as the averages were 
calculated by dividing the final total viable lymphocyte count (after preparation) by the 
number of spleens harvested for that experiment.) 
A 
Average: 3.91 x 106 
B 
Average: 2.77 x 107 
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C 
Average: 3.56 x 107 
D 
Average: 2.93 x 107 
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Trial Enrichment of B cells  
It has been reported that the high level of expression of CD23 and IgD on conventional 
B cells, and the absence of these markers on B-1 cells, allows B-1 cells to be selectively 
enriched by magnetic bead separation (Metzger et al., 1992). Accordingly, biotin-
conjugated CD23 and IgD were bound to Strep-Magnaspheres and used to selectively 
enrich B-1 cells from splenic lymphocyte populations (through negative selection to 
reduce any activation of this subset during the enrichment process). However, this 
enrichment process proved problematic (data not shown), with unacceptably low yields 
of cells.  
Therefore, the unenriched, mixed population of splenic lymphocytes (T cells, 
conventional and B-1 B cells) was used as the combination of fluorescently labelled 
monoclonal antibodies used for the flow cytometric analysis allowed the discrimination 
of T cells, conventional B cells (B-2 cells) and B-1 cells in the splenic lymphocyte 
populations without the requirement for prior enrichment. 
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Appendix 3 
Sample plate map 
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The plate mat above is for the B sample set for CD80 (no fill) and CD86 (dark grey 
shading) analysis. Wells A8 and A9 contain the CD80 positive and negative control 
samples respectively whilst wells E8 and E9 contain the positive and negative controls 
for CD86. 
All four cell sample types were included on each plate (one for each of the three 
experimental runs; A, B, and C); 
− WEHI-279 with S. enteritidis LPS (WEHI SE) 
− WEHI-279 with P. gingivalis LPS (WEHI PG) 
− CH12 with S. enteritidis LPS (CH12 SE) 
− CH12 with P. gingivalis LPS (CH12 PG) 
Appendix 5                     192 
 
Appendix 4 
The importance of innate immunity in instructing 
adaptive immune responses 
 
 
All multicellular organisms have defence mechanisms that can be triggered by infection 
to protect the host organism. These defence mechanisms can be divided into the innate 
and adaptive systems. 
Vertebrates are the only organisms that have an adaptive immune system, but the 
contribution of an innate immune system, combined with the resistance to reinfection 
inherent in an adaptive immune system, provides a selective advantage (Parish and 
O'Neill, 1997). Chondrichthyes (sharks, rays, and other cartilaginous fish) are the most 
phylogenetically primitive vertebrates with an adaptive immune system; including 
immunoglobulins (Igs), T cell receptors (TCRs), and MHC class I and II receptors 
(Bartl et al., 1997). The Ig genes in cartilaginous fish are restricted in terms of diversity 
relative to mammalian prototypes (Haire et al., 1997). 
 
The initiation of adaptive immune responses and the induction of particular effector 
function mechanisms appear to depend on the signals provided by the innate system 
(Parish and O'Neill, 1997; Medzhitov and Janeway, 1998). Medzhitov and Janeway 
suggested that the evolution of innate immunity is directed toward recognition of 
invariant molecular constituents of infectious agents. The relatively slow rate of 
evolution and adaptation of the innate immune system receptors would not be a major 
selective disadvantage in this case as the targets of these receptors are also stable. The 
targets of this recognition represent molecular patterns rather than particular structures 
(Medzhitov and Janeway, 1997). The innate immune system uses germ line-encoded 
receptors for the recognition of microbial pathogens, so changes in receptor specificity 
reflecting changes in pathogen structure occur only during meiosis. Many of the 
components of the innate immune system are conserved across classes and even phyla. 
In the fruit fly, Drosophila melanogaster, the protein encoded by the toll gene induces 
the innate anti-fungal immune response. The plant tobacco-mosaic-virus resistance gene 
encodes a protein very similar to Toll and murine and human homologues have also 
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been identified and characterised (Medzhitov et al., 1997; Rock et al., 1998; Yang et al., 
1998; Takeuchi et al., 1999; Takeuchi et al., 1999; Miyake et al., 2000; Ogata et al., 
2000; Rhee and Hwang, 2000; Hayashi et al., 2001; Rassa et al., 2002). It therefore 
appears that the immune-response system mediated by Toll represents an ancient host 
defence mechanism (Medzhitov et al., 1997). 
 
A number of individual Toll-like receptors (TLR) have been identified, and each has a 
distinct specificity for pathogen-derived products. These include flagellin (TLR5) 
(Hayashi et al., 2001), dsRNA (TLR3) (Alexopoulou et al., 2001), lipopeptides (TLR2 
homodimers) (Ozinsky et al., 2000), peptidoglycan (TLR2/6 heterodimers) (Ozinsky et 
al., 2000), unmethylated CpG motifs (TLR9) (Hemmi et al., 2000) and LPS (TLR4) 
(Poltorak et al., 1998; Poltorak et al., 1998). 
 
TLR2 and TLR4 recognise different bacterial cell wall components and TLR2 plays a 
major role in Gram-positive bacterial recognition (Takeuchi et al., 1999). 
Enterobacterial LPS binds to TLR4 and P. gingivalis LPS binds to TLR2 but not TLR4 
(Bainbridge and Darveau, 2001; Hirschfeld et al., 2001) and TLR2 signalling pathways 
appear to be different to those activated by TLR4 (Arbibe et al., 2000). Different TLRs 
as well as different combinations of TLR heterodimers can be used by cells of the 
immune system to differentiate among the large number of pathogen associated 
molecular patterns (PAMP) found on pathogens (Akira et al., 2001).  
 
The activation of TLRs can also lead to tissue injury, including the manifestations of 
septic shock (Poltorak et al., 1998) and the induction of apoptosis (Hoshino et al., 
1999). Bacterial lipoproteins (BLP) induce apoptosis in THP-1 monocytic cells through 
human Toll-like receptor–2(hTLR2). BLPs also initiated apoptosis in an epithelial cell 
line transfected with hTLR2. In addition, BLPs stimulated nuclear factor–kB, a 
transcriptional activator of multiple host defence genes, and activated the respiratory 
burst through hTLR2. Thus, hTLR2 is a molecular link between microbial products, 
apoptosis, and host defence mechanisms and signals for both cell activation and 
apoptosis (Aliprantis et al., 1999).  
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Mammalian Toll-like receptors (TLRs) signal through the adapter protein MyD88 
(Medzhitov et al., 1998; Muzio et al., 1998; Kawai et al., 1999). Human MyD88 
contains an N-terminal death domain, followed by an intermediate domain and a C-
terminal TIR domain. MyD88 is recruited to activated Toll and IL-1Rs through 
homophilic interactions between the TIR domains of the receptor and MyD88 
(Medzhitov et al., 1998; Muzio et al., 1998). The death domain of MyD88, in turn, 
associates with the death domain of the serine threonine protein kinase IL-1R-associated 
kinase (IRAK) (Cao et al., 1996; Muzio et al., 1997; Wesche et al., 1997). Recruitment 
of IRAK leads to its activation and association with another adapter, tumour necrosis 
factor receptor-associated factor (TRAF6) (Cao et al., 1996). Oligomerisation of 
TRAF6 results in activation of IkB kinases, followed by phosphorylation and 
degradation of IkB. On IkB degradation, NF-kB factors translocate into the nucleus, 
where they induce transcription of target genes (Ghosh et al., 1998; Horng and 
Medzhitov, 2001).  
 
Mycobacteria contain well-defined ligands for TLR-2 (Means et al., 1999)and 
prolonged signalling through TLR-2 by the 19-kDa lipoprotein of M. tuberculosis 
blocked IFN-γ activation of human macrophages (Gehring et al., 2003). Signalling 
through TLR-2 has been described to cause apoptosis of human macrophages 
(Aliprantis et al., 1999; Aliprantis et al., 2000). Apoptosis of macrophages in response 
to M. tuberculosis  p19 was found to be caspase-8 dependent and caspase-9 independent 
consistent with a transmembrane pathway signalling cell death through TLR-2 (Lopez 
et al., 2003). 
 
TLR2 was expressed by Schwann cells and the activation of Schwann cells with a 
lipopeptide comprising the functional N-terminal portion of the putative M. leprae 19-
kDa lipoprotein triggered nuclear apoptosis. Schwann cells in leprosy lesions were also 
found to have undergone nuclear apoptosis. These data suggest that the activation of 
TLR2 on Schwann cells contributes to nerve damage in leprosy (Oliveira et al., 2003). 
TLR2-induced apoptosis has been shown to involve a novel pathway requiring myeloid 
differentiation factor 88 and nuclear factor B and involving Fas-associated death 
domain protein and caspase 8 (Aliprantis et al., 2000).  
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Aliprantis has suggested that apoptotic signalling through TLR4 is likely to be 
mechanistically similar to apoptotic signalling mediated by TLR2 (Aliprantis et al., 
2000).  TLR4 activation by LPS has been shown to lead to extensive neuronal death in 
vitro that depends on the presence of microglia (Lehnardt et al., 2003).  
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